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TO THE READERS
OF ACTA PAEDIATRICA HUNGARICA
As editor of the Acta Paediatrica Hungarica it is my job to inform our readers that 
they keep the last issue of our journal in their hands. With this volume the publication of 
our periodical has come to its end.
The predecessor of Acta Paediatrica Hungarica, Paediatrica Danubiana, was edited by 
Professor P. Véghelyi and was published between 1947 and 1949. In 1949, due to the 
cultural policy of the communist regime, publication of the English-language scientific 
journal was prohibited. Only a decade later in I960 when the political climate changed 
could the periodical be started again with the title Acta Paediatrica Hungarica under the 
sponsorship of the Hungarian Academy of Sciences. Professor Véghelyi was appointed 
editor again and worked with enthusiasm until his death in 1986. Thereafter Professor 
M. Miltényi took over as the editor of the journal.
Until the end of the 1980s Acta Paediatrica Hungarica published papers of high 
scientific level submitted by paediatricians working in university paediatric departments 
and in various children’s hospitals. In the majority of the cases the authors were, of 
course, Hungarians, however some 35-40% of the papers came from abroad, e.g. from 
Poland, Germany, Czechoslovakia, Israel, Turkey, USA. Those years our Acta had a high 
international reputation and could be found in the major university libraries of various 
Western European institutions.
In the last 4-5 years, as a consequence of the dramatic changes which have taken place 
also in the health care and scientific life in Hungary, the number of submitted 
manuscripts decreased considerably and occasionally their scientific level, as well. Thus, 
the offer of Springer Verlag to incorporate the Acta Paediatrica Hungarica into the 
European Journal of Pediatrics similarly to Acta Paediatrica Belgica and Helvetica
Akadémiai Kiadó, Budapest
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Paediatrica Acta has been considered and readily accepted by the editorial board. The 
fusion was proposed by Springer Verlag already in 1992 and after 3 years of 
discussions the time for realization has now arrived. Therefore, the editorial board of 
Acta Paediatrica Hungarica is calling all the Hungarian paediatricians to submit their 
papers for publication in the future directly to the European Journal of Pediatrics.
The offer of Springer Verlag includes about 25 copies of the European Journal of 
Pediatrics which will be provided gratis for the Hungarian Paediatric Association.
Last but not least we would like to express our sincere gratitude to our authors and to 
the editorial board of the Acta Paediatrica Hungarica for their activity and cooperation. 
Similarly I owe my thanks to the Division of Medical Sciences and the Publishing House 
of the Hungarian Academy of Sciences for their support in providing an international 
scientific forum to represent the activity of the Hungarian physicians.
Budapest, February 1995
Prof. em. Miklós Miltényi
Editor of Acta Paediatrica Hungarica
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TO THE READERS OF ACTA PAEDIATRICA HUNGARICA
In the name of the editors and editorial board I wish to welcome you to the 
readership of the European Journal of Pediatrics. The fusion of our two journals reflects a 
growing sense of togetherness in Europe. We are proud that the Hungarian Academy of 
Sciences has chosen the European Journal of Pediatrics to carry on the task that the Acta 
Paediatrica Hungarica has fullfilled so well in the past. We will strive to incorporate and 
continue its tradition as we continue to do with the journals of our Belgian and Swiss 
colleagues. In spite of the universality of science, contributions from so many different 
countries with their own needs and styles mirror the cultural diversity of our continent.
By combining forces we will be able to select the best articles from West and East 
and to inform you about advances in the various subspecialties of pediatrics. Scientists 
from Eastern Europe will Find a platform to publish the best of their work and to make it 
known to their colleagues in other parts of the world. Review articles will present the 
state of art in many fields. The section called ‘Pioneers in Pediatrics’ will remind you of 
the great pediatricians of the past. ‘News for practitioners’ summarizes data from other 
journals that we think may assist pediatricians in their daily routine. We will be delighted 
to publish letters dealing with previous articles, raising questions or offering criticism. 
This section is also a forum to present preliminary data and we encourage you to actively 
participate in its formation and to add to its livelihood. Let us have your criticism and 
your suggestions to produce an even better journal. A journal not only lives for its 
readers but also through them.
The European Journal of Pediatrics looks forward to serving you.
J. Spranger 
Coordinating Editor 
European Journal of Pediatrics
Akadémiai Kiadó, Budapest

Acta Pacdialrica Hungarica 34(1-4), pp. 13-17(1994)
BONE ANOMALIES IN LEUKAEMIC CHILDREN AND IN THEIR PARENTS
AND SIBLINGS
J. WEISENBACH, L. SZIJJÁRTÓ, K. MÉHES 
Department of Pediatrics University Medical School, Pécs, Hungary
Received 17 January 1994
Earlier studies suggested an increased prevalence in leukaemic children. 
Family investigations in this field have not been performed so far. In the 
present survey the prevalence of bone anomalies and variants of the hand 
and lower arm was determined in 35 children with acute lymphoblastic 
leukaemia, in their 30 fathers, 33 mothers and 39 siblings. 
Roentgenograms of 403 children and 237 adults examined for trauma 
served as controls. As compared to the controls, a significantly increased 
prevalence of bone anomalies was found in both leukaemic children and 
their first degree relatives.
INTRODUCTION
The relationship between childhood malignancy and malformations with special 
reference to minor morphological aberrations has often been investigated /1, 4, 5, 7, 10/. 
An association of leukaemia and tumours with mild anomalies of leukaemia and tumours 
with mild anomalies of the skeleton has also been shown /2, 3, 9, 12/. Since extreme 
variants and mild malformations of the bones may occur as harmless familial features, 
only family investigations could determine how far their appearance is related to 
malignancy in the affected children. To our knowledge no such survey has been 
published so far. This is why we reviewed hand and lower arm roentgenographs of 
children with acute lymphoblastic leukaemia (ALL) and of their first degree relatives.
Akadémiai Kiadó, Budapest
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SUBJECTS AND METHODS
X-ray pictures of the left lower arm, wrist and hand used for bone age determination of 
35 ALL-patients (17 boys) were reviewed for morphological anomalies. The mean age of 
the patients was 17.6 year (range 2-16 years).
With permission of the local ethical committee, on voluntary basis with written 
content, a roentgenogram of the left lower arm and hand was taken from 102 first degree 
relatives of the patients. Thus the films of 39 siblings (21 boys; mean age 12.2 years), 30 
fathers (mean age 39.5 years) and 33 mothers (mean age 35.4 years) were analysed.
For comparison roentgenograms of 403 children (mean age 11.2 years) and 237 adults 
examined for trauma were reviewed.
For statistical evaluation the chi-square test was used.
RESULTS
The prevalence of the bone anomalies observed is demonstrated in the Table. As shown 
by the figures, the frequencies of mild aberrations were 2.7 and 2.9% in the control 
groups, whereas 22.8% of the patients and 12.8 to 69.6% of their family members had at 
least one anomaly. The differences between controls and any other groups are statistically 
significant.
The majority of the subjects had a single anomaly, only one mother had two mild 
aberrations. Familial anomalies were found only in two cases, these were excluded from 
the evaluation. No association of ALL with specific anomalies was observed.
DISCUSSION
Gefferth /2/ was the first to call attention to an increased prevalence of mild anomalies 
of bones in children with ALL. Similar results were obtained in recent surveys /9, 12/ 
which also failed to demonstrate specific associations between individual skeletal 
anomalies and ALL. The present findings are in accordance with these observations.
To our knowledge this is the first study in which family investigations are reported. 
The results suggest significantly higher than normal prevalence of bone anomalies of the 
lower arm and hand in both the siblings and parents of children with ALL. The anomalies
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TABLE I
Anomalies observed on roentgenograms of the left hand and lower arm in children with 
ALL, in their parents and sibs and in control subjects
ALL
patients
N=35
Sibs
N=39
Control
children
N=403
Fathers
N=30
Mothers
N=33
Control
adults
N=237
Narrow bone 
cavity 1 0 1 1 3 1
Short bone 0 0 0 1 1 0
Persisting
epiphysis 0 0 0 8 10 4
Bone cysts l a 0 l a 0 0 1 2 0
Intraosseal
calcification 1 0 0 2 1 2
Pseudo­
epiphysis 1 2 1 0 0 0
Twisted radius 
and/or ulna 2 la 3 9 l a 4 3 0
Metacarpal or
phalangeal
deformities
2 0 0 2 4 0
Total
anomalies 7 5 11 19 24 7
Anomaly/
subject 0.20 0.13 0.03 0.63 0.73 0.03
Total number 
of positive 
subjects (per 
centi
7
(22.8)b
5
(12.8)b
11
(2.7%)
19
(57.6%)c
23
(69.6%)
7
(2.9%)
a familial cases, not included in the evaluation 
b p < 0.01 against controls
c p < 0.001 against controls
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proved to be familial in only two cases that were not included in the final evaluation. The 
majority of extreme variants and mild malformations observed in the patients differed 
from those of their siblings and parents. This suggests a tendency to non specific mild 
congenital skeletal anomalies in families with childhood ALL. A similar phenomenon 
was observed when examining so-called informative morphogenetic variants /8/ in the 
families of ALL-patients. However, the increased prevalence of these minor 
morphological aberrations was found in the patients and in their siblings but not in the 
parents that may suggest a possible recessive association of ALL with minor errors of 
morphogenesis in general /7, 11/.
Irrespective of inheritance and of limitations of the small series examined, the existence 
of such an association seems to be probable from different approaches. For lack of more 
convincing evidence, the increased prevalence of mild morphological anomalies should 
not be regarded as a sign of predisposition for leukaemia, but the findings so far cannot 
be ignored.
In addition to morphological anomalies of the body surface and bones, correlations 
between ALL and other factors such as greater than normal height /6/ and high social 
class have also been shown. Multivariance analysis of such factors, cytogenetic and 
immunologic marker characteristics might contribute to the research of predisposition 
and genetics of ALL. Therefore we think that further family investigations are warranted.
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THE FINAL DATA BASE OF CONGENITAL ABNORMALITIES IN THE 
HUNGARIAN RANDOMISED CONTROLLED TRIAL OF 
PERICONCEPTIONAL MULTIVITAMIN SUPPLEMENTATION
A.E. CZEIZEL
Department of Human Genetics and Teratology, National Institute of Hygiene - WHO 
Collaborating Centre for the Community Control of Hereditary Diseases, Budapest,
Hungary
Received 30 May 1994
The final data base of congenital abnormalities in the Hungarian 
randomised controlled trial of periconceptional multivitamin (including
0.8 mg of folic acid) supplementation is presented here. Of 5453 
pregnancies with known outcome, 4862 informative offspring were 
evaluated. The total rate of all congenital abnormalities was 5.91% 
(182/2391) in the multivitamin group and 7.61% (182/2391) in the 
placebo-like trace element group. After the exclusion of 6 cases with 
neural-tube defect, the difference has remained significant (p=0.04) 
and the relative risk was 0.80 (0.65, 0.99). This protective effect was 
explained mainly by the lower rate of cases with congenital 
cardiovascular malformations, the defects of the urinary system and 
congenital hypertrophic pyloric stenosis.
INTRODUCTION
Intervention studies indicate that periconceptional supplementation with a 
multivitamin including the physiological dose of folic acid reduce both the 
occurrence /8/ and recurrence /18, 19/ of neural-tube defects (NTD) while the 
pharmacological dose of folic acid alone /14, 15/ reduces the recurrence of NTD. The 
preliminary results of the Hungarian randomised controlled trial demonstrated a 
significant reduction of other major congenital abnormalities (CAs) by 
periconceptional multivitamin (including 0.8 mg of folic acid) supplementation /4/. 
This primary preventive method has great public health significance as a better 
alternative to prenatal diagnosis and selective abortion. In addition to the lessening of 
human suffering, the practical relevance includes the decrease in medical costs.
Akadémiai Kiadó, Budapest
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The Hungarian randomised controlled trial was appropriate to study the effect of 
periconceptional multivitamin supplementation on CAs other than NTD. A previous 
report showed a protective effect of multivitamins on the recurrence of cleft lip /20/. 
In addition we were interested in the other schisis-type on nonneural midline CAs,
i.e., CAs of abdominal wall and diaphragmatic defects because they prefer to 
associate with NTD, oral clefts and each other /2/. However, our purpose was to 
evaluate all kinds of CA-types or groups /7/. This paper summarizes the final data 
base of CAs and some results of its analysis.
METHOD
The Hungarian randomised controlled trial of periconceptional multivitamin 
supplementation was part of the Hungarian Optimal Family Planning Programme 
(HOFPP) which was established on February 1, 1984. The HOFPP involves three 
main steps performed or supervised by qualified nurses: (I) a check of reproductive 
health /7/, (ii) a three month preparation for conception including multivitamin 
supplementation and (iii) protection of early pregnancy /3/. Couples who satisfy the 
following criteria are eligible for participation in the HOFPP: no delayed conception 
or infertility (i.e., no conception after more than 12 months of sexual activity without 
contraception); not currently pregnant; voluntary participation. In the First four years 
of the HOFPP, there were two other criteria: age under 35 in females (older women 
were referred to the genetic counselling clinic) and no previous wanted pregnancy 
(induced abortion was not a reason for exclusion).
At the first visit eligible females were informed about the purpose of 
multivitamin supplementation; and about the 'blind' use of one of two kinds of 
tablets, i.e., asked about whether they agree to their allocation on the basis of a 
randomisation table. After this, the women were asked to sign a written informed 
consent and to stop any intake of other vitamins. The participants were advised to 
take a single tablet of either the “multivitamin”: ELEVIT pronatal® (Roche), 
composed of 12 vitamins (vitamin A 6000 IU until the end of 1989 and 4000 IU in 
1990-1992, B1 1.6 mg, B2 1.8 mg, nicotinamide 19.0 mg, B6 2.6 mg, calcium 
pantothenate 10 mg, biotin 0.2 mg, В12 4.0 pg, C 100.0 mg, D 500.0 IU, E 15.0 mg, 
folic acid 0.8 mg), four minerals (calcium 125 mg, phosphorous 125 mg, magnesium 
100 mg, iron 6.0 mg), and three trace elements (copper 1 mg, manganese 1 mg, and 
zinc 7.5 mg) or the placebo-like “trace element” (copper 1 mg, manganese 1 mg, zinc 
7.5 mg, and vitamin C 7.5 mg) each day for one month before planned conception.
At the second visit women were supplied with supplements for a further three 
months and were asked to attempt to conceive and to visit us again immediately after 
the first missed menstrual period. If the participant did not conceive within three 
months, tablets for the next three months were supplied a month at a time. The 
purpose of the third visit was the confirmation of pregnancy by a sensitive serum 
pregnancy test after the first missed menstrual period. Pregnancy was also confirmed
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by ultrasonography within two weeks. Further tablets were supplied until the 12th 
week of gestation. The fourth visit was a 'farewell' meeting at the 12th week of 
pregnancy because after this pregnant women were referred to other clinics for 
routine prenatal care.
The compliance with the regimen of supplementation was verified (i) verbally in 
discussion with the women, (ii) by evaluating the check marks of the form for the 
basal body temperature measurement and (iii) by counting unused tablets when boxes 
were returned. Women who received a full course of the supplement were defined as 
those who took the supplement for 28 days before conception and at least until the 
date of the second missed menstrual period. Women who did not take the supplement 
on any one day during the pre- and/or postconceptional periods were also classified as 
having received a full course. Women who received a partial course of the 
supplement were defined as those who failed for more than one day to take the 
supplement during the pre- and/or postconceptional periods (in general, these women 
failed to take the supplement for only a few days). Women who conceived before or 
during the first month of administration were considered not to have received a 
supplement.
After the end of the pregnancy we were sent the completed certificate for each of 
the participants which included, among others, the data and type of pregnancy 
outcome and any CAs of the offspring, i.e., fetuses or infants. The certificate was 
filled in by the mothers and confirmed (consigned) by their physician. In Hungary all 
deliveries and terminations of pregnancies take place in obstetrical inpatient clinics. 
Considerable effort was undertaken to assure that pregnancy outcomes of all women 
with a confirmed pregnancy were evaluated. If the completed certificate was not 
received by one month after the expected date of delivery, a letter was mailed to 
women asking them to send the completed certificate and/or discharge summary. If 
there was no response, one of our coworkers visited them home. Only after such 
efforts were the lack of contact considered as a “dropout” from the study.
Informative offspring with known outcomes (prenatally diagnosed fetuses with 
CA which were terminated in the second or third trimesters, stillborn fetuses and 
liveborn infants) were evaluated with particular attention to the occurrence and 
correct diagnosis or description of CAs. After the report of a case as having CA, as 
much clinical and pathological information as possible was obtained including any 
prenatal ultrasonography films, a detailed physician's description (discharge 
summary, a written report from the examining physician, etc.) and autopsy records in 
lethal cases. The data concerning CAs were evaluated by an independent Data 
Monitoring Group every six month. In addition infants were given a physical 
examination after the eighth month of life (the average examination was in the 11th 
month /4/) after a mail or telephone invitation to our Family Planning Centre. After 
review of medical documents concerning previously diagnosed CAs and diseases, 
treatments and operations, the examination included, among other things, a paediatric 
evaluation performed 'blind' by two paediatricians. If families did not fulfill our 
request, they were reinvited. If there was still no response, we contacted the infant's 
paediatrician and the medical history, particularly data concerning CAs, diagnosed 
after birth, were obtained.
Two-tailed chi-square and Fisher exact tests were used for statistical evaluation.
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RESULTS
The randomisation of multivitamin/trace element supplementation was stopped 
on April 30, 1992, while the evaluation of pregnancy outcomes was closed on April 
30, 1993. The data on CAs including the postnatal flow-up were evaluated until the 
end of 1993. Of 5502 participants with confirmed pregnancies, pregnancy outcomes 
were ascertained in 5453 cases (dropout 0.9%). The numbers of women given full, 
partial, and no supplements were not significantly different between multivitamin and 
trace element groups (x^= 3.96; p=0.14). Demographic factors were similar in the 
two groups.
The number of informative offspring in the intention-to-treat analysis was 2471 
in the multivitamin group and 2391 in the trace element group. In the follow-up study 
3692 (81.7%) infants were examined directly by the investigators and the data from 
413 (8.5%) were obtained from their paediatricians, thus 4375 infants (90.2%) were 
evaluated. There was no significant difference in the number of the above subgroups 
between the multivitamin (m=2222) and trace-element groups (n=2153).
In general CAs are divided into three groups according to severities: lethal, 
severe (which together constitute major) and mild /9/. However, the differential- 
diagnosis between severe and mild groups sometimes is not consistent and may be 
subjective. In addition CAs were separated into two main categories: isolated and 
multiple (two or more different CAs in the same person) /11/.
The total rate of CAs was 5.91% (146/2471) in the multivitamin group and 
7.61 % (182/2391) in the trace element group (Table I). The difference is significant 
(Xj^S.óO;  p=0.018). After the exclusion of 6 cases with NTD, the difference is also 
significant (x-^4-15; p=0.042) relative risk is 0.80 (0.65, 0.99).
Some CA groups merit a more detailed discussion and it is the purpose of this 
papier.
There was one CA-group: NTDs related to the main hypothesis that the trial was 
designed to test. There were six cases of NTD in the group receiving the trace 
element supplement compared with none in the multivitamin group (Table II). The 
difference in the occurrence of NTD was highly significant (x^=6.21; p>=0.01) 
between the study groups. None of the mothers with NTD pregnancy had taken 
valproic acid or other known teratogens, nor did they have a family history of NTD 
(Figures 1-6). The expected numbers of different NTD types were calculated on the 
basis of Hungarian data /10/. Two observed offspring with anencephaly and 
rachischisis (i.e., spina bifida) seem to be unexpiectedly high (expected figure is 0.5),
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Placebo I 433
07. 02. 1985
Capsule use; fully supplemented;
( no omission )
О
о
1960
I • Ultrasound:
anencephalus 
( 16th week )
Selective TOP 
27. 06 1986
1987 
Dávid 
3800 g
О
1989 
Anita 
3100 g
Clinical diagnosis: anencephalus 
Autopsy record : anencephalus with spina bifida 
( lumbal region ), dextrocardia, 
embryonic -  like chorion, fibrosis of 
placenta
Final diagnosis: anencephalia with 
spina bifida
Figure 1 : Family and pregnancy history of case 433
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Placebo I
Capsule use: fully supplemented
(no omission )
2122
13. 02.1986
38th week 38 th week 
Frequent 
infectious 
d iseases  
due to low 
level of IgA
40 th week 40th week
Spina bifida aperta (Th4-L2)with  
hydrocephalus and rib abnormalities 
No surgery
Ф 01. 06.1987 : cardial insufficiency 
Clinical diagnosis : Spina bifida with 
hydrocephalus and with 
club feet
Autopsy record: spina bifida aperta 
(thoracolumbal ); Arnold-Chiari, 
hydrocephalus internus, micogyria; 
synchondrosis of ribs IV-V, left 
and aplasia of arcus costae, III- 
VI, right; pyelectasia and hydro­
ureter, Material 
Final diagnosis: spina bifida 
cystica
Figure 2: Family and pregnancy history of case 2122
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Placebo III 2374
11.12. 1990
Capsule use: no supplemented.
She conceived about 14.12.90. She w as supplied with 
capsules on 11.12.90, she had to start the use of 
capsules on about March. After the recognition, she w as 
not supplied further capsules.
1964
M = 14yr 
5 -6 /30
LMP:02.12.90 
Pregnancy history; 
flu (II. month) ♦ 
Semicillin treatment 
MS-AFP= negative I 
(16ug/ml, 16—17th week) 
Ultrasound = anencephalus 
(19th week) i
S  N 
V* !
Pregnant (1992)
Selective TOP,- 04.05.1991 
20th week, 220g 
Clinical diagnosis: anencephalus 
Fetal autopsy record : anencephalus, 
spina bifida aperta with 
meningo-myelocele (thoracal region)
Final diagnosis: anencephalus with 
spina bifida cystica
Figure 3: Family and pregnancy history of case 2374
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P lacebo  I 2918
21. 08.1986
Capsule use: fully supplemented.
One day om ission before conception, no omission after 
conception.
Clinical diagnosis : anencephalus 
Fetal autopsy record: anencephalus with 
eventration and embryonic chorion 
structure with chorionic fibrosis. 
However, the abdominal wall lesion 
was considered to be the consequence 
of autolytic process in the fetus
Final diagnosis: anencephalus
Figure 4: Family and pregnancy history of case 2918
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Placebo II 3963
12. 12. 1987
Capsule use: Partially supplemented
No omission within 10 months, after one year of participation 
she was supplied with capsules and she used them. 
However, it was not cheked, AIH was launched, the third one 
was successful.
Clinical diagnosis: Spina biftda 
cystica  
(lumbosacral )
Opus: 2U. 08. 1990
Final diagnosis: Spina bifida 
cystica
Figure 5: Family and pregnancy history of case 3963
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Placebo I 5331
07. 03. 1989
Capsule use: fully supplemented.
One day omission before conception and one or two days 
after conception, but after the 8th week of gestation.
>
□
Stroke
О
Coronary 
heart disease
О
1965
1989
M = 13yr ( 
4/31 35 N
1965
Anovulation
VI-VII. 
month
LMP= 07. 08. 1989
Pregnancy history: threatened abortion 
(Norcolut, Microfollin)
^ у Ultrasound: anencephalus with polyhyd­
ramnios (18th week)
Selective TOP 05. 01. 1990
Clinical diagnosis : anencephalus 
Autopsy record: anencephalus, but it is 
difficult to identify details in 
disintegrated fetus and placenta
Final diagnosis : anencephalus
Figure 6: Family and pregnancy history of case 5331
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while the expected number of spina bifida was 4 instead of the observed 2, but these 
differences might be caused by chance.
TABLE I
The data base of congenital abnormality (CA) groups/types in full course (I), partial 
course (II), no supplementation (III) and total (T) material in the multivitamin and trace
element groups
CA types/groups
Isolated__ __________
Neural-tube defect 
Microcephalus 
Hydrocephalus 
Other CA of nervous 
system (cerebellar 
agenesis, porencephalic 
cyst in brain)
CAs of eye
(buphthalmos, coloboma) 
Cardiovascular CAs 
CAs of respiratory system 
(tracheal stenosis, 
bronchial stenosis)
Cleft palate 
Cleft lipt palate 
Cong, hypertrophic 
pyloric stenosis 
Other CAs of digestive 
system (colon malformation 
due to mesenterium 
commune, anal atresia) 
Undescended testis 
Hypospadias 
Renal agenesis 
Obstructive CAs of 
urinary system 
Other CAs of urinary 
system (cystic 
kidney II, dystopia 
renis, exstrophia vesicae)
Multivitamin 
I П Ш T
о о о 0 " 
1 0  0 1 
0 0 0 0 
1 0  0 1
2 4 0 6 
5 1 0  6 
0 0 0 0 
1 0  0 1
1 0  0 1
Trace element 
I II Ш T 
4 1 1 6 
1 0  0 1 
1 0  1 2  
1 0  0 1
2 0 0 2 1 0 0 1
9 1 0 10 14 4 2 20
2 0 0 2 0 0 0 0
0 0 0 0 0 1 1 2
3 1 0 4 1 2 0 3
2 0 0 2 6 1 1 8
1 0 0 1 1 0 0 1
2 0 10 
1 0 6 
2 0 2 
0 0 4
2 0 0 2
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TABLE I Cont.
CA types/groups Multivitamin Trace element
Isolated I П П1 T I II Ш T
Torticollis 0 0 0 0 l 1 0 2
Cong, dislocation of hip 28 9 3 40 19 4 3 26
Deformities of feet 10 2 0 12 14 1 0 15
Reduction CA of limb 1 0 0 *1 4 1 0 5
Arthrogryposis 0 0 0 0 1 0 1 2
Pectus excavatum 3 0 0 3 0 0 0 0
Foramina parietale permagna 0 0 0 0 2 0 0 2
CAs of abdominal wall 
(gastroschisis, omphalocele)
1 0 0 1 0 1 0 1
Faciocranial hemangioma or 
portwine stain
2 1 0 3 3 0 0 3
Cong, inguinal hernia 22 9 0 31 22 7 0 29
Other CAs (non-immun- 
hydrops, polydactyly in foot, 
syndactyly in foot, dermoid 
cyst, hymen imperforatus, 
craniosynostosis)
Multiple
0 0 0 0 6 0 0 6
Down syndrome 2 0 0 2 3 1 1 5
Other chromosome 
CA-syndrome (Turner)
0 0 0 0 1 0 0 1
Monogenic CA-syndromes 
(Allagille, collodium)
1 1 0 2 0 0 0 0
Cong, postural deformity 
association
2 2 0 4 6 0 0 6
GAM (genital anomalies 
of male)
2 1 0 3 3 1 0 4
Unidentified multiple CAs 5 1 1 7 4 1 1 6
Total 109 33 4 146 138 32 12 132
TABLEП
Data of offspring with neural-tube defect (NTD) in the trace element (ТЕ) group
Entry
Year
Birth
NTD Associated
defects
Outcome Sex Supplement
1985 1986 Anencephalus with 
lumbal rachischisis
Dextrocardia TOP girl TE-I
1986 1987 Thoracolumbal 
(Th4-L2) spina 
bifida cystica
Amold-Chiari, 
hydrocephalus 
rib defects, 
bilat. pyelectasia 
and hydroureter, 
bilat. clubfeet
Livebirth 
(infant death)
girl TE-I
1986 1987 Anencephalus Eventration of 
abdominal wall
TOP girl TE-I
1987 1990 Sacral spina bifida 
cystica (4 cm)
Hydrocephaly, 
spontaneous 
recovery (strabismus)
Livebirth boy ТЕ-П
1989 1990 Anencephalus TOP girl TE-I
1990 1991 Anencephalus with 
thoracal rachischisis
- TOP girl ТЕ-Ш
TOP = termination of pregnancy 
F = female 
M = male
TR I = lull supplementation 
TR П = partial supplementation 
TR Ш = no supplementation
D
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TABLEШ U)S)
Data of livebom cases with oral cleft in the multivitamin (MV) and trace element (ТЕ) group
Birth year Oral cleft Comments Sex Birth weight 
(8)
Gestation age 
(wk)
Supplement
1985 Left cleft lip Closed spontaneously boy 3150 40 ТЕ-П
1985 Bilateral cleft lips 
with cleft palate
- boy 3200 40 ТЕ-П
1986 Right cleft lip Epicanthal fold in 
the infant
boy 2450 37 MV-I
1986 Right cleft lip with 
cleft palate
Father is affected 
with cleft lip with 
cleft palate
boy 3800 40 TE-I
1987 Bilateral cleft lips 
with cleft palate
- boy 3000 39 MV-I
1988 Right cleft lip with 
cleft palate
- boy 4000 41 MV-I
1988 Bilateral cleft lips 
with cleft palate
Epileptic mother 
without anticonvul­
sant treatment 
during pregnancy
girl 2950 40 MV-n
1987 Cleft palate - girl 3250 40 ТЕ-Ш
1990 Cleft palate - g>rl___ 3200 41 ТЕ-II
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TABLE IV
The data base of cases with congenital cardiovascular malformation (CCM) in the multivitamin (MV) and trace element (ТЕ) groups
Group Birth CCM Diagnosis Outcome Sex Birth Gestation Supple- Family history
year time method weight age (wk) ment
(g)
Multivitamin 1986 Left heart hypoplasia At birth Autopsy LB girl 3000 39 MV-I Situs inversus
(ID) with dextrocar­
dia in mother
1987 Ventricular septal 
defect* (small)
Follow-up Cardiol LB girl 3700 40 MV-I -
1988 Double onset of 
pulmonary
artery with pseudovalvcs 
and stenosis
At birth Autopsy SB boy 2700 42 MV-I
1988 Stenosis of aortic valve Follow-up Cardiol LB boy 4000 39 MV-Д -
1989 Pulmonary' stenosis 
(min. grad.)
Follow-up Cardiol LB girl 2300 38 MV-I -
1990 Atrial septal defect, At birth Surgery LB girl 2800 39 MV-I Aortic stenosis
type П in mother
1990 Atrial septal defect, 
type П
At birth Surgery LB boy 3900 38 MV-I -
1991 Atrial septal defect, type I, 
ventricular septal defect
At birth Autopsy SB boy 2250 34 MV-I -
1991 Ventricular septal defect Follow-up Cardiol LB boy 3350 36 MV-I -
1989 Stenosis of aortic valve At birth Cardiol LB girl 2950 39 MV-I -
' Closed spontaneously
** It was confirmed by the cardiological institute but the family moved to an unknown address later. 
LB = Livebirth; SB = Stillbirth; ГО = Infant death
D
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TABLE IV Cont.
Group Birth
year
CCM Diagnosis 
time method
Outcome Sex Birth
wight
(ft)
Gestation 
age (wk)
Supple­
ment
Family history
Trace- 1987 Left heart hypoplasia At birth Autopsy LB girl 2350 40 ТЕ-Ш -
element
1986
(aortic atresia, hypoplastic 
mitral valves)
Tetralogy of Fallot At birth Surgery
(Ю)
LB boy 4100 40 TE-I
1986 Ventricular septal defect* At birth Cardiol LB girl 2950 38 TE-I -
1987 Aortic stenosis At birth Cardiol LB girl 3100 39 TE-I -
1987 Ventricular septal defect Follow-up Cardiol LB boy 3150 39 ТЕ-П WPW syndrom
1987
(moderate) 
Unspecified CCM** Follow-up Cardiol LB girl 2500 37 TE-I
in mother
1987 Ventricular septal defect Follow-up Cardiol LB boy 3950 41 TE-I -
1988
(small)
Atrial septal defect, Follow-up Surgery LB girl 3250 39 TE-I Mitral prolap- •
1987
type П
Ventricular septal defect Follow-up Surgery LB boy 3650 40 ТЕ-Ш
sus syndrome 
ill mother
1989 Transposition of great At birth Autopsy LB boy 3300 40 TE-I -
1989
vessels
Aortic stenosis Follow-up Cardiol
(ID)
LB boy 3050 41 TE-I
1989 Atrial septal defect, At birth Surgery LB boy 3150 38 TE-I -
1989
type II
Patent ductus arteriosus Follow-up Suregery LB girl 3000 40 TE-I
1990 Ventricular septal defect* At birth Cardiol LB boy 3610 40 TE-I -
1990 Ventricular septal defect Follow-up Cardiol LB girl 3100 40 TE-I -
1990 Aortic stenosis Follow-up Cardiol LB boy 3950 41 ТЕ-П -
1990 Left heart hypoplasia At birth Autopsy LB boy 2300 35 TE-I -
1990 Atrial septal defect, Follow-up Surgery
(ID)
LB boy 3550 39 TE-I _
1991
type П
Ventricular septal defect* At birth Cardiol LB girl 3230 40 ТЕ-П
1991 Ventricular septal defect At birth Cardiol LB boy 2600 37 ТЕ-П -
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TABLEV
Data of cases with defect of urinary system m the multivitamin (MV) and trace element (ТЕ) groups
Birth year Urinary defects Time of 
diagnosis
Outcome Sex Birth weight
(g)
Gestation age 
(week)
Supplement
1985 Right renal agenesis 
Left ectopic kidney
Follow-up LB Girl 3050 39 ТЕ-П
1986 Left stenosis of 
pyeloureteral junction, 
pyelectasia - caly- 
cestasia, ren duplex
At birth LB Boy 3050 41 TE-I
1986 Hydronephrosis (poly­
cystic kidney type IV) 
Potter sequence)
Prenatal FD Girl 19 TE-I
1987 Left ureter stenosis 
with pyelectasia
Follow-up LB Girl 3800 40 TE-I
1987 Urethral atresia with 
bilateral hydronephro­
sis
Hydronephrosis*
Prenatal FD Boy
'
19 MV-I
1987 Prenatal FD Girl _ 22 TE-I
1988 Bilateral renal
agenesis (Potter 
sequence)
Prenatal FD Girl 23 ТЕ-П
1988 Dystopia renis 
(hospitalised)
Follow-up LB Boy 3400 40 TE-I
1990 Exstrophia vesicae 
urinariae
At birth LB Boy 3300 40 TE-I
1991 Left cystic kidney, 
type П.
At birth LB Girl 4870 40 MV-I
FD = fetal diagnosis * Clinical diagnosis was false hydrocephalus 
LB = live birth
D
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ЫOn
Data of infants with congenital hypertrophic pyloric stenosis in the multivitamin (MV) and trace element (ТЕ) groups
Birth year Sex Birth weight 
(g)
Gestation age 
(week)
Day of surgery Other defects and 
family history
Supplement
1986 boy 3150 41 28 - TE-I
1988 girl 3000 41 No surgery, 
(hospitalisation 
in two occasions)
Alopecia loc. TE-I
1987 boy 3550 39 58 Pectus excavatum in 
father
TE-I
1987 boy 3400 41 29 Cong, dislocation of 
hip and inguinal 
hernia in father
TE-I
1987 boy 2900 31 15 Twin A is healthy ТЕ-Ш
1990 girl 3650 40 94 - TE-I
1991 boy 3350 38 67 - MV-I
1992 boy 3850 39 64 Cong, dislocation of 
hip in mother
TE-I
1992 boy 3200 41 21 - MV-I
1991 girl 3000 41 28 Right choanal stenosis 
was diagnosed, 
however,
it had a spontaneous 
recovery
ТЕ-П
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table vn
DATA of cases with congenital limb deficiency in the multivitamin (MV) and trace element (ТЕ) groups
Birth year Outcome Sex Birth weight 
(g)
Gestation age 
(week)
Congenital limb deficiency Supplement
1986 LB boy 3350 40 Femur-fibula-ulna complex, atypical 
(left femoral hypoplasia and missing 
of left fibula)
ТЕ-П
1986 LB girl 3700 41 Terminal transverse (left achena 
with finger buds)
TE-I
1987 LB boy 2100 36 Femur-fibula-ulna complex (missing 
of rV-V fingers in left hand, left 
femoral hypoplasia)
TE-I
1988 LB boy 3350 40 Terminal transverse (left adactylcy I-V) MV-I
1990 LB
(ID)
girl 1300 37 Split hand/foot (severe hypoplasia of 
right III finger, adactyly of right 
lii-IV toes, syndactyly of left Ш-ГУ 
toes)
TE-I
1990 LB boy 4000 42 Terminal transverse (lack of two-thirds 
of left forearm)
TE-I
LB = livebirth 
Ш = infant death
OJ^4
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TABLE УШ
Data of livebom infants weith Down syndrome
Birth year Birth weight
(g)
Gestation 
age (week)
Maternal 
age (yr)
Karyotype Supplement Comments
1987 2850 38 25 47,XY,21+ TE-I Maternal smoking
1987 3100 38 28 47,XY,21+ TE-I -
1988 3150 39 27 47,XX,21+ MV-I Large congenital 
hemangioma in 
lumbosacral region
1988 2630 39 34 47,XX,21+ TE-I -
1991 2850 41 21 47,XX,21+ ТЕ-П Atrial septal defect 
type I (other CAs, 
pregnancy history)
1990 2650 40 25 47,XX,21+ MV-I Condyloma in mother
1989 3200 38 22 47,XX,21+ TE-I -
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TABLE IX
Data of offspring with unidentified multiple congenital abnormality in the multivitamin (MV) and trace element (ТЕ) groups
Birth year Outcome Sex Birth 
wight (g)
Gestation 
age (wk)
Component defects Group Time of 
diagnosis
Comment
1985 LB boy 2550 36 Hydrocephalus, atrial septal 
defect type П, bilateral 
cong. inguinal hernias, minor 
anomalies (e.g., lowset ears), 
somatic retardation (46,XY)
TE-I At birth
1986 LB boy 3300 39 Left bronchial stenosis, 
pectus excavatum
ТЕ-П Follow-up Sequence (?)
1987 LB
(ID)
gjrl 920 28 Cleft palate, micrognathia 
(Robin sequence), absence of 
nbs
MV-Ш At birth 
(autopsy)
1987 LB boy 2100 39 Malrotation of right kidney, 
right cong. inguinal hernia, 
right undescended testis
MV-I Follow-up Congenita] postural 
deformity association
1987 LB boy 4040 40 Obstructive defect of urinary 
system (urethral stenosis), 
undescended testes
MV-n Follow-up
1987 SB girl 1200 36 Bilateral cleft lips with 
cleft palate, spmabifida 
occulta, bilateral pos 
equinovarus
MV-I At birth 
(autopsy)
Schisis association 18
U>NO
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TABLE IX Cont.
aO
Birth year Outcome Sex Birth 
weight (g)
Gestation 
age (wk)
Component defects Group Time of 
diagnosis
Comment
1988 FD
(Ш)
boy 1550 34 Esophageal atresia, annular 
pancreas with duodenal 
atresia, anal atresia
MV-I Prenatal Multiple intestinal 
atresia of autosomal 
recessive origin
1989 SB ? 1990 35 Hermaphroditism, bilateral 
clubfeet, minor anomalies, 
e.g., hypertelorism
TE-I At birth 
(autopsy)
No chromosomal 
analysis
1990 LB girl 4400 40 Syndactyly complete, preauri- 
cular tag, cong. dislocation 
of hips
TE-I At birth
1991 LB girl 3100 40 Dermoid cyst, left cong. 
inguinal hernia
TE-I Follow up
'
1991 LB
(ID)
boy 770 30 Ventricular septal defect, 
congenital inguinal hernias
MV-I Follow-up
(autopsy)
Richard, the III 
association 18
1992 LB boy 3900 38 Right pyelon-ureter duplex, 
bilateral cong. dislocation 
of hips
ТЕ-Ш Follow-up
1993 FD girl 800 26 Hydrocephalus, bilateral MV-I Prenatal -
hydronephrosis
LB = livebirth Ю = infant death
SB = stillbirth 
FD = fetal diagnosis
A
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The expected and observed numbers of anencephalus showed a good agreement (2.2 
versus 2).
Other CA-groups were not related to the main hypothesis of this trial.
Isolated oral clefts were differentiated in two groups. Four newborn infants with 
cleft lip with or without cleft palate were found in the multivitamin group and three in 
the trace element group (Table III). Two children with cleft palate occurred in the 
trace element group and none in the multivitamin group.
Table IV shows the data of cases with cardiovascular CAs. There were 10 cases 
with cardiovascular CAs in the multivitamin group and 20 in the trace element group 
(X2jf3.69; p=0.055), relative risk is 0.48 (0.23, 1.03). The difference is mainly 
explained by two cases of ventricular septal defect in the multivitamin group and 8 
cases in the trace element group (x2f=3.81; p=0.051). However, their diagnosis was 
based only on clinical Findings in nine cases.
It is interesting to see the distribution of offspring with the CAs of the urinary 
system (Table V). The difference in their number (2 versus 8) is very near to the level 
of significance (x^.=3.81); p=0.051). It is worthwhile differentiating the group of 
renal agenesis (0 versus 2) and obstructive CAs of the urinary system ( 1 versus 4) in 
the multivitamin and trace element groups.
The number of clinical diagnosis of congenital hypertrophic pyloric stenosis 
indicated a surprising difference (2 versus 8) between the study groups (x^,=3.81; 
p=0.051) (Table VI). However, one case had no surgery in the trace element group, 
thus it is better to diagnose it as pyloric spasm. After the exclusion of this case the 
difference is not significant (x^ p= 2.95 %; p=0.086).
One offspring with congenital limb deficiency was found in the multivitamin 
group, while there were five in the trace element group (Table VII). The difference is 
not significant (x2/Vates = 1.60; Fisher p=0.12). There was a 6th case with 
hypoplasia of toe IV with flexion contracture in the trace element group, after its 
inclusion of the data base, the difference is near to the level of significance (x^F3.74; 
p=0.053). However, this case had also a torticollis, thus it was considered as a 
congenital postural deformity association /14/.
Two multiple CA groups are worth mentioning. The number of offspring with 
Down syndrome was two in the multivitamin group and five in the trace element 
group. All cases had trisomy 21 (Table VIII). The data of unidentified multiple CAs 
are summarised in Table IX. Of 13 cases, 8 had only two component CAs, if minor 
anomalies and functional defects (e.g., somatic retardation) were not considered. Five 
cases had a putative multiple CA-entity but without evidence. Two offspring had 
obstructive CAs of the urinary system, it was associated with hydrocephalus in one
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case and with ventricular septal defect in another case in the multivitamin group. 
These seem to be against the trends of isolated CAs. However, the origin of multiple 
CAs differs from that of isolated developmental disturbances.
DISCUSSION
The rate of CAs diagnosed from the second trimester of pregnancy until the age 
of 1 year is 65/1000 in Hungary /7/. The total rate of CAs was 59/1000 in the 
multivitamin group, while 76/1000 in the trace element group. The latter surprising 
high rate is probably due to the complete ascertainment and the inclusion of some 
borderline defects between mild CAs and minor anomalies (e.g., deformities of feet, 
torticollis, pectus excavatum, faciocranial hemangioma).
Our trial has resulted in three main findings. First, the periconceptional 
multivitamin supplementation including 0.8 mg of folic acid can reduce significantly 
the first occurrence of NTD. This was the first intervention study to demonstrate this 
important preventive effect. Previously our preliminary results were published /8/. 
Second, our finding did not confirm the results of Tolarova /20/, who found that 
periconceptional multivitamin supplementation with a dose of 10 mg folic acid per 
day protected against cleft lip. It was the case in other nonneural midline CAs /5/ and 
it is in an agreement with the report of Bower and Stanley /1/. Third, some other CA 
entities had a lower rate in the multivitamin group than in the trace element group. 
The difference was at the 0.05 level of significance in ventricular septal defect, the 
CAs of urinary system and congenital hypertrophic pyloric stenosis.
In 1964 Hibbard /12/ reported a higher rate of CAs (3%) in the offspring of 
folate-deficient mothers than in controls (1.6%). Later Hibbard and Smithells /13/ 
showed a relationship between CAs and a defect of folic acid metabolism based on 
FIGLU (formiminoglutamic acid excretion) test. This test was positive in 62% of 
mothers with malformed infants and in 15% of mothers with normal infants. This 4 
times difference was significant. However, later this line of research was concentrated 
only on NTD and other CAs were neglected.
Folic acid acts as a co-factor for enzymes involved in DNA and RNA 
biosynthesis and is also involved in the supply of methyl groups to the so-called 
méthylation cycle which converts homocysteine to methionine /17/. However, folic 
acid, vitamin В12, vitamin B6, vitamin C and zinc interact with one another in many 
metabolic pathways. Thus, the decreased rate of CAs may also be related to both folic 
acid and other vitamin intakes. Cell division is exceptionally rapid at the critical
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stages of specific developmental fields in embryos. The cell's ability to increase the 
synthesis of nuclein acids and to methylate important compounds such as proteins and 
lipids could be compromised by the deficiency of folic and other vitamins resulting in 
impaired cell function and subsequently CAs. Genetically determined vitamin- 
dependency rather than vitamin-deficiency may have some causal role in the origin of 
NTD and some other CAs.
A further cohort study is ongoing to differentiate the chance effect and effect of 
multivitamins in the origin of these CAs and to clarify the mechanism(s) of this 
primary preventive method.
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INFLUENCE OF PARENTAL BIRTH WEIGHT ON BIRTH WEIGHT OF
THE OFFSPRING
Mária ASZMANN, K. MÉHES
Kerpel-Fronius Children’s Hospital, Pécs and Department of Paediatrics, 
University Medical School, Pécs, Hungary
Received 14 October 1994
The birth weights of 660 newborn infants of various 
intrauterine growth were related to the birth weight of their parents. 
The findings offer further support for a maternal regulation of fetal 
growth in small-forgestational age infants. This regulation is less 
effective in true prematurity where pathological and environmental 
factors seem to prevail over familial features.
INTRODUCTION
The role of intergenerational factors in pregnancy outcome has often been 
investigated. As recently reviewed by Emanuel /3/, both direct and indirect evidence 
document the importance of pre- and postnatal growth of females to the quality of 
their reproductive experience as adults.
Ounsted and Ounsted /10/ claimed that through maternal regulatory genes the 
mother’s own intrauterine experience affects her reproductive performance. This 
theory was supported by two Hungarian studies, also showing that the maternal 
regulation was less effective in true prematurity where the role of environmental and 
actual pathological factors seemed to prevail over the familial/genetic features /2, 12/.
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MATERIALS AND METHODS
In the neonatal units of the Baranya County Hospital, Pécs and Department of 
Pediatrics, University Medical School, Pécs, gestational age, birth weight, length and 
head circumference of a total of 660 newborn infants were determined. Only 
singletons were included, babies of gipsy or other ethnic origin as well as infants with 
malformations were excluded from the study. The mothers and fathers of the infants 
with malformations were excluded from the study. The mothers and fathers of the 
infants were personally interviewed and their age, height, profession, social status 
were registered. Inquiries were also made about the mothers previous diseases and 
pregnancies. Gestational age of the family members could not be detected. Birth 
weight of the parents could be checked from medical records in one third of families: 
the oral information proved to be highly reliable in these cases.
The newborn infants were grouped according to gestational age and birth 
weight as follows:
1. Full-term appropiate-for-gestational age (AGA) neonates with a gestational 
age from 37 to 42 weeks, and with a birth weight between the 10th and 90th 
percentile values of the local standards.
2. “Mature” small-for-gestational age (SGA) newborn infants with a 
gestational age of 37 or more weeks, whose birth weight was under the 10th 
percentile.
3. True premature infants with a gestational age under 37 weeks, whose birth 
weight fell between the 10th and 90th centile curves of the local chart.
4. Premature SGA neonates with a gestational age of less than 37 weeks, and 
with a birth weight under the 10th percentile value.
Large-for-gestational age babies were not involved in this study.
RESULTS
Table I shows the mean age, height and weight values of the parents. Both 
mothers and fathers of mature SGA infants were slightly younger, smaller and lighter 
than those of mature AGA neonates. The parental age and birth rank of premature 
SGA infants were somewhat higher than in the other groups, but the parental height 
and weight values of premature AGA and SGA babies were very similar both to each 
other and to the values of the mature AGA group.
Analysis of medical history of the mothers and social status of the families did 
not result in relevant differences.
The mean birth weights are summarized in Table II. As shown by the figures, 
the birth weight of the mothers of mature SGA neonates was lower than that of the 
AGA infants, the difference being more expressed among the mothers of boys. The
TABLE I
Birth weights (g) of the index neonates and their parents 
(mean ± S. D.)
M A T U R E  N E O N A T E S  ( q e s t . a g e T . 3 7  w e e k s ) P R E M A T U R E S  ( g e s t . a g e < 3 7  w e e k s )
B i r t h w e i g h t  c e n t i l e s B i r t h w e i g h t  c e n t i l e s
10 - 9 0 I <  10 10 - 9 0 < 10
B o y s G ir l s B o y s G ir l s B o y s G ir ls B o y s G ir l s
n = 2 1 8 n = 2 0 2 n = 2 9
COCOIIc n = 7 9 n = 6 9 n = 1 1 n = 1 4
I n d e x  n e o n a t e 3 5 5 5 3 3 6 8 2 4 2 6 2 2 2 2 2 2 5 0 2 0 3 9 1 2 1 6 1 2 2 8
± 4 2 8 ± 4 3 4 ±286*** ±330*** ±665*** ± 6 4 9 * “ ±389*** ± 1 8 8 * “
M o t h e r 3 1 9 9 3 1 6 2 2 6 2 6 2 9 5 7 3 1 0 4 2 9 5 5 2 5 9 3 2 9 2 5
± 5 6 2 ± 5 6 6 ±511*** ±590*** ± 7 0 2 ± 6 3 5 * ± 5 1 9 * “
. , -  .*** 
± 4 9 4
F a t h e r 3 4 1 2 3 4 2 9 3 3 1 0 3 0 0 1 3 1 6 8 3 3 3 9 2 9 8 9 3 0 3 6
± 6 1 6 ± 5 6 8 ± 6 3 7 ± 4 9 6 * ± 6 1 5 * ± 5 8 1 ± 6 4 3 * * ± 4 8 0 “
* p < 0.05
** p < 0.01
'** p < 0.001 against the corresponding value of the mature AGA (10-90 ccntilcs) group
- - j
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TABLE II
aoo
Parental age, height and parity of the newborn infants examined 
(mean±S.D.)
M A T U R E  N E O N A T E S  ( g e s t . a g e > 3 7  w e e k s ) P R E M A T U R E S  ( g e s t . a g e < 3 7  w e e k s )
B i r t h w e i g h t  c e n t i l e s  
1 0 - 9 0  I < 1 0
B i r t h w e iç
1 0 - 9 0
h t  c e n t i l e s
<  10
B o y s
n = 2 1 8
G ir ls
n = 2 0 2
B o y s
n = 2 9
G ir ls
n = 3 8
B o y s
n = 7 9
G ir ls
n = 6 9
B o y s
n = 1 1
G ir ls
n = 1 4
M o t h e r  
A g e  (y e a r )  
H e i g h t  ( c m )
2 5 . 5 + 5 . 2  
1 6 4 . 3 ± 6 .1
2 5 . 0 ± 4 . 7
1 6 3 . 6 ± 6 .1
2 4 . 8 + 4 . 2
1 6 1 .6 + 5 .8 *
2 3 . 5 ± 6 .5 *  
1 6 1 .1  ± 5 .9 *
2 3 . 2 ± 4 .0 *
1 6 3 .7 + 6 .1
2 6 . 0 1 6 . 2
1 6 2 . 8 1 6 . 5
2 7 . 1 1 3 . 8
1 6 0 . 7 1 4 .7 *
3 0 . 1 1 4 .4 *
1 6 3 . 8 1 7 . 6
F a t h e r  
A g e  (y e a r )  
H e i g h t  ( c m )
2 8 . 5 ± 6 . 7
1 7 6 . 6 ± 6 . 4
2 8 . 4 ± 6 . 0
1 7 7 . 5 ± 6 .2
2 7 . 7 ± 7 . 5
1 7 2 .0 ± 7 .6 *
2 5 . 7 ± 8 .0 *
1 7 3 . 8 ± 7 .2 *
2 5 . 0 ± 4 .3 *
1 7 5 . 6 1 6 . 7
2 7 . 6 1 5 . 3
1 7 7 . 1 1 7 .1
2 9 . 3 1 5 . 0
1 7 5 . 9 1 8 . 9
3 0 . 2 1 2 .5 *
1 7 6 . 7 1 5 . 8
P a r i ty 1 . 6 ± 0 .7 1 .5 ± 0 .6 1 .5 ± 0 .9 1 . 5 ± 0 .8 1 .7 1 0 .8
•
1 . 7 1 0 .9 2 . 1 1 1 .1 * 1 . 9 1 0 .9
p < 0.05 against the corresponding value of the mature AGA (10-90 centile) group
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paternal means of mature AGA and SGA boys did not significantly differ, whereas 
the birth weights of fathers of SGA girls proved to be slightly lower.
The birth weight of mothers of premature SGA neonates was significantly 
lower than those of the mothers of premature AGA infants, which were very similar 
to the values in the mature AGA group. The differences were greater among the 
mothers of boys. The paternal birth weights were slightly lower in the case of 
premature SGA infants.
DISCUSSION
The aim of the present study was to reinvestigate the relation of birth weights 
in two generations in a new series of Hungarian infants. Unfortunately, the effect of 
parental gestational age on birth weight and duration of gestation could not be 
examined, although this could have contributed to a better understanding of 
intergenerational factors in pregnancy outcome /1, 5/. It should be mentioned, 
however, that parent-children and marital correlations in gestational age are rather 
difficult, if not impossible, to obtain /7/.
The relative role of intrinsic and extrinsic factors /3/ could not be evaluated 
either. Thus, smoking, dietary habits, alcohol consumption, triceps skinfold thickness, 
and several other factors including possible secular trends /4, 9/ were disregarded in 
this study.
At the same time, parental age, height, parity, pregnancy history and social 
class were considered. Apart from a certain variation, the differences in birth weights 
could probably not be attributed to these factors.
In spite of the limitations, in accordance with earlier studies /2, 4, 5, 10, 12/ 
the present results offer further support for an intergenerational influence on birth 
weight through the maternal line. Our findings seem to confirm the assumption that 
maternal regulation plays a major role in intrauterine growth retardation but is less 
significant in prematurity which is caused rather by various other biological and 
environmental factors /12/. From a merely practical point of view this means that 
women who had been SGA should be considered at increased risk to give birth to 
SGA infants /6, 10/. The findings aie also in harmony with the conclusion by Magnus
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et al. /8/ who claimed that, in contrast to birth weight, human variation in gestational 
age does not appear to be influenced by genetic factors to any large degree.
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The present study was carried out to determine the response of 
urinary ET-1 excretion to furosemide administration in human 
neonates. Ten newborn infants with mean birthweight of 2752 g and 
mean gestational age of 37.1 weeks were given furosemide in a dose of 
1 mg/kg. Prior to and following furosemide therapy urine was 
collected for a period of 12 hours and analyzed for creatinine, 
osmolatity, sodium and potassium, as well as for AVP, aldosterone and 
ET-1. In response to furosemide administration urine flow rate and 
urinary osmolar, sodium and potassium excretion increased 
significantly, whereas creatinine excretion remained unchanged. 
Furthermore, following furosemide therapy there was an increase in 
AVP (19.5 ±5.4 vs 28.7 ± 7.8 pg/kg/h, p = 0.06, NS), aldosterone 
(5071120 vs 751 ± 203 ng/kg/h, p < 0.05) and ET-1 (36.0 ± 5.6 vs 
61.4 ± 8.7 fmol/kg/h, p < 0.05) excretion, respectively. Urinary ET-1 
excretion was found to correlate positively with diuresis 
(r= 0.75, p < 0.001), sodium (r = 0.53, p < 0.0025), osmolar 
(r = 0.73, p < 0.001) and AVP excretion (r = 0.72, p < 0.001) but not 
with aldosterone excretion (r = -0.10, p = 0.96). It is concluded that the 
furosemide-induced diuresis and natriuresis is associated with 
significantly increased urinary ET-1 excretion which may further 
inhibit sodium and water reabsorption in the distal nephron. The 
enhanced generation of ET-1 in the renal medulla appears to be related 
to decreased medullary tonicity and AVP stimulation.
Akadémiai Kiadó, Budapest
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INTRODUCTION
Endothelin-1 (ET-1) originally isolated from the culture media of porcine aortic 
endothelial cells /31/ has been considered to play an important role in the renal 
control of salt and water metabolism /24/.
ET-1 administration in a high dose produced marked reduction in renal blood flow, 
glomerular filtration rate, urine flow and sodium excretion /5/. In low dose, however 
ET-1 induced profound diuresis and natriuresis without affecting renal circulation and 
glomerular filtration /23/. Several lines of evidences indicate that the physiological 
responses to ET-1 in the kidney are likely due to locally generated peptide rather than 
circulating hormone /4/. In support of this contention renal epithelial cells, in 
particular cells from the inner medullary collecting ducts are capable of high rates of 
ET-1 synthesis /12, 28/, exhibit abundance of ET-1 receptors /17, 27/ and have high 
cellular levels of ET-1 /15, 30/. The locally produced ET-1 functions as an 
autocrine/paracrine factor to modulate renal tubular transport of sodium and water, 
either directly or indirectly through interacting with other regulating hormones.
The involvement of endogenous ET-1 in the regulation of renal tubular sodium and 
water reabsorption during the neonatal period is not clearly defined.
However, recent studies from our laboratory have shown that urinary ET-1 
excretion, an estimate of renal ET-1 production /1, 3, 4, 18/, is flow-dependent and 
higher in preterm than in term neonates (26) and it can be markedly suppressed by 
giving NaCl supplement /21/.
The present study was undertaken to determine whether the increased diuresis and 
natriuresis in furosemide-treated neonates is causally related to changes in renal ET-1 
production and whether the response of renal ET-1 if any, is mediated by volume 
regulatory hormones i.e. AVP and RAAS, or by reduction in renal medullary tonicity.
MATERIALS AND METHODS
The study was performed in 10 newborn infants with mean birth weight of 2752 g 
(range: 1920-3670 g) and mean gestational age of 37.1 weeks (range: 32-41 weeks) at 
the age of 2 to 5 days (means: 3.4 days). Male infants were selected for the study to 
overcome the technical difficulties in urine collection. The infants were fed pooled 
breast milk when necessary completed with 10% glucose in water of formula 
(Prematil, Milupa) to provide daily fluid intake of 80 to 130 ml/kg. The indication for 
furosemide administration was cardiopulmonary fluid retention in five infants, 
symptoms of increased intracranial pressure in four infants who recovered from 
perinatal asphyxia and oliguria with moderate peripheral edema in one infant. Prior to
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furosemide therapy plasma electrolyte concentrations and blood acid-base parameters 
were within the normal range and the respiratory support could be terminated.
Before furosemide administration urine was fractionally collected for a control 
period of 12 hours then furosemide was given i.m. in a single dose of 1 mg/kg and 
urine collection continued for another 12 hours. The specimens were refrigerated, 
pooled and stored at -20 °C until analyzed for creatinine (modified Jaffe's method), 
osmolality (vapor pressure osmometer, Wescor Co, Utah, USA), sodium and 
potassium (ion-selective electrodes) as well as for AVP, aldosterone and ET-1. AVP 
Д / and 18-aldosterone-glucuronide /29/ were measured by radioimmunoassays. For 
the measurement of ET-1 radioimmunoassay was also applied using specific antibody 
(RPA 555, Amersham, Braunschweig, Germany) after extraction which was 
performed on Am prep 500 mg C2 columns according to the protocol provided by 
Amersham. The detection limit was 1.0 pmol/1 with 50% binding at 4 pmol/1. The 
intra- and interassay coefficients of variation were 8.1 % (n = 10) and 13.9% (n = 24), 
respectively.
Data were evaluated by Student's paired t-test and by least squares linear regression 
analysis. Results are expressed as the mean ± SEM. Approval of the institutional 
ethical committee and informed parental consent were obtained for the study.
RESULTS
Table I shows that in response to furosemide administration there was a marked 
increase in urine flow rate and in urinary excretion of sodium and 
osmolality (p < 0.001). Urinary potassium excretion double (p < 0.05), whereas 
creatinine excretion remained practically unchanged.
TABLE I
Changes in urine volume and urinary excretion of creatinine, osmolality, sodium and 
potassium in newborn infants treated with furosemide
volume
(ml/kg/h)
creatinine
(mg/kg/h)
osmolality
(mosm/kg/h)
sodium
(mEq/kg/h)
potassium
(mEq/kg/h)
before 2.46 0.42 0.41 0.04 0.02
furosemide ±0.41 ±0.03 ±0.07 ±0.02 ±0.01
after 5.41*** 0.50 1.05*** 0.34*** 0.04* *
furosemide ±0.24 ±0.07 ±0.07 ±0.04 ±0.01
* p < 0.05
*** p <  0.001
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The furosemide-induced alterations in urinary AVP, aldosterone and ET-1 
excretion are shown in Figure 1. AVP excretion increased from the baseline value of 
19.5+ 5.4 pg/kg/h to 28.7+7.8 pg/kg/h after furosemide, this increase however, just 
fell short of statistical significance (p = 0.06). Furosemide administration resulted in a 
significant rise in urinary aldosterone and ET-1 excretion from the control values of 
507+120 ng/kg/h to 751+203 ng/kg/h (p < 0.05) and from 36.0+5.6 fmol/kg/h to 
61.4+8.7 fmol/kg/h (p < 0.005) following furosemide therapy, respectively.
Urinary ET-1 excretion was found to correlate directly with urine flow 
rate (r= 0.75, p < 0.001) and sodium excretion (r = 0.53, p < 0.0025). Furthermore, 
there was a significant positive correlation between urinary ET-1 and AVP 
excretion (r = 0.72, p < 0.001), and ET-1 and osmolar excretion (r = 0.73, p < 0.001) 
but such a relationship between ET-1 aldosterone excretion could not be 
established (r = 0.10, p = 0.96) (Fig. 2).
DISCUSSION
The present study provides evidences that in newborn infants the marked increase 
of sodium and water diuresis following furosemide administration is associated with a 
significant rise in renal ET-1 production which may contribute to the complex 
pharmacological actions of furosemide.
Since furosemide inhibits sodium and water reabsorption in the thick ascending 
limb of Henle's loop, it is conceivable to assume therefore that the flow-dependent 
increase of renal ET-1 production can be localized mostly in nephron segments distal 
to the sites of furosemide action. This notion is consistent with the observations that 
the highest rate of ET-1 synthesis /12, 28/ and the most abundant ET-1 binding sites 
have been detected in the inner medullary collecting ducts further augments sodium 
and water excretion by inhibiting Na+-K+ATPase activity /32/ as well as vasopressin- 
stimulated osmotic water permeability and cAMP accumulation /16, 19/.
The mechanisms of enhanced renal ET-1 production in furosemide treated neonates 
is far from clear. Furosemide-induced volume depletion tended to increase urinary 
AVP excretion and there was a strong, positive relationship of AVP to ET-1 
excretion. Moreover, both AVP and ET-1 receptors have been identified in the inner 
medullary structures of developing kidney /9, 20/. In this regard it is to be noted that 
AVP has been shown to stimulate ET-1 release in a variety of experimental
Fig. 1. Response of urinary AVP, aldosterone and ET-1 excretion to furosemide 
administration in newborn infants
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conditions via a mechanism possible involving receptor-mediated mobilization of 
intracellular Ca^+ and activation of protein kinase C /7, 8, 11/.
Reduced tonicity in the renal medulla as reflected by the markedly increased 
osmolar excretion may also account for the higher rate of ET-1 secretion and may 
explain the close relationship between urinary osmolar and ET-1 excretion. In good 
agreement with this notion Kohan and Padilla most recently published that increasing 
media osmolality from 300 to 450 mosm/kg with NaCl or mannitol caused a dose- 
and time-dependent reduction in ET-1 mRNA in cultured rat inner medullary 
collecting duct cells. Similarly, induction of low or high medullary tonicity by 
volume expansion or depletion in vivo was associated with significantly elevated or 
reduced urinary ET-1 excretion and medullary ET-1 mRNA production, respectively. 
In addition, the authors provided evidences that the osmolar regulation of ET-1 
production is unique to cells in the medullary collecting duct /13/.
As an alternative possibility it is also to be considered that some of the excreted 
ET-1 derive from the proximal tubules. Furosemide administration to human neonates 
in a dose of 1 mg/kg resulted in an increased activity of RAAS; plasma renin activity 
doubled and there was an about 50 percent increase in plasma aldosterone level and 
urinary aldosterone excretion /25/. Estimated by the response in urinary aldosterone 
excretion, RAAS in the present study was similarly activated. The elevated 
angiotensin II simultaneously stimulated proximal tubular sodium reabsorption, 
aldosterone production and the release of ET-1-like immunoreactivity in endothelial 
cells through immediate and dose-dependent induction of the ET-1 gene expression 
/11/. Sparsely distributed ET-1 binding sites and low rate ET-1 synthesis /12, 17, 27, 
28/ have been demonstrated in the proximal tubule and ET-1 has been shown to 
specifically increase the activity of proximal tubular sodium transporters /6/.
It has been claimed therefore, that the angiotensin II-induced ET-1 acts in concert 
with angiotensin II to stimulate proximal tubular sodium reabsorption and aldosterone 
production /10, 22/.
As a result of the combined effects of furosemide and the related endocrine 
reactions profuse diuresis and natriuresis occurs in association with significantly 
increased urinary ET-1 excretion. Urinary ET-1 appears to be released by the distal 
nephron which is the major site of its production and the main target of its action. The 
contribution of the proximal tubules is most likely insignificant at this level of RAAS 
stimulation because the ET-1-mediated proximal tubular sodium reabsorption lags far 
behind the distal tubular sodium loss that is strongly related to the locally 
generated ET-1.
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Infant mortality rate in the United States is higher than in many 
other developed countries. Substance abuse in the United States is one of the 
major causes of premature deliveries and increased infant morbidity, and 
thus of infant mortality. Although no specific syndrome results from perinatal 
cocaine exposure, the impact of cocaine on intrauterine development and 
perinatal events results in adverse effects on the neonate. Maternal cocaine 
abuse is expected to become more frequent in the Central European countries 
in the near future. To draw the attention of Central European medical 
communities to fetal cocaine exposure, maternal and fetal pathophysiologic 
changes associated with cocaine abuse are discussed in view of a few 
selected cases from recent admissions to the Neonatal Intensive Care Unit of 
the Medical Center of Louisiana at New Orleans.
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INTRODUCTION
In 1993, the United States ranked 16th in the world in infant mortality, far behind 
many other developed countries /27/. Several studies have attempted to try to determine 
the major factors involved in the etiology of the high infant mortality rate. Most studies 
suggest that 1. -lack of prenatal care, 2. -high rate of teen pregnancies, and 3. -substance 
abuse alone or in combination are the most important factors. Research on substance 
abuse in the United States continues to focus on crack cocain. Although alcohol is still 
the most frequently abused substance, the prevalence of cocaine use by pregnant women 
has been estimated by most studies to range from 5.5-18% and more than 100,000 crack 
babies are born each year in the United States. The annual medical cost of the 
consequences of in utero exposure to cocaine in the neonatal period is estimated to 
exceed $500 million dollars in the United States /21/. Although no definitive unique 
syndrome results from prenatal cocaine exposure, cocaine has a significant impact on 
child health and development /9, 20, 21/. Cocaine use during pregnancy correlates 
strongly with a number of other maternal characteristics such as alcohol and other drug 
abuse, smoking and malnutrition. Women who use cocaine during pregnancy are 
usually older and black and use other drugs as well. Because the use of cocaine is illegal, 
maternal self-report alone will fail to identify many exposed neonates, however, cocaine 
and its metabolite (benzoylecgonine) can be detected in amniotic fluid, fetal and maternal 
urine samples, hair, and meconium /10, 12, 13, 16/.
An increased occurrence of premature labor, premature rupture of membranes 
(PROM), stillbirth, abruptio placenta, and meconium stained amniotic fluid have all been 
observed among women who use cocaine. The cocaine exposed infant is at risk for a 
variety of complications including fetal distress, prematurity, small length, height and 
head circumference for gestational age, cerebral infarction, neurobehavioral disturbances, 
and congenital malformations /9, 20, 21/. Because cocaine readily crosses the placenta 
and the blood-brain barrier, its primary neonatal effects could be explained by its direct 
action on catecholamine synthesis /18, 19, 26/. Secondary effects are those attributable to 
changes in maternal physiology with subsequent alterations in fetal perfusion and transfer 
of nutrients and oxygen to the fetus /30/.
Since it is expected that maternal drug abuse will be more frequent in the Central 
European countries in the near future, this article discusses selected cases observed in the 
United States in an attempt to draw attention of Central European medical communities 
to this issue.
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MATERIALS AND METHODS
The Medical Center of Louisiana at New Orleans is an inner city hospital facilitated 
by two universities (Tulane University Medical Center and Louisiana State University) 
and represents predominantly low-income black population. In 1993 4,186 babies were 
born and 392 were admitted to the level II and III Neonatal Intensive Care Units (NICU) 
in this hospital. The rate of premature deliveries was 6.2%, and the neonatal mortality 
rate was 13.0/1000 live births. Because of the high frequency of drug abuse (mostly 
crack cocaine) during pregnancy, urine analysis for maternal drug abuse is routinely 
performed using commercially available RIA kits. Twelve percent (12%) of mothers 
admitted in labor had positive urine toxicology screen for cocaine (Table I). We selected 
the following representative cases for publication to illustrate the most common 
consequences of maternal substance abuse.
TABLE I
Rate of maternal cocaine abuse and neonatal mortality in the Medical Center of Louisiana
at New Orleans in 1993
Number of deliveries 4.186
Admission to level II + III NICU 392
Premature rate 6.2%
Neonatal mortality rate 13.0/1 (XX) live births
Positive maternal cocaine urine test 12%
rate at admission
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Patient 1
1228 g black female was born to a 28-year old G3P2 who had no prenatal care. 
Mother presented to the Emergency Room with profuse vaginal bleeding and admitted to 
using crack cocain in the evening of delivery. There was no placenta previa, and abruptio 
placentae was diagnosed. An emergency Cesarean section was performed, and patient 
emerged crying with Apgar score 7 at one minute and 8 at five minutes. She was 
intubated and transported to the NICU, where umbilical artery and venous catheters were 
placed. Percentiles for body weight, length, and head circumference were appropriate for 
the estimated gestational age of 28-29 weeks. Both the maternal and neonatal urine 
samples were positive for cocaine. She required minimal ventilatory support. Ampicillin 
and Gentamicin were started for presumed sepsis. Antibiotics were discontinued after 3 
days since cultures remained negative. She advanced to full feedings without difficulties. 
Repeated ultrasound examinations showed no intraventricular or periventricular 
hemorrhage. During her hospital course no retinopathy of prematurity or 
bronchopulmonary dysplasia developed. Her brainstem evoked auditory response study 
was within the normal limits at discharge.
Patient 2
2807 g black female was born to a 29-year-old G6P3 mother who had no prenatal care 
with a history of two previous premature deliveries. She admitted to using crack cocaine 
the day prior to delivery. There was thick meconium upon rupture of membranes. The 
baby was delivered via precipitous vaginal delivery with Apgar scores of 2 and 6. The 
estimated gestational age was 41 weeks; percentiles of body weight, length, and head 
circumference were appropriate for gestational age. There was thick meconium below the 
vocal cords, and the baby was intubated and suctioned. Following intratracheal 
suctioning, she required a brief period of bag ventilation with 100% oxygen for 
bradycardia. On arrival to the NICU, the patient was noted to be jittery. She was given 
lorazépam (0.1 mg/kg). She did not develop clinical seizures, but she continued to be 
jittery and tremorous. The urine samples of the mothers and the newborn proved to be 
positive for cocaine. The infant was discharged without symptoms on the 5th postnatal 
day.
Patient 3
1205 g black female was bom via vaginal delivery at 28 weeks estimated gestational 
age to an 18-year-old G2P1 mother who had no prenatal care. She admitted to marijuana, 
cocaine and alcohol abuse. Apgar scores were 7 at one minute and 8 at five minutes; the
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infant was appropiate for gestational age for birth weight, length, and head 
circumference. The baby was initially intubated for less than 12 hours. She was kept on 
antibiotics for three days until cultures taken at delivery proved to be negative. The 
results of maternal and neonatal urine toxicology were positive for cocaine. On the 
second day of life gavage feedings were introduced with 3 mis of Similac Special Care 
formula on 3-hour schedule. By the 5th postnatal day she tolerated full feedings taking 
180 ml/kg/day. On postnatal day 6, bilious emesis developed without evidence of 
necrotizing enterocolitis (NEC) or obstruction of other etiology. The enteral feeding was 
suspended until the 10th day of life. Then bolus feeds were once again attempted, but two 
days afterwards abdominal distension developed. Her repeated evaluation was again 
negative, so on the 12th postnatal day she was started on continuous feeds of Preterm 
Enfamil formula containing 81 cal/100 ml. After she tolerated feedings, the rate was 
advanced slowly until she met caloric requirements via the enteral route. The remaining 
neonatal course was uneventful.
DISCUSSION
In 1985 Chasnoff et al. suggested that a mother's cocaine use during pregnancy is 
associated with significant adverse effects in the newborn infant /5/. However, cocaine 
use in pregnant women has continued to increase substantially in the United States. 
Cocaine abuse is associated with the use of other substances and high risk life style, 
making the mother prone to multiple infections, trauma, neglect, and malnutrition. The 
effect of cocaine on the fetus is determined by the pattern of abuse. Cocaine has a half- 
life of about 40 to 60 minutes after intravenous or intranasal administration. Crack 
cocaine is the alkaloidái form, that, when smoked, produces a rapid increase in blood 
concentration and a half-life similar to those obtained after intravenous administration. In 
vivo animal studies have shown cocaine to cross the placenta freely /29/. In vitro 
perfusion of the human term placental cotyledon provided evidence that the steady-state 
maternal-to-fetal transfer of cocaine is significantly greater than benzoylecgonine 
transfer. Since the placenta serves as a depot for large amounts of cocaine, it offers some 
degree of fetal protection after bolus administration /23/. Cocain-binding protein has also 
been described in the placenta, but its role in the regulation of placental cocaine transport 
is not known /1/. Benzoylecgonine, which was thought to be a pharmacologically 
inactive metabolite of cocaine, has recently been shown to have a greater contractile 
effect than cocaine on isolated cerebral arteries of the lamb /22/.
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As a stimulant drug, cocaine affects multiple neurotransmitter systems in the central 
nervous system (CNS) including the dopaminergic and norepinephrinergic systems. 
Cocaine blocks the re-uptake of these neurotransmitters. Cocaine also stimulates 
dopamine synthesis and causes an up-regulation of postsynaptic dopamine receptors. 
During pregnancy the norepinephrine-mediated vasoactive consequences of cocaine 
exposure in animals include decreased uterine blood flow and constriction of umbilical 
arteries leading to fetal hypoxemia and decreased nutrient transfer /30/. Blood levels of 
the norepinephrine precursor dihydroxyphenylalanine were higher in prenatally cocaine 
exposed than in unexposed newborns. The effects of cocaine on the dopaminergic, 
norepinephrinergic system may be due entirely to chronic stress associated with the 
cocaine-induced vasoconstriction and hypoxia in utero /18)/ In the cerebrospinal fluid 
(CSF), cocaine exposed infants had significantly lower levels of homovanillic acid, one 
of the principal metabolite of dopamine, when compared with unexposed infants /19/. In 
rabbit pups, cocaine exposure reduced striatal dopamine content and also affected the 
trophic activity in this region /26/.
A large variety of pathological conditions during pregnancy, delivery, and the 
neonatal period are thought to be associated with maternal cocain abuse /9, 20, 21/. 
Namely, PROM, abruptio placentae, meconium stained amniotic fluid, premature 
delivery, stillbirth, fetal distress, intrauterine retardation and failure to thrive, cerebral 
infarctions, neurobehavioral defects, and congenital malformations (especially 
genitourinary tract, cardiovascular, and limb deformities) are the most significant. 
However, meta-analysis of 45 articles on the fetal effects of cocaine exposure /14/ 
suggests that there may be less reproductive risks associated with fetal cocaine exposure 
than generally believed. For instance, only genitourinary malformations, premature birth, 
and spontaneous abortions could be shown to be significantly associated with cocaine use 
in polydrug users when compared to control groups of polydrug users not using cocaine. 
Comparison of users of cocain alone with no drug users revealed a higher risk for in 
utero death, in addition to genitourinary tract malformations /14/.
Complex méthodologie issues contribute to scientific uncertainty regarding the 
possible effects of prenatal cocaine exposure. These include difficulties in accurate 
identification of users, uncertain measurement of dose and gestational timing of 
exposure, sample selection bias, failure to control for confounding variables, 
identification of appropriate control populations, and selection of sensitive outcome 
measures /32/.
During normal early neonatal transition, the changes in the function of cardio­
respiratory system are the most striking events. Intrauterine cocaine exposure
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significantly affects these aspects of neonatal adaptation. It is associated with transient 
ST segment abnormalities in the infants and these abnormalities postnatally suggesting 
consistent and transient myocardial ichemia /17/. On the first day of life, cardiac output 
and stroke volume were lower, and arterial blood pressure was higher in infants exposed 
to cocaine in utero /25/. These infants are also at increased risk of intraventricular 
hemorrhage, periventricular leukomalacia /24/, and NEC /7/ signifying the importance of 
the vasoconstrictive actions of cocaine in the development of neonatal pathology. There 
is a decreased incidence of respiratory distress syndrome and neonatal jaundice among 
premature infants prenatally exposed to cocaine /28, 31/. This may be related to the 
observation that chronic intrauterine stress enhances maturation of enzymes including 
those involved in surfactant production and bilirubin metabolism. Infants prenatally 
exposed to cocaine have a higher incidence of apnea and sudden infant death /6/, have 
increased tremulousness and startles, and state stability, decreased interactive behaviors 
/5/, and have higher incidences of cognitive and motor delays at follow up /24/. 
Furthermore, cocaine exposed infants had significantly lower cortisol levels postnatally 
when responding to stress. These infants have decreased modulation capability to 
normally stressful events /15/. Indomethacin treatment may also enhance the adverse 
effects of intrauterine cocaine exposure on renal, cardiovasular, and platelet function /4/. 
Finally, hyponatremia was noted to be associated with regular cocaine use during the last 
stages of pregnancy /8/.
The primary mode of cocaine action is maternal and fetal vasoconstriction. Therefore 
a well-defined fetal cocaine syndrome does not exist. Most fetal defects - including the 
birth defects - may be related to vasoconstriction, hypertension, and infarcts at any time 
during gestation in any structure. Subsequent loss of vascular supply and tissue necrosis 
produce fetal damage that is beyond capacity for repair.
The social and financial impact of maternal cocaine abuse needs to be further 
clarified. In the United States neonatal hospital cost was by $5200 more for cocaine- 
exposed infants at the time of medical discharge readiness than for unexposed infants. 
Fetal exposure to crack was associated with much larger cost increases. The cost of 
infants remaining in the nursery while awaiting home and social evaluation or foster care 
placement further increased this cost difference /21/. These infants continue to be at risk 
because of the parents' life style. The inappropriate home environment and improper care 
contribute to delayed cognitive and motor development. Postnatal exposure to cocaine 
has been reported via breast-feeding, by direct ingestion, and by passive inhalation. Of 
interest, parents' cocaine use during the year preceding their child's birth may increase the 
risk of rhabdomyosarcoma by 5 fold in their children /11/.
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In 1993, the provisional infant mortality rate in the United States was 8.3/1000 live 
birth. In Louisiana it is estimated to be 9.8/1000 live birth, higher than the national 
average /27/. In the level II and III NICU at the Medical Center of Louisiana at New 
Orleans the neonatal mortality rate was 13.0/1000 live births and 12% of the mothers 
admitted in labor have positive urine toxicology screens for cocaine. These represent the 
women who have used cocaine within 48 hours of the test and thus probably significantly 
underestimates the existing rate of abuse. Our first case presented an abruptio placentae 
with severe maternal bleeding, emergency Cesarean section and, as it is commonly seen, 
a completely asymptomatic infant. The mother admitted to using cocaine and both the 
mother’s and infant's urine sample were positive for the substance. Although premature 
birth is a major risk of maternal cocaine abuse, even the fullterm infant could be 
adversely effected as shown in case 2. Thick meconium below the vocal cords and signs 
of early withdrawal required medical attention. The most classic presentation of 
consequences of maternal cocain use is an infant who is very irritable and difficult to 
feed in the initial days of life. With appropriate differential diagnosis and treatment the 
irritability gradually declines, and the infant's feeding pattern improves. Maternal 
methyldopa treatment may result in an excessive tremor in neonates which was thought 
to be related with striking depression of CSF noradrenaline level /3/. In our last case, the 
feeding intolerance was prolonged but physical exam, radiologic, and laboratory tests 
were unremarkable. Since neonates exposed to cocaine in utero are at significantly 
elevated risk for the development of NEC /7/, this must always be first considered in the 
differential diagnosis when those infants present with signs of feeding intolerance. 
However, in the last case, besides maternal cocaine abuse, several other factors may have 
been also involved in the pathomechanism of feeding difficulties including prematurity, 
and alcohol and marijuana abuse. Prenatal care and maternal nutritional supplementation 
may decrease the risk of adverse neonatal outcome, even among women who continue to 
use cocaine. Health care providers should approach addicted women with empathy and 
concern, emphasizing the woman's real potential to improve the future for herself and her 
children if she receives appropriate drug rehabilitation treatment and medical care.
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The authors prove by pollen analytical examinations that the 
commercially available unwashed pet food: parrot, canary, rodent food, 
canary grass (seed and seed mixtures) contain several seriously allergen 
pollen as grass, weed (ragweed, pigweed, mugwort) pollen and moulds' 
spores. In the available pet food 37 types of seeds and stuck to these seeds 
23 types of pollen grains could be identified. It was observed that 3 grass 
pollen allergic children who showed asthma, allergic rhinitis, urticaria, 
Quincke edem in winter time were not allergic to either the feathers or the 
fur of their pets. After removing the pets from the patients' flats, and 
stoping to store pet food, the symptoms disappeared. Pet food unproperly 
cleansed can prove to be an indirect indoor source of allergy. It is 
advisable for pollen allergic people not to keep grain consuming pet 
animals.
INTRODUCTION
It is not unusual for the allergic patients or their families to keep a pet at home. Over 
60% of the households in the United States have animals /1/. Dogs, cats and small 
mammals are far more common in families having children. For instance dog ownership 
in families with no children is 33.1%, once there is at least one child over six in the 
family, dog ownership jumps to 56.1% /2/. Caged birds' ownership occurs in 5.0 percent 
of households /1/. A preliminary survey conducted by Herring /6/ suggests that the 
incidence of pet ownership may be even higher among the families of allergic children 
than among families of non-allergic children.
Our attention was drawn by the phenomenon that pollinotic children showed allergic 
symptoms even out of the pollen season. For example children allergic to grass pollen 
suffered from allergic symptoms in the winter months also without infection. Searching
Akadémiai Kiadó, Budapest
74 Gy. Mezei et al.
for allergens, it became clear that in the home of these children pets (e.g. caged birds, 
hamsters) fed with seeds were kept.
Since the children did not show hypersensitivity to feathers and fur, the animals must 
have caused the allergy in some other ways. It was suggested that the food of the 
animals, containing pollens could be the pathogenetic factor.
PATIENTS AND METHODS
We observed three pollinotic children who suffered from allergic symptoms in the 
winter without sensibilisation against perennial allergens and without having positive 
responses to their pet's fur. Skin prick tests were performed with Bencard (Beecham) and 
Pharmalgen allergens. The positive control was 1 mg/ml Histamine solution.
Nasal challenge was performed with Pharmalgen allergens. The allergen was diluted in 
albumin. We counted the number of sneezes, the drops from nasal discharge and 
measured nasal inspiratory peak flow with a Youlten (Clement Clark) Instrument.
Pollen and seed identification in the pets' food: after extraction, filtration, 
centrifugation the microscopic elements (pollen and spores) were acetolysed by 
Erdtman's method and embedded in a mixture of glycerine-water.
The animal food was also simultaneously analysed and identified by seed experts (P. 
Erdos and Z. Madas). As control examination pet food originating from different sources 
and different times were also studied.
RESULTS
The three case reports are summarised in Table I. All the patients had grass pollen 
allergy but did not have positive results in the house dust mite and feather skin prick 
tests, nor did they have positive response to their pet's fur. After the removal of the pet all 
the children became symptom free. Two of them later had symptoms in the summer 
period as well, thus proving grass pollen sensitivity.
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TABLE I
Data of the three patients
Patients No. 1 No. 2 No. 3
allergic family history + - -
age at examinations 10.5 15 5
symptoms (in winter) rhinitis 
urticaria 
Quincke edema
rhinitis
urticaria
asthma
pet in the flat 
symptoms ceased
parrot hamster parrot
after pet elimination + + +
symptoms at summer + - +
skin prick pos. grass
cladospora
grass grass
Spec. IgE positivity 
nasal provocation
grass 
Altern aria
not done grass
positive with grass not done grass
The skin prick tests of the three pollen sensitive children are summarised in Table II. 
Analysis of the pets' food:
A. Parrot food
1 kg of parrot food contained an average of 1200 pollen grains. Most of them belonged 
to the goose foot family and grasses, but also a quite a large number belonged to the 
ragweed (Table III/A). No seeds of Ambrosia (ragweed), garden sorrel or Artemisia 
(mugwort) were found in the parrot food while their pollen and even fern spores were 
stuck to the other seeds.
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TABLE II
The skin prick tests of three pollen sensitive children keeping pets 
(the crosses indicate the level of skin sensitivity)
Allergen
1 .
case
2. 3.
PHARMALGEN
gm4 (grass mixture)* ++ +++ + + +
g l (Anthoxanthum odoratum) +++ +++ +++
g8 (Poa pratensis) +++ neg. +++
g 12 (Secale cereale) ++ neg. +++
w l (Ambrosia artemisiifolia) ++ neg. neg.
w6 (Artemisia vulgaris) neg. neg. neg.
w9 (Plantago lanceolata) neg. neg. neg.
arborpollen **tm neg. neg. neg.
m2 (Cladospora) +++ neg. neg.
BENCARD
feathers (mixture) neg. neg. neg.
canary feathers neg. neg. neg.
budgerigard feathers neg. neg. neg.
hamsterfur neg.
rabbit fur neg.
house dust mite neg. neg. neg.
* gm4 (g5,6,12,13) Lolium perenne, Phleum pratense,
Secale cereale, Holcus lanatus.
** tm Betula verrucosa, Cory lus avellane, Alnus incana, Quercus alba.
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TABLE III
Seeds and pollen grains with allergic character in parrot food (A); in canary food (B); in 
hamster food (C) and stuck to the panicle of Phalaris canariensis (D)
FAMILY
Genus A
POLLEN 
В C D A
SEEDS 
В C D
CHENOPODIACEAE
-AMARANTHACEAE +++ +++ + ++
Chenopodium album + - + -
Amaranthus retroflexus + - + -
Amaranthus albus - + - -
COMPOSITAE
TUBULIFLORAE + ++ + +
Ambrosia artemisiifolia ++ ++ ++ +++ + - - -
Artemisia sp. + - - ++ - - - -
Arctium sp. - - - - + - - -
Helianthus annuus - - - - + - +++ -
PLANTAGINACEAE
Plantago sp. + + - + - - - -
POACEAE-CEREALIA + + + + + + + + + + +
Avena fatua - - + -
Avena sativa +++ +++ +++ -
Agropyron repens + - - -
Echinochloa
cruss-galli + + + -
Hordeum vulgare - + - -
Panicum sp. +++ ++ +++ -
Phalaris canariensis + + - + + +
Secale sp. - - + -
Setaria italica + + + + + -
Setaria pumila + + - -
Sorghum sp. - - + + + -
Triticum aestivum + + + + + -
Zea mays + - + + + -
POLYGONACEAE + - - -
Polygonum aviculare - + - -
Polygonum convolvulus - - + -
Polygonum lapathifolium + + - -
Rumex sp. + - + - - - - -
FUNGI + + + + + + + +
Claviceps purpurea - + - -
+++ = dominant ++ = frequent + = sporadic
78 Gy. Mezei et al.
B. Canary food
1 kg of canary food contained an average of 3500 pollen grains. The prevailing pollen 
were those of mild grasses (Table III/B). The canary food was the richest in pollen and 
mould per unit of surface. The canary food contained ragweed pollen, although among 
the seeds no Ambrosia seed was detected.
C. Rodent food (guinea-pig, hamster)
This mixture contained the least amount of pollen but the highest of mould spores 
(both protophytes and polycellular organisms) (Table III/C).
D. Canary grass
More kinds and a larger amount of pollen stuck to the grass were found than expected. 
The majority of them were the very allergenic ragweed, grass, pigweed and mugwort 
(Table III/D).
DISCUSSION
Beck /2/ acknowledged that pet owner experience is so pervasive and of such 
importance in the lives of people that many, especially the young, have more contact 
with animals than even those who work with animals. Nearly 25% of the allergic 
population are sensitive to dogs and cats /5/.
By keeping pets one has to count both with direct and indirect consequences. All 
animals lose their epithel or feathers, therefore the flat would contain more mites. The 
allergologists are aware of the fact that the fur or feathers of animals may be allergen 
sources and try to convince their patients not to keep animals at home. It happens quite 
often, that this request is denied by the patient and/or his family, thus causing serious 
disputes between the doctor and family, and this can even influence their relationship /6/, 
as we experienced in our third case. That is why we consider it very important to make it 
clear for the parents, that not only the animal presents a potential danger for the allergic 
patient, but also the food that it is fed with, and other substances used for caring /7/, may 
provide an allergen source being responsible for the disease.
The mixed grass pollen found in pet food can be responsible for the severe allergic 
complaints that occur out of the pollen season.
Pet food allergy 79
Our pollen analytical examination proved that the commercially available unwashed 
pet food contains several pollen and mould spores. In the case of Patient 1 the moulds 
can also be considered as allergy inducing agents. It has to be emphasized that even pet 
food which is not a mixture consists of the fruitful clusters of canary grass, contains 9 
kinds of pollen and moulds stuck to the plant (Table III/D).
In several flats dry products of plants are tied in bunches as decoration in flower pots 
which can also be a source of pollen dispersion in the air of the flat.
One can also consider that it is possible for workers in agriculture to have allergic 
symptoms in the winter when they feed their animals with pollen containing seed 
mixtures. In conclusion it can be stated that the pet food examined contained a great 
number of various allergenic pollen grains and mould spores which by getting into the 
ambient air may provoke allergic complaints. Accordingly, pollinotic individuals are 
advised against keeping seed consuming animals.
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DOES DEXAMETHASONE TREATMENT IMPROVE THE OUTCOME OF 
BACTERIAL MENINGITIS?
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Although steroids show marked modulation in inflammatory 
processes in experimental meningitis, their use in clinical field remains 
controversial. This study deals with 89 cases of bacterial meningitis in 
children treated between 1983 and 1993 in Saint László Hospital. Patients 
younger than 2 months of age were treated with cefotaxime, while older 
infants and children with ceftriaxone as a presumptive therapy. 
Dexamethasone as an adjunctive therapy was administered in 32 cases 
while in 57 cases only antibiotic was given (historical control). The 
causative agent (H. influenzae) was prevalent in the dexamethasone 
treated group, and N. meningitidis in the historical control group. The 
mortality rate after 24 hours of hospitalization was О in the 
dexamethasone treated group, while 11 died in the historical, not 
dexamethasone-treated group. Hearing impairment and other sequelae 
were nearly similar in both groups. Authors think that this can be 
explained by the fact that even severe bacterial meningitis cases remain 
alive by the dexamethasone therapy. Sequelae can be improved by 
appropriate therapy so these children can live a relatively normal life.
INTRODUCTION
The study of molecular pathophysiology of experimental meningitis showed that 
cerebral damage is partly due to the direct impact of bacterial components 
(polysaccharides, cell-wall components, endotoxin, etc.). On the other hand the host’s 
inflammatory pathway activation is probably more important. This is manifested by 
release of the cytokines like interleukin-1 and tumor necrosis factor (TNF) and other
* El Fatah Children Hospital. Bcnghazi-Libya
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mediators. These mediators lead to the alteration of the blood-brain barrier, 
cerebrospinal fluid dynamics and brain metabolism. These changes cause vasogenic 
cerebral edema, increased intracranial pressure with consecutive decrease of cerebral 
perfusion, regional hypoxia and focal ischemia of the brain tissue. Steroids have been 
shown to block the release of cytokines “in vitro” /1, 2, 3, 4, 5, 6, 7, 8, 9/. They have 
also potent anti-prostaglandin E2 effect /3, 4, 10/. On the other hand, it was also 
suggested that corticosteroids may potentiate ischemic injury of neurons in vitro /10/.
In the following we present the data of a retrospective study which we undertook in 
order to decide whether the use of dexamethasone is a useful additional therapy in 
bacterial meningitis of infants and children.
PATIENTS AND METHODS
Data were collected from case reports of children with bacterial meningitis 
hospitalized in Hungary /Saint László Hospital, Budapest/ during the period between 
January 1983 and June 1993.
The diagnosis of bacterial meningitis was confirmed by the examination of CSF 
including bacteriological culture. Quick diagnostic test (latex particles agglutination) 
was performed in most of the cases.
The empirical antimicrobial therapy was generally cefotaxime (Claforan®) under 
two months of age and ceftriaxone (Rocephine®) for older children.
Dexamethasone was administered in the second half of the investigation period (32 
patients), while 57 patients served as historical control. The dose of dexamethasone 
was 0.6 mg/kg devided in four doses and given through the first four days of the 
disease. The first dose was administered one hour before the presumptive antibiotic 
treatment.
Results were analyzed according to the average time of the sterilization of CSF; 
average duration of fever; mortality rate; frequency of sequelae. Sequelae were checked 
by neurological examination and by BERA audiometry.
RESULTS
Table I presents the distribution of patients according to the causative agents. Table 
II shows the distribution of patients according to age. It is clear that in the second 
half of the decade the H. influenzae became the most frequent causative agent of
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TABLE I
Etiology of bacterial meningitis treated and non-treated with dexamethasone as
adjunctive therapy
Pathogen Number of patients
Treated with dexamethasone Non-treated with 
dexamethasone
H. influenza 24 16
N. meningitidis 6 18
S. pneumoniae 2 11
Gram negative
bacteria* - 9
Others - 3
*E coli, Salmonellae
TABLE II
Distribution of patients with bacterial meningitis treated and non-treated with 
dexamethasone as adjunctive therapy
Age Number of patients
Treated with dexamethasone Non-treated with dexamethasone
< 1 year 22 36
> 1 year 10 21
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TABLE III
Outcome of bacterial meningitis of children treated and non-treated with 
dexamethasone as an adjunctive therapy
Treated with 
dexamethasone
Non-treated with 
dexamethasone
Average time to sterilize CSF/day 1.8 1.8
Average duration of fever/day 5.0 6.5
Number of death after 24 hours
of hospitalization 0 11
Number of patients with hearing
impairment 7 9
Number of patients with other
sequelae* 6 5
Total number 32 57
*Muscular hypertonia or hypotonia, ataxia
bacterial meningitis in Hungary. At the same time no changes can be observed in the 
age distribution of bacterial meningitis.
Table III shows the results of adjunctive dexamethasone therapy. There was no 
difference between the dexamethasone-treated and non-treated groups as far as 
sterilization of the CSF is concerned. Fever lasted for somewhat longer in the 
dexamethasone non treated group, however not significantly.
The mortality rate (after 24 hours) was significantly lower in the dexamethasone 
treated than in the non-treated group.
The rate of sequelae was similar in both groups.
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DISCUSSION
In spite of literary data /10/, dexamethasone therapy had no deleterious effect on the 
course of bacterial meningitis. The sterilization of the CSF was not influenced by the 
dexamethasone therapy. The most striking effect of the dexamethasone is that no child 
with bacterial meningitis died after 24 hours of hospitalization, while the mortality was 
19 per cent in the dexamethasone non-treated historical group.
The similar rate of sequelae can be explained by the fact, that even more severe cases 
remained alive. Authors think that dexamethasone therapy along with appropriate 
antibiotic treatment is indicated in all cases of bacterial meningitis, though there are 
authors, who indicate it only in H. influenzae-caused meningitis and not for infants 
under 2 month of age /11/.
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Pivampicillin can cause carnitine depletion because the 
xenobiotic acid pivalate is liberated from the drug which forms an acyl 
ester with carnitine. The sustained urinary elimination of this ester can 
produce carnitine depletion. In this study the effect of pivampicillin 
treatment on amino acid metabolism in two groups of children with 
different carnitine reserves was investigated. In one group six children 
were treated with pivampicillin and with an equal molar amount of L- 
camitine (group A), the second group received a 5.7-fold molar excess 
of carnitine to pivampicillin (group B) for a week. In group A a partial 
carnitine depletion developed, while the plasma level of valine 
(122%), isoleucine (121%), leucine (116%), alanine (121%) and 
glycine (125%) were elevated compared to control levels on the last 
day of treatment, which was accompanied by increased urinary output 
of glycine. In group В no carnitine depletion was detected, and the 
higher urinary carnitine ester output than group A showed a more 
efficient elimination of the administered xenobiotic acid. In group В 
only alanine (153%) and glycine (136%) levels in plasma were 
elevated compared with the control levels, urinary glycine output also 
increased. The results suggest that the pivampicillin induced carnitine 
depletion could affect the metabolism of branched chain amino acids in 
vivo.
INTRODUCTION
The primary biochemical function of carnitine is associated with the ester 
forming capacity of its ß hydroxyl group /1-3/. In the different organelles and/or 
compartments of the tissues numerous carnitine acyltransferase activities having
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distinct characteristics are described Д/. Similarly, as products of these enzymes 
numerous aliphatic carnitine esters have been identified in the tissues and biological 
fluids /2, 3/.
With the ester forming capability carnitine plays a regulatory role in the ß 
oxidation of the long-chain fatty acids. Besides this function the esterification process 
involves many endogenous or exogenous short- and medium-chain acyl residues /2, 
3/. Amongst them a special point is the proposed role of carnitine in the oxidation of 
the carbon skeleton of the branched chain amino acids /3-9/. After converting to-2- 
oxo acids the acyl moiety undergoes an oxidative-decarboxylation by a common 
branched chain 2-oxo acid dehydrogenase intramitochondrially resulting in the 
generation of branched-chain acyl-CoA esters /10, 11/. Products of the degradation 
pathway have been identified as carnitine esters /2, 3/, moreover, in different tissues 
or in isolated mitochondria a stimulatory effect of carnitine on oxidation process has 
been described /5-9/. However, as a marker of the biological significance the opposite 
possibility, the degradation process in carnitine deficiency has not been investigated.
After pivampicillin is absorbed, pivalate is liberated from the drug which then 
is activated to a CoA ester /12/. Sequestrating the free CoA pools /12/ as pivaloyl- 
CoA can impair those metabolic processes in which CoA is an acyl acceptor or in 
which the ratio of free/ester-CoA is regulatory /13/. Thus, the pathway of degradation 
of branched chain amino acids may interact with both of the above possibilities /3/. 
Since carnitine can accept the pivaloyl moiety from CoA, pivampicillin can cause 
carnitine depletion due to the enormous urinary loss of pivaloylcarnitine /14, 15/. The 
above metabolic events induced by pivampicillin treatment in humans provided a 
useful model for study the possible role of carnitine availability in the preservation of 
amino acid metabolism.
MATERIALS AND METHODS
Patients. Pivampicillin and lower dose o f  carnitine treated group (group A). 
Six female children were selected for the study. The mean age was 10 yrs (range 8.13 
yrs), the mean body weight was 35 kg (range 25-48) at the start of the study. The 
study period was 8 days. After a control day (day 0) the patients were treated for 
seven days with pivampicillin (average dose 1250 mg, range 1000-2000 mg) and an
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equal molar quantity of carnitine (for each mg of pivampicillin, 0.35 mg L-camitine 
internal salt was used), the dose was divided into two or three equal doses (one tablet 
contains 500 mg pivampicillin which corresponds to 1.08 mmoles pivalate).
Pivampicillin and higher dose o f  carnitine treated group (group B). Seven 
children (3 males, 4 females) participated in the study. The average body weight was 
40 kg (range 14-87), the mean age was 11.3 yrs (range 5-17 yrs). The dose of 
pivampicillin was 1500 mg with 3000 mg L-camitine (this dose is within the 
clinically recommended dose range, average 75 mg/kg body weight) divided into 
three doses in all cases. The duration of treatment was seven days as in group A.
Procedures. The current study design was constructed with the acceptance of 
the following generally approved principles: 1, the plasma levels of free amino acids 
reflect the tissue levels, and 2, an overnight fast is adequate to reach a steady state 
concentration which is not affected directly by the last food intake but reflects the 
intracellular metabolic state. Normally the children were fed with a standardized 
isocaloric clinical food. Before (day 0) and on the last day (day 7) of treatment urine 
was collected over 24 h, started at 8:00 AM. On the same days blood was taken into 
heparinized tubes between 8:00 and 9:00 AM. Before the days of blood collections 
the children were requested to fast overnight to reach definitive steady state 
metabolite levels (the last meal was before 9:00 PM, and after this only water was 
given on request by the supervising nurses). The plasma and the urine samples were 
stored at -80 °C until analysis. The study design was approved by the local Ethical 
Committee. Informed consent was obtained from the parents of all participants. The 
treatments were indicated by clinical decision based on the development of infection 
caused by ampicillin sensitive bacteria. The history of children was negative for 
serious illness and they were healthy with good general condition.
Methods. Plasma acid soluble and urinary carnitines were measured by a 
radiochemical assay as described /15, 16/. Presence of pivaloylcamitine in the urine 
was determined in random samples by gas-chromatography /15/. Amino acids were 
quantitated by a Biotronic LC 2000 amino acid analyzer using ninhydrin 
derivatization /17/ according to the method recommended by the manufacturer 
(Maintal, Germany).
Statistics. Because within the groups relationship of means at different times 
was tested, for statistical comparisons the Student’s t-test for paired samples was 
used.
RESULTS
Plasma and urinary carnitine levels are shown in Table I. In both groups 
increase was found in plasma acid soluble carnitine esters due to the presence of the 
xenobiotic pivaloylcamitine /15/. The urinary output of carnitine esters was
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significantly increased on the last day of treatment (Table II). The increase was 
primarily due to the excreted pivaloyl-carnitine as it was determined by 
gaschromatography (not shown). The daily excreted amount of carnitine esters was 
higher in group B. Different results were obtained in the two groups regarding the 
plasma levels and urinary output of free carnitine. In group A the plasma level and 
urinary output of free carnitine was low, while in group В an increase was found in 
plasma free carnitine level with unchanged urinary output of free carnitine (Table I).
TABLE I
Plasma levels (pmol/1) and urinary output (pmol/day) of carnitine and carnitine esters 
in the two groups of pivampicillin and carnitine treated children
Plasma Urine
Day 0 Day 7 Day 0 Day 7
G r o u p  A
total 4 4 .0 + 3 .5 8 3 0 .4+ 3 .5 5 * 3 3 4 .2 + 197.3 2 2 4 3 .5 + 5 7 9 .4 *
acyl 11 .4 + 1 .97 18.9+ 1.9 2 * 2 1 1 .7+ 94.3 2 2 3 8 .8 + 5 6 0 .8 *
free 3 2 .6 + 3 .4 3 11.5+ 1.7 9 * 122 .5+ 103.7 4 .2 7 + 4 .6 5 *
G r o u p  В
total 4 2 .7 + 1.58 5 7 .0+ 8 .0 4 * 2 9 8 . 1+ 68.1 3 3 8 9 .7 + 6 4 7 .5 *
acyl 9 .6 0 + 1.20 16. 1+ 3 .3 9 * 158 .0+ 54.1 3 1 6 1 .3 + 5 8 6 .5 *
free 3 3 . 1+ 2 .2 3 4 1 .0+ 5 .5 2 * 140 . 1+ 41.8 128 .4 + 49 .1
* p<0.05 vs day 0 of the same group
Plasma levels of free amino acids in the two groups of children are shown in 
Tables II and III. In group A a statistically significant increase was found in the levels 
of glycine, alanine, valine isoleucine and leucine (Table II), whereas in group В the 
levels of glycine and alanine were elevated on the last day of treatment compared
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with the original values (Table III). Comparing the daily excretion rates of amino 
acids in all groups the output of glycine was increased on the last day of treatment as 
compared to the initial values (Tables IV and V).
TABLE II
Levels of plasma free amino acids (pmol/1) in patients treated with pivampicillin and 
equal molar carnitine, group A
(means ± SEM * p<0.05 vs day 0)
day 0 day 7
aspartate 26.3+2.S6 26.4+5.80
hydroxyp rolinc 12.4+1.30 14.5+1.13
threonine 129.9+8.91 139.4+14.6
serine 154.9+6.25 152.8+10.4
asparagine 21.7+3.96 23.6+4.90
glutamate 2 1 0 .6 + 12 .6 189.6+14.4
glutamine 233.6+19.7 215.9+19.9
p rolinc 197.3+24.7 218.0+16.6
glycine 204.8+17.4 256.4+18.2*
alanine 308.6+35.6 372.4+23.4*
citrulliue 12.7+1.48 15.5+1.57
valine 216.6+11.2 263.3+25.0*
methionine 10.3+0.88 10.6+1.36
isolcucine 109.5+4.95 132.1+8.40*
leucine 132.7+5.24 153.5+5.40*
tyrosine 54.2+2.91 55.8+3.26
phenylalanine 53.0+3.70 52.4+4.68
ornithine 59.1+3.96 72.7+9.04
lysine 172.4+8.20 169.0+13.5
histidine 68.2+2.57 72.2+3.02
3-incthylhistidinc 2.71+0.43 3.68+0.54
tryptophane 39.3+1.34 41.9+3.41
^lr^ininci 110.1 + 12.1 115.2+21.4
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TABLE III
Plasma level of free amino acids (pmol/1) in children treated with pivampicillin and 
elevated molar dose of carnitine, group В
(n=7, means ± SEM, * p<0.05 vs day 0)
day 0 day 7
aspartate 14.2+1.91 15.1+1.85
hydroxyproline 15.1+2.49 17.4+2.79
threonine 130.1+12.0 138.9+12.0
serine 135.6+10.3 143.9±7.25
asparagine 23.5+4.S6 37.8j;4.76
glutamate 180.1+22.7 228.2+30.4
glutamine 263.1+31.2 277.6+18.0
proline 263.3+37.1 291.9+23.8
glycine 184.7+1 S. 2. 251.4+16.6*
alanine 283.7+47.1 433.0+41.2*
citrulline 11.1+1.06 16.3+1.66
valine 257.1+27.9 267.1+26.0
methionine 21.8+2.48 27.3+2.66
isoleucine 133.6+11.0 145.6+9.69
leucine 158.4+22.4 157.3+15.8
tyrosine 58.3+6.08 59.9+6.00
phenylalanine 57.6+5.92 55.9±4.76
ornithine 53.4+4.11 65.6±4.71
lysine 154.2+18.1 176.4+11.5
histidine 59.9+4.26 73.3+3.49
3-methylhistidine 3.77+0.76 3.21+0.33
tryptophane 43.1+1.72 48.9+1.52
itroinin^^ 90.2+7.87 106.4+6.67
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TABLE IV
Urinary excreted amounts of amino acids (pmol/1) in combined pivampicillin and 
equal molar carnitine treated group, group A
(n=6, * p<0.05 vs day 0)
day 0 day 7
aspartate 18.7+3.71 15.7+3.06
threonine 67.0+8.97 58.5+16.6
serine 173.8+32.4 152.0+40.8
asparagine 36.4+7.81 42.5+10.3
glutamate 25.0+8.21 21.5 + 12.6
glutamine 155.0+42.7 172.3+62.3
glycine 715.3+152.5 854.3+225.0*
alanine 126.2+17.3 116.3+29.6
citrulline 8.17+2.67 7.17+1.74
valine 27.9+6.60 27.4+6.01
methionine 27.9+6.63 27.4+6.01
isoleucinc 6.54+2.53 9.96+2.48
leucine 22.7+5.45 30.0+7.70
tyrosine 50.2+21.5 46.9+9.93
phenylalanine 31.5+9.19 27.7+7.02
ornithine 4.36+0.69 5.33+1.44
lysine 46.3+15.3 33.1+10.3
histidine 376.0+89.3 304.7+65.5
3-methylhistidine 139.1+28.0 135.1+27.4
tryptophane 5.78+1.14 4.67+1.14
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TABLE V
Urinary excreted amounts of free amino acids (pmol/day) in children treated with 
pivampicillin and elevated molar dose of carnitine, group В
(n=6, * p<0.05 vs day 0)
day 0 day 7
aspartate 12.3+3.79 12.8+3.32
threonine 50.5+15.4 55.5+29.6
serine 139.3+43.9 155.2-93.8
asparagine 45.7+12.1 33.S±7.99
glutamate 17.3+3.SI 12.5+3.45
glutamine 178.3+21.8 154.6+56.1
glycine 57S.5-217.5 S99.3-396.4*
alanine 103.3+13.2 115.3+63.3
citrulliue 3.98+2.41 7.36+5.75
valine 12.2+3.32 12.6+2.99
methionine 12.2±3.32 12.5+2.99
isoleucine 3.78+1.43 3.80+1.64
leucine 11.0+2.69 10.7+3.10
tyrosine 39.0+14.7 35.8+12.3
phenylalanine 23.3+7.54 19.7+5.18
ornithine 7.10+2.29 4.00+1.25
lysine 43.1+18.1 38.1+18.7
histidine 333.0+98.9 291.8+100.4
3-methylhistidine 101.6+30.7 82.7+22.0
tnmtophantj 4.34+0.35 6.19+1.68
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DISCUSSION
The results presented herein are consistent with previous studies with pivampicillin 
treatment that demonstrated variability of carnitine reserves depending on the amount 
of the carnitine supplement given /14, 15, 18/. In this study, while in group A the 
given lower dose of carnitine was not enough to reserve the free carnitine stores, in 
group В the elevated intake resulted in elimination of the majority of the given 
xenobiotic acid load (3.24 mmoles/day pivalate) and there was no decrease in 
circulating free carnitine levels and urinary output of free carnitine. In addition, 
taking also into consideration that the plasma level of carnitine can reflect the changes 
of the tissue concentration /19/, the data of the current work show different carnitine 
reserves of the body in the two groups.
So far cumulative data show an effect of carnitine in the metabolism of the 
branched chain amino acids /3-9/. Derivates of the catabolism of these amino acids 
have been identified as carnitine esters (propionyl-, isovaleryl carnitine) in tissues 
and body fluids /3, 16/. Furthermore, carnitine could stimulate the oxidation of 
branched chain a-ketoacids in different tissues and in mitochondria having different 
origin /4-9/. However, the biological significance of these observations have not been 
established in humans, no data have been available demonstrating that carnitine is 
required for the normal oxidation process of these amino acids. A reason for this is 
that useful model for human carnitine deficiency syndrome has not been available.
In the current work, different changes of amino acid profiles were observed in the 
two groups. In group A increase was found in the levels of glycine, alanine, valine, 
isoleucine and leucine, whereas in group В only the levels of glycine and alanine 
were elevated on the last day of treatment. Since a basic difference between the two 
groups was the altered car nitine status, the differing results of the two groups suggest 
a role of carnitine in the maintenance of normal flux in the catabolic pathway of 
branched chain fatty acids.
Theoretically the above role of carnitine can be explained by at least three ways 
/3/. First, carnitine may be required for shuttling the activated acyl groups from the 
cytosol into the mitochondria across the membrane barrier for subsequent 
metabolism. Second, via accepting the acyl groups from acyl-CoA it regenerates the 
free CoA reserves required at the branched chain a-ketoacid dehydrogenase step.
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Pivalate administration is known to increase the ratio of acyl/free CoA ratio in rat 
hepatocyte decreasing the level of free- and some of short-chain (acetyl and succinyl) 
CoA esters accompanied by the formation of pivaloyl CoA /12/. Third, pivalate or its 
CoA ester is inhibitory to transport and/or metabolic steps of branched chain amino 
(or keto) acids.
It is noteworthy, that the increase of two amino acids (glycine and alanine) seems 
to be independent from the carnitine status since increase was observed in both 
groups. The background of the altered metabolism of these amino acids is not known. 
As analogy, an other branched chain xenobiotic acid, the valproate (dipropyl acetate) 
is known to affect the metabolism of glycine /20, 21/ via inhibition the glycine 
cleavage enzyme system /22/, which leads to increased plasma levels and urinary 
output of this amino acid. Similarly, in normal humans administration of valproate 
inceases plasma alanine concentrations /23/.
The daily urinary output of amino acids was similar in the two groups of children. 
Except the elevated output of glycine on the last day of combined treatment in both 
groups, excretion of other amino acids remained unchanged, however, in some cases 
a trend to increase was found (isoleucine and leucine in group A). This disassociation 
between the plasma levels and urinary output of amino acids suggests, that except 
glycine, the plasma level did not elevate above the normal boundary of tubular 
reabsorption threshold. However, in the case of glycine even altered kidney 
metabolism or transport of this amino acid cannot be ruled out.
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NEONATAL MULTICYSTIC DYSPLASTIC KIDNEY TOGETHER WITH 
AN OVARIAN CYST DIAGNOSED ANTENATALLY: A CASE REPORT
H. SARIHAN, H. GÜMELE, R. AKYAZICI
Karadeniz Technical University, Faculty of Medicine, Turkey
Received 19 October 1994
We report on a neonate with multicystic dysplasia of the right 
kidney together with a left ovarian cyst. The prenatal diagnosis of both 
anomalies was accurately made using ultrasound. The infant was 
treated surgically.
INTRODUCTION
Multicystic dysplastic kidney is the most common renal cystic disease encountered 
in the newborn /1/. The routine use of ultrasonography in pregnancy facilitates the 
diagnosis of these lesions more often in utero /2/. Associated congenital anomalies are 
frequent. On the other hand, it is also associated with extrarenal congenital anomalies 
such as oesophageal atresia, cardiac, muscular, skeletal, neural and gastrointestinal 
anomalies /3/. Up to now, multicystic dysplasia together with an ovarian cyst has not 
been reported.
CASE REPORT
A woman (gravida 3, para 2) was at 36 weeks gestation when a prenatal 
ultrasonogram showed multicystic dysplasia of the right kidney and an 
intraabdominal cyst measuring 6x5 cm (Fig. 1). Fetal movement and amniotic fluid 
volume were normal. The fetus appeared to be female and it was felt that the cyst was 
mesenteric or ovarian. The fetus was followed with occasional ultrasonic evaluation.
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Physical examination following normal vaginal delivery revealed a large, 
uniloculated and mobile intraabdominal cystic mass. Right kidney was palpable. 
There were no audible bruites and no cardiac murmurs. Blood pressure was normal. 
Urinanalysis, serum creatinin, electrolytes and bilirubin were normal. 
Ultrasonographic examination of the abdomen demonstrated multicystic dysplasia of 
right kidney, normal left kidney and large abdominal cyst but its origin could not be 
identified. An intravenous urogram showed no function of the right kidney with 
normal function in the left kidney.
Fig. 1: Antenatal ultrasound scan shows, A: left ovarian cyst and B: multicystic 
dysplasia of right kidney
The infant was operated on the third day of admission. A laparatomy was 
performed through an intraumbilical transverse incision. A left ovarian cyst 
measuring 9x7 cm and multicystic dysplasia of the right kidney was observed 
(Fig. 2). Nephrectomy and oophorectomy were performed.
Histopathological examination of the specimens demonstrated multicystic 
dysplasia and follicular cyst.
Fig. 2: Intraoperative photograph shows, A: multicystic dysplastic kidney and, B: left 
ovarian cyst
.MAGYAR
TUD O M ÁN YO S AKADÉMIA
KÖNYVTARA
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DISCUSSION
Multicystic dysplastic kidney is a commonly occurring condition now 
frequently identified prenatally. It is a developmental anomaly of the kidney that can 
be distinguished readily from other forms of cystic renal diseases in childhood /4/. 
The renal parenchyma is replaced by tense noncommunicating cysts and the proximal 
ureter is atretic or nonpatent. In the course of time multicystic dysplasia may reduce 
in size or it may fully disappear /4, 5/. Malignancy, hypertension, pain, hematuria and 
infection have been reported as late complications of multicystic kidneys /3-5/. Some 
authors have suggested routine prophylactic nephrectomy to prevent these 
complications, but others preferred conservative treatment /3-5/.
Cystic and solid tumors of the ovary are rare during the newborn period. The 
most frequent tumor is ovarian follicular cyst which can be diagnosed prenatally /6/. 
Ovarian cysts are thought to be the result of excessive stimulation of the fetal ovaries 
by human chorionic gonadotropin /7/. When the fetus is removed from the maternal 
influence of these hormones, spontaneous resolution of the cyst can occur. It is 
suggested that conservative management with sonographic réévaluation is an 
acceptable alternative to surgical therapy in uncomplicated cases /8/. Complications 
of large ovarian cysts include torsion and rupture. Thus ovarian masses with a solid or 
complex component aie treated surgically /8, 9/.
In this patient, multicystic dysplastic kidney and an abdominal cyst were diagnosed 
in utero. The origin of the abdominal cyst could not be defined at this stage. 
Following her birth, control ultrasonographic examination demonstrated that the cyst 
was ovarian or mesenteric. It may be difficult to differentiate between mesenteric, 
enteric and ovarian cysts even via ultrasonography. She was operated due to this 
reason.
There should not be a relationship between multicystic dysplasia and ovarian cyst 
because multicystic dysplasia develops due to intrauterine vascular catastrophe or 
ureteral obstruction /3/ and ovarian cyst occurs due to excessive human chorionic 
gonadotropin.
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MIDGUT DELETION: A CASE REPORT AND LITERATURE REVIEW
H. SARIHAN
Karadeniz Technical University, Faculty of Medicine, Department of Pediatric 
Surgery, Trabzon, Turkey
An unusual case of midgut deletion secondary to intrauterine 
midgut volvulus with total and irreparable ischemia and sloughing 
is reported.
INTRODUCTION
Deletion of the midgut was first reported by Moore in 1986 /1/. The patient had no 
intestine from just beyond the ligament of treitz to the mid-transverse colon. Up to 
now, two additional, somewhat similar cases have been reported /2/. Here a fourth 
case of midgut deletion will be presented.
CASE REPORT
A 1.200 g boy was born by normal vaginal delivery at 28 weeks’s gestation to a 
22-year-old (gravida 2, para 2) mother, and the mother did not have any antenatal 
check-up. The infant was admitted to Faculty of Medicine, Trabzon, with bilious 
vomiting and no meconium passage of the anus. Physical examination showed upper 
abdominal distension and rectal irrigation provided passage of small pellets. 
Abdominal plain film demonstrated double-bubble sign of duodenal obstruction 
(Fig. 1). His serum bilirubin was 5 mg/dl. Following preoperative preparation with 
nasogastric tube and intravenous fluids, laparatomy was performed through a right 
transverse supraumbilical incision. Distended stomach and three parts of duodenum, 5 
cm of atretic jejunum just beyond the ligament of Treitz and entirely unused and 
edematous colon were found. The colon had malrotation but no fixation. The 
remaining jejunum and ileum were absent (Fig. 2).
Duodeno-jejuno-cecostomi was performed and abdominal wound was closed in a 
single layer.
On the first postoperative day hyperalimentation treatment and third day rectal 
irrigation were stalled. On the sixth day postoperatively a passage of the anus was 
observed. Eighth day, oral liquid nutrient was started and continued with semiliquid 
oral infant formula. On the 27th postoperative day the general status of the patient 
deteriorated and 28th day he died of septicemia. The blood culture grew 
pseudomonas aeruginasa resistent to all antibiotics.
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Fig. 1. Plain erect X-ray film demonstrates double-bubble sign of duodenal 
obstruction
Fig. 2. Operative photograph showing atretic proximal jejunum and unused and 
edematous entire colon. There is no remaining jejunum and ileum
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DISCUSSION
Intestinal atresia is a significant cause of neonatal intestinal obstruction. The 
experimental works demonstrated that intestinal atresia is an acquired disease and 
likely the result of late intrauterine mesenteric vascular catastrophe, commonly a 
volvulus /3/. If volvulus occurs in utero, it will produce ischaemic necrosis of 
different degree, resulting in single or multiple short segment or extensive atresia of 
the jejunum and/or ileum /4, 5/. Further experimental studies showed that if an 
intestinal loop was isolated, resorption of the loop occurred if its blood supply was 
poor /3/.
Grosfeld and Clatworthy /6/ observed the occurrence of jejunal atresia with 
infarction of the entire midgut in a tight gastroschisis defect. It can be presumed that 
if entire midgut is suffered by volvulus in utero and the superior mesenteric vessels 
will become occluded, <he midgut will undergo infarction /1, 2/. This is the most 
likely cause of midgut deletion.
Our patient had midgut deletion with intact right colon and proximal atretic 
jejunum in a length of 5 cm. It is described that intact right colon is due to the 
presence of postaxial branches of the superior mesenteric artery and intact proximal 
jejunum is due to presence of inferior pancreatic artery /2/. He had no meconium 
peritonitis. It is demonstrated that healed intrauterine perforation might or might not 
be associated with the meconium peritonitis /3/.
Patients with midgut deletion have bad prognosis because there is no intestine to 
handle. In these patients hyperalimentation treatment and small bowel transplantation 
may be suitable as an alternative treatment /7, 8/.
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The fatty acid composition of three infant formulae available in 
Hungary for feeding healthy, term infants was analysed by high- 
resolution capillary gas-liquid chromatography. Percentage 
contribution of linoleic acid (C18:2n-6) was higher, while that of 
saturated fatty acids was lower in the formula with the highest 
contribution of vegetable fat to total fat content than in the other 
products. No other difference of considerable extent was seen between 
the fatty acid composition of the formulae investigated. Concentrations 
of linoleic acid, the precursor essential fatty acid for omega-6 long- 
chain polyunsaturated (LCP) fatty acids, in the three formulae were 
higher than the median value in mature human milk. In contrast, 
percentage contribution of alpha-linolenic acid (C18:3n-3), the 
precursor essential fatty acid for omega-3 LCP fatty acids, in all 
formulae was less than half of the median value of breast-milk. 
Percentage contributions of the principal omega-6 LCP fatty acid, 
arachidonic acid (C20:4n-6), corresponded to 26 to 32% of the median 
value of human milk. None of the products contained detectable 
amounts of docosahexaenoic acid (C22:6n-3), the major omega-3 LCP 
metabolite. Percentage contributions of other omega-3 and omega-6 
long-chain polyunsaturates were also markedly lower in the formulae 
than the values characteristic to mature human milk.
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INTRODUCTION
Polyunsaturated fatty acids play an important role in early postnatal growth and 
development /3, 9/, and the awareness of the quality and composition of fats supplied 
to infants increased considerably during the past decade. Composition of human milk 
is often used as a model for artificial feeding. It has been demonstrated in a number of 
investigations that human milk contains considerable amounts of long-chain 
polyunsaturated fatty acids (LCP), and the milk content of 20 and 22 carbon LCP 
fatty acids remains surprisingly consistent with different self-selected maternal diets 
at different geographical locations /12/. In contrast, infant formulae usually contain 
the precursors of omega-6 and omega-3 LCP fatty acid synthesis, linoleic (C18:2n-6) 
and alpha-linolenic (C18:3n-3) acids, in amounts comparable to that measured in 
human milk, but contain little 20 and 22 carbon LCP fatty acids /7, 8, 10, 15/.
In Hungary, the contribution of three infant formulae (Mildibé, Robébi A and 
Robébi В, EGIS, Hungary) to the nutrition of formula-fed, healthy, term infants is 
overwhelming. In 1992, 1 058 229, 222 028 and 248 470 units (0.5 kg boxes) of 
these three formulae, respectively, were purchased through Hungarian pharmacies 
(Annual Report on the Pharmaceutical Market, data source available in Hungarian 
alone). The three formulae in question amounted to about 95% of all term infant 
formulae distributed through Hungarian pharmacies in 1992. If one assumes that the 
purchased amount was utilized completely, it can be concluded that in 1992 these 
three products represented substitute for 5 801 242 liters of human milk.
The fatty acid composition of two of these three formulae has been analysed by 
Gere and coworkers, and the results have been published in this journal /6/. However, 
the technical facilities available at that time rendered possible the indentification of 
only seven different fatty acids, including no long-chain polyunsaturate. Therefore we 
determined the fatty acid composition of these three Hungarian infant formulae by 
using high-resolution capillary gas-liquid chromatography and compared the LCP 
content to data on the fatty acid composition of mature human milk in Hungary and in 
Europe.
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MATERIALS AND METHODS
Two-two units of the three formulae (Mildibé, Tobébi A and Robébi B, EGIS, 
Hungary) were purchased through the Pharmacy of the University Medical School of 
Pécs and stored at room temperature until analysis. All products were well within the 
guaranteed shelf-live at analysis. Prior to analysis, products were reconstituted with 
tap water according to the manufacturer’s declaration.
Total lipids were extracted from 4 ml of formula with methanolcloroform 
(2:1, vol/vol) /2/. (Previous analysis revealed that in infant formulae, just as in human 
milk, almost all fatty acids were present in triglycerides, and only minor amounts in 
sterol esters and phospholipids; therefore, we measured fatty acids in formula total 
lipids). Fatty acids were transesterified with methanol and hydrochloric acid /16/ and 
dissolved in hexane including 2 g/1 butylated hydroxytoluene as an antioxidant. Fatty 
acid composition was analysed by high/resolution capillary gas/liquid 
chromatography using a Hewlett-Packard Series II 5890 gas chromatograph with on 
column injection and flame ionisation detection. Technical details of chromatography 
have been described elsewhere /4/. Fatty acid results are expressed as percentage 
(wt/wt) of all fatty acids detected with a chain length between 10 and 24 carbon atoms 
(mean of 2 measurements). The precision of fatty acid quantification with this 
methodology has been previously described /11/.
RESULTS
Fat content (according to manufacturer’s declaration) of the three formulae is 
shown in Table I. The contribution of vegetable to total fat was identical (21%) in 
two products, while it was markedly higher (35%) in the third one. Percentage 
contributions of 21 fatty acids which were present in more than 0.1% concentration in 
at least one of the formulae investigated are given in Table II. (Data of three of the 
lower than 0.1% concentrated LCP fatty acids (C20:2n-6, C22:4n-6 and C20:5 n-3) 
are additionally shown in Table III, whereas data for three other lower concentrated 
fatty (C20:3n-9, C22:ln-9 and C24:ln-9) are not shown.)
The formula with the highest contribution of vegetable fat to total fat content 
(Robébi A) had markedly higher linoleic acid (C18:2n-6) content and showed 
moderately lower values for the principal saturated fatty acids (lauric /C12:0, palmitic 
/С16:0/ and stearic /С18:0/ acids) than the other two formulae. No other difference of
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considerable extent was observed between the fatty acid composition of the three 
formulae.
Ta b le  I
Fat content (according to manufacturer’s declaration) of the three infant formulae
investigated
Mildibé Robébi A Robébi В
Fat content
Milk fat (g/1) 2.6 2.2 3.0
Vegatable fat (g/1) 0.7 1.2* 0.8*
Contribution of 21.0 35.0 21.0
vegetable to total fat (%)
Total fat (g/1) 3.3 3.4 3.8
* Sunflower oil
When data were compared to the median value of 14 Europen studies on fatty acid 
composition of mature human milk /12/, lower value for monounsaturated fatty acids 
(human milk median: 38.8%) and, with the exception of the formula with higher 
vegetable fat content, higher values for saturated fatty acids were seen (human milk 
median: 45.2%). Concentrations of linoleic acid, the precursor essential fatty acid for 
omega/6 LCP synthesis, in all the three formulae investigated were higher than the 
mdian value (11%) of mature human milk in Europe /12/. In contrast, percentage 
contributions of alphalinolenic acid (C18:3n:3), the precursor essential fatty acid for 
omega:3 LCP synthesis, in all formulae was less than half of the median value (0.9%) 
characteristic to mature human milk /12/.
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T a b le  II
Fatty acid composition in the three infant formulae (% wt/wt)
Mildibé Robébi A Robébi В
Saturated fatty acids
0 0 :0 1.47 1.20 1.60
0 2 :0 2.54 2.04 2.49
0 4 :0 9.08 7.17 8.93
0 6 :0 29.35 25.46 30.01
0 7 :0 0.76 0.52 0.62
0 8 :0 9.91 8.49 9.56
C20:0 0.26 0.35 0.38
C22:0 0.26 0.34 0.25
C24:0 0.13 0.13 0.11
Total 53.81 45.68 54.04
Monounsaturated fatty acids
0 4 :  ln-5 1.03 0.81 1.01
0 5 :  ln-5 0.30 0.24 0.31
0 6 :  ln-7 1.41 1.27 1.52
0 8 :  ln-9 25.51 24.98 25.55
0 8 :  ln-7 0.68 0.65 0.64
C20: ln-9 0.11 0.10 0.09
Total 29.45 28.37 29.50
Polyunsaturated fatty acids
0 8 :  2n-6 15.43 25.10 15.47
0 8 :  3n-6 0.15 0.13 0.16
0 8 :  3n-3 0.44 0.20 0.24
C20: 3n-6 0.11 0.08 0.10
C20: 4n-6 0.14 0.13 0.16
C22: 5n-3 0.11 0.06 0.08
Total 16.62 25.84 16.32
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Table  III
Omega-6 and omega-3 long-chain polyunsaturated fatty acids (LCP) in the three 
infant formulae investigated compared to human milk in Hungary1 and to average 
values in 14 studies reported on fatty acid composition of mature human milk in
Europe2
Mildibé Robébi A Robébi В Human milk 
in Hungary in Europe*
Omega-6 LCP
C20: 2n-6 0.02 0.02 0.03 0.3 0.3 (0.2-0.5)
C20: 3n-6 0.11 0.08 0.10 0.3 0.3 (0.2-0.7)
C20: 4n-6 0.14 0.13 0.16 0.5 0.5 (0.2-1.2)
C22: 4n-6 0.06 0.03 0.03 0.1 0.1 (0.0-0.2)
Total 0.44 0.33 0.36 1.2 1.2 (0.4-2.2)
Omega-3 LCP
C20: 5n-3 0.05 0.02 0.02 n.d. 0.2 (0.0-0.6)
C22: 5n-3 0.11 0.06 0.08 0.1 0.2 (0.1-0.6)
C22: 6n-3 n.d. n.d. n.d. 0.3 0.3 (0.1-0.6)
Total 0.16 0.07 0.10 0.3 0.6 (0.3-1.8)
1 Drury et al., Prog Lipid Res 25: 235, 1986
2 Koletzko et al. J Pediatr 120: S62, 1992 
* Median (ranges)
The long-chain polyunsaturated fatty acid content in the three formulae 
investigated is compared with published data on fatty acid composition of mature 
human milk in Hungary /5/ and in Europe /12/ in Table III. Percentage contribution 
of LCP fatty acids was similar in the three formulae, and the values detected were 
markedly lower than the values characteristic for human milk. Percentage 
contribution of the principal omega/6 LCP fatty acid, arachidonic acid (C20:4n-6), 
corresponded to 26 to 32% of the median value of human milk. None of the formulae
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investigated contained detectable amounts of docosahexaenoic acid (C22:6n-3), the 
principal omega-3 LCP fatty acid in human milk and infant tissues.
DISCUSSION
The quality and composition of dietary fat supplied to infants is of concern because 
fatty acids have important structural and functional effects on the developing organs, 
especially on lipid-rich neuronal tissues, such as the brain and retina /9/. Lipid 
deposition in developing cerebral tissues is closely linked to the vulnareble period of 
neural differentiation with rapid neuronal cell multiplication, their dendritic 
arborization and formation of synaptosomes, all processes that require sufficient 
availability of polyunsaturated fatty acids /9/. Lipids of the central nervous system
contain in the neonatal period only minor proportions of the precursor essential fatty
«
acids, linoleic (C18:2n-6) and alpha-linolenic (C18:3n-3) acids, but almost all 
polyunsaturated fatty acids in the neonatal brain are LCP fatty acids with 201 and 22 
carbon atoms, mostly arachidonic (C20:4n-6), cervonis (C22:4n-6) and 
decosahexaenoic (C22:6n-3) acids /11, 17/. Three LCP fatty acids, namely dihomo- 
gamma-linolenic acid (C20:3n-6), arachidonic acid (C20:4n-6) and eicosapentaenoic 
acid (C20:5n-3), are also needed as indispensible precursors for the synthesis of 
biologically active eicosanoids.
The foetus appears not do depend on active endogenous synthesis of LCP, since 
active placental transport of LCP fatty acids seems to cover the needs of fetal growth. 
After birth, the breast-fed infant receives considerable amounts of preformed LCP 
with human milk. The average LCP fatty acid intake of breast-fed infants is about 100 
mg/kg body weigh/day, with an approximately 2:1 ratio of omega-6 to omega-3 fatty 
acids /11/. The exogenous LCP supply to formula-fed infants depends, however, on 
the composition of the formula administered.
Both fat content and long-chain polyunsaturated fatty acid composition of the three 
formulae investigated in the present study were similar, i.e. feeding of any of them 
provides approximately similar exogenous LCP supply to the formula-fed infant. 
Higher contribution of vegetable fat (sunflower oil) to the fat content of one of the
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formulae resulted in increased percentage contribution of linoleic acid, but did not 
influence the availability of LCP fatty acids.
As to omega-6 LCP metabolites, the exogenous LCP intake of infants fed one of 
the formulae investigated can be estimated to approximate one third of the intake of 
the breast-fed infant. Nevertheless, the precursor omega-6 essential fatty acid, linoleic 
acid (C18:2n-6), was present in two formulae in higher, and in one formula in 
substantially higher concentration than in human milk. It is not known, however, to 
which extent the elevated linoleic acid intake can facilitate endogenous omega-6 LCP 
synthesis and, thus, compensate for the lower exogenous omega-6 LCP supply. As to 
omega-3 metabolites, however, the differences between intakes with breast-milk or 
with formula were unequivocal. Not only omega-3 LCP values, but also the 
percentage contributions of the precursor essential fatty acid, alpha-linolenic acid 
(C18:3n-3), were considerably lower in the formulae than the data reported for 
mature human milk.
The markedly lower omega-3 polyunsaturated fatty acid intake with formula 
feeding than with breast-feeding is of concern, since sufficient omega-3 fatty acid 
supply seems to be of functional importance in infancy. On the one hand, 
docosahexaenoic acid (C22:6n-3) levels were found to be lower in formula-fed than 
in breast-fed term infants in several comparative studies /3/. On the other hand, recent 
observational studies on the development of visual functions in term infants suggested 
possible functional deficiencies related to biochemical deficiency of omega-3 long 
chain polyunsaturated fatty acids /1, 13/. These data strongly suggest that the role of 
preformed dietary LCP in the composition of infant formulae for term infants should 
be reevaluated.
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FOREWORD
Paediatricians and researchers unanimously believe that obesity is a hazard to 
health and well-being. It is one of the most important public health problems of the 
westernised societies as shown by shorter expectation of life, increased morbidity, or 
cost to the community in terms of money and anxiety. The atherosclerosis, 
hypertension and metabolic dysfunctions leading to serious diseases in adult life have 
their origins in childhood obesity. Recognition of the significance of this problem on 
the one hand and its underrepresentation in national and international obesity 
conferences on the other, led to the foundation of The European Childhood Obesity 
Group (ECOG) in 1990 at a meeting on the Obese Child in Ancona, Italy, with the 
following main purposes:
1. to bring together professionals who are clinically involved in the treatment of 
childhood obesity
2. to improve clinical and scientific knowledge of obesity in childhood
3. to increase understanding of childhood obesity through promotion of studies, 
research and professional publications
4. to develop programmes for the prevention and treatment of childhood obesity
5. to provide facilities for the interchange of views and experience so as to improve 
knowledge, skills and clinical practice in all aspects of childhood obesity
6. to encourage training for health professionals and others in all fields of the 
management and prevention of childhood obesity
The prevention and treatment of childhood obesity is particularly important in 
Hungary, where the incidence of overweight is around 14% among the 6 - 18 years 
old population. Unfortunately the undergraduate and postgraduate medical university 
curricula in Hungary do not emphasise this problem according to its importance. 
There is a growing concern for obesity in children among paediatricians, general 
practitioners and other health professionals. However, actually there is a lack of 
knowledge, skills and clinical practice. To fill the gap, the 4th ECOG Workshop 
organised in Pécs was combined with a postgraduate course in accordance with the
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aims of ECOG. The lectures of 11 invited speakers reviewed up to date information 
on nearly all aspects of childhood obesity and demonstrated the applicability of recent 
results to everyday practice for paediatricians, general practitioners, nutritionists and 
dieticians.
The workshop (with two main topics - "Prevention of childhood obesity" and 
"Important (nonanthropometric) medical investigations in the assessment of the obese 
child") tried to bring different approaches closer and to provide guidelines concerning 
clinical and laboratory investigations essential for the assessment of the obese child 
and to define the target population for prevention programmes.
It was gratifying to welcome more than 70 active participants representing 11 
European countries. I would like to thank once more all the participants for their 
enthusiasm and activity throughout the two-day meeting.
I thank Dr. Miklós Miltényi, editor-in-chief of the Acta Paediatrica Hungarica, for 
providing the opportunity to publish the postgraduate lectures and abstracts of the free 
oral papiers and posters. And last but not least I thank the financial support of 
ACCORD (Assistance of the Community in Co-operation in R&D).
D. MOLNÁR
Department of Pediatrics 
University Medical School 
Pécs, Hungary
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GENETIC AND FAMILIAL ENVIRONMENTAL INFLUENCES ON 
CHILDHOOD OBESITY
T.I.A. SORENSEN
University of Copenhagen Institute of Preventive Medicine Copenhagen Health
Services, Denmark
It has been known for long time that fatness and its extreme variant-obesity- 
aggregates in some families and not in others /1/. The obese parents presenting their 
obese children is a classical paediatric problem. The frequently seen addition to this 
picture of an obese pet dog reveals the widespread belief that the problem in the 
family is their environment, namely their shared habit of overeating or their shared 
physical laziness. However, the scientific basis for this belief is very scanty. The 
obese subjects may eat a lot, but they may do so to satisfy their current needs, and it 
does not at all imply that their obesity is due to a preceding overeating. They may not 
move their bodies a lot because this may be rather unpleasant and exhausting, and this 
does not imply that laziness preceded the development of their obesity. Development 
of obesity of course requires a positive energy balance, which however in any case is 
rather tiny (less than 5%) compared to the total energy turnover per time unit. This 
positive energy balance may not necessarily be enforced by increased energy intake 
or reduced energy expenditure. The primary disturbance may as well be a tendency to 
accumulate energy as fat in the fat cells, which then creates the positive energy 
balance by compensation via a variety of feed-back systems influencing energy intake 
and/or expenditure. The familial aggregation of obesity may be due to the shared 
environment, but also to the genes they have in common, and the environmental 
factors and the gene products may operate primarily on any of the components of the 
energy balance equation. The observation of familial aggregation of obesity therefore 
immediately raises the question about the role of the genes common to the family 
members.
In human beings, there are two classical ways of answering this question, namely 
the twin method and the adoption method. The technology of molecular genetics now 
allow for search for polymorphic DNA markers of the genome possibly associated 
with the phenotype in the family (quantitative trait linkage). However, it may be more 
rational to restrict the use of this technique to the search for sites of the genome 
possibly containing important genes for phenotypes, in which the classical methods 
have demonstrated a genetic influence.
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The overall conclusion from many different studies is now that the familial 
resemblance in fatness and obesity among adults is due to the genes they have in 
common rather than to persisting influences of the rearing family environment they 
shared in childhood. The question regarding childhood fatness and obesity is then 
whether or not this conclusion applies at that age and, if not, what the roles then are 
of the genes and of the family environment they live in.
In the twin method, the evidence for genetic influence is obtained by comparing 
the resemblance of monozygotic twins with the resemblance of dizygotic twins. 
Monozygotic twins have identical genes and dizygotic twins have, as other full 
siblings, on average half of their genes in common Therefore, the extent to which the 
resemblance of monozygotic twins exceeds the resemblance of dizygotic twins can be 
taken as a measure of the genetic influence. Several such twin studies have been 
carried out for adults, adolescents and children /1/, and they all support that genes 
play a very important role for fatness and obesity. Most of them even suggest that all 
resemblance of siblings can be attributed to the genes they have in common.
The inference from the twin method assumes that any important environmental 
influences on the phenotype are similar for monozygotic twin pairs and for dizygotic 
twin pairs. This may not be true. Common experience shows that monozygotic twins 
because of their considerable similarity in physical appearance often are treated much 
more alike than are dizygotic twin pairs. Such greater similarity in environment may 
contribute to increase resemblance in the phenotype under study and therefore bias 
the inference about genetic influence upwards. One possible way of avoiding this bias 
is by studying twin pairs separated early in life. The separation happens, however, so 
rarely that it is very difficult to establish sufficient samples, and there is, moreover, in 
these samples often concern about how effective the separation has been. A few 
studies have been carried out in adults, and they support the conclusions drawn from 
the use of the classical twin method /1/.
Another way of removing the possible bias of the classical twin method is by 
studying subjects adopted away from their biological family early in life. Two 
methods have been employed - the complete and the partial adoption method - that 
differ with regard to whether or not there is access to information about the biological 
family of the adoptees. In the complete adoption study, genetic influences are 
assessed by the resemblance of the adoptee and their biological family members 
(assuming that the preadoptive - usually only prenatal - environment are unimportant 
for the familial resemblance of the phenotype). The influence of the family 
environment is assessed by the resemblance of the adoptee and the members of the 
adoptive family. In the partial adoption study, the influence of the family 
environment is assessed in the same way as in the complete adoption study, but there
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is not direct way of assessing the genetic influence. This has been performed by 
comparing the resemblance of the adoptee and the adoptive family members with the 
resemblance observed in natural families (which have been other families or the 
adoptive parents and their own biological children).
The first series of adoption studies of fatness and obesity were partial adoption 
studies with adoptees in childhood or adolescence /1/. They produced a very 
heterogenous set of results ranging from almost no genetic influence to a strong 
genetic influence explaining all familial resemblance. In studies where both parent 
offspring and sibling-sibling comparisons were used, the two types of analysis 
differed with more support for genetic effects among the latter. It may have been 
quite critical for the results how the adoptive parents with their adoptees were 
selected for the study. Any tendency to selective recruitment among those resembling 
each other in the fatness would inflate the estimate of the effects of the family 
environment.
One complete adoption study of chilhood fatness (assessed by BMI) has been 
carried out in Denmark /3/, and another one in Colorado, USA /2/. Both studies 
included the biological parents, adoptive parents and adoptive siblings of the adoptee, 
but only the former also included the biological full and half siblings of the adoptee. 
Both studies clearly supported that the genetic influence is important already in 
childhood. The Danish study supported some weak influence of the shared family 
environment, but this was not found in the study from Colorado.
It is important to notice that the traditional question about the magnitude of the 
heritability (proportion of the total varience of the phenotype in the population that 
can be ascribed to genetic variance) has not been discussed. Twin studies consistently 
produce much higher heritabilities than adoption studies, possibly because of complex 
gene-gene and gene-environment interactions and correlations. Moreover, the 
magnitude of the heritability will depend on the variation of environmental influences 
as well (heritability is 1 if there is no variation in exposure to relevant environmental 
factors).
In conclusion, both twin and adoption studies strongly support that most if not all 
familial resemblance in fatness and obesity in human beings is due to the genes they 
have in common. There may be some weak contribution to the resemblance of the 
shared family environment as long that they live in it. On the other hand, the twin and 
adoption studies as well as other epidemiological studies leave no doubt that, despite 
the clear role of the genes, the environment - not assessed as the shared family 
environment - play as important a role as the genes. In addition to the obvious need of 
search for the specific genes involved, there is an obvious a need for more detailed
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studies of specific environmental factors, and how they may interact with the genes in 
producing obesity.
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GENETIC, NUTRITIONAL AND SOCIOCULTURAL ASPECTS OF
OBESITY
EME POSKITT
MRC Laboratories, Banjul, Gambia
Obesity is an excess of body fat. In childhood most obesity is associated with 
increased lean body mass (LBM) for age, although pathological conditions such as 
Prader-Willi syndrome, can have normal or low LBM with excess fat. If obesity is by 
definition excess stored fat and in normal circumstances LBM is not reduced, obesity 
must have resulted from an excess of energy intake over energy expenditure. Such 
imbalance could havë occurred in the past so that nutritional status is stable when the 
child is assessed and energy intake balances expenditure.
The study of energy balance in obesity is full of controversy and contradiction. It 
has long been debated whether there are physiological differences in the ways the 
obese deal with ingested energy and mobilise stored energy for expenditure when 
compared with similar processes in the nonobese /1/. Are the obese simply those who 
consume more energy than they need? Are they individuals who have poor appetite 
control or an appetite centre set 'too high' for their nutritional status? Much effort has 
been spent in studying appetite regulation in obesity. Areas of the brain can be related 
to initiation and cessation of eating in experimental animals. Problems in similar areas 
of the human brain are sometimes related to abnormalities of appetite and nutritional 
status in clinical practice. Is the 'appetite centre' the main regulator of energy intake in 
those populations where food is available in excessive amounts /2/? It seems 
surprising when we consider how easily food intakes and 'appetite' are influenced by 
family and peer group activities, by environmental pressures such as food 
presentation and availability, by emotional states and by social conditioning. The role 
of appetite in balancing energy intake with expenditure must be seen in the context of 
wider sociocultural and environmental issues.
Concepts become fashionable yet often later decline in support as scientific 
knowledge changes and advances. Current views are that underlying most 'simple' 
obesity there is a strong familial, and now presumed genetic, predisposition for 
obesity. Environmental factors influence this predisposition by encouraging or 
inhibiting the manifestation of this predisposition. The strength of the inherent 
predisposition and the frequency of environmental features which encourage excess 
of energy intake over expenditure, lead to high or low prevalences of obesity in 
communities.
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It used to be thought that the number of fat cells was largely set in the first year of 
life and the predisposition to obesity determined in early life. It is now recognised 
that the number of fat cells is determined by the size and fat content of existing cells 
rather than by the age of the individual /3/. A need to store fat recruits potential 
adipocytes from connective tissue stroma. Current evidence shows little to support an 
influence of early infant feeding practices on later obesity in terms of persisting 
abnormal nutritional status /4/. However, if early feeding sets styles of feeding and 
attitudes to food which encourage disorganised eating habits and excessive energy 
intakes, these could lead to later obesity.
GENETIC INFLUENCES IN OBESITY
Fat children commonly have fat parents /5, 6/. In my experience with children 
attending obesity clinics attached to children's hospitals, only about twenty percent of 
obese children did not have at least one parent who was overweight or obese. Thirty 
to forty percent of children had both parents overweight or obese. In many cases other 
children in the family were also significantly overweight. Since families tend to eat 
and exercise together especially when the children are quite young, familial obesity 
need not indicate genetic determinants for obesity. Nevertheless, studies of 
monozygotic and dizygotic twins /7, 8/ and of adoptees /9/ in relation to their 
biological and adoptive parents suggest that even in different environments, 
similarities in genetic makeup lead to similarities in body composition.
How might genetic influences determine fatness or leanness? We do not know. For 
a condition as common in the western world as obesity and so variable in time of 
development, in degree and in complications. A single gene effect is unlikely. More 
likely is a variety of genetic factors influencing the intake, partition and utilisation of 
energy. Such factors may include faulty appetite control; variation in the thermic 
response to food; excessively efficient fat deposition; less ready fat mobilisation; 
variable metabolic efficiency. A variety of degrees of difference between individuals, 
rather than an 'all or nothing’ risk also seems likely for such fundamental 
physiological processes. Together genetic factors may account for 40% of the 
metabolic differences recorded between individuals /10/.
Are there data to support any of these suggested genetically determined 
differences? Some families have resting metabolic rates that tend to be in the lower 
range of normal for age and lean body mass and others tend towards the higher range 
of normal /11/. Such differences do not correlate with relative fatness or any familial 
predisposition to obesity. Nevertheless, if we consider obesity the consequence of a
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variety of genetic and environmental factors, a relatively low resting metabolic rate 
may be one contributing genetic factor which predisposes a family to the development 
of obesity.
Other studies suggest some individuals store ingested fat more readily than others. 
Overfed individuals store fat at varying rates even with the same excess of intake over 
expenditure. Monozygotic twins show similarities in the rate at which they store fat 
which are much greater than similarities between unrelated individuals /12/. If a 
tendency to store fat readily is also associated with more difficult mobilisation of 
stored fat, obesity is a likely result.
Some obese children have very high LBM as well as fat mass for age. They also 
have tall, large, parents. These children may be high birth weight infants who have 
increased LBM from birth and a genetic propensity for large lean and fat mass. 
Growth is exuberant and obesity seems almost inevitable in westernised environments 
where food is readily available /13/.
ENVIRONMENTAL INFLUENCES ON THE DEVELOPMENT OF 
CHILDHOOD OBESITY
The prevalence of obesity is increasing in most westernised and westernising 
countries today despite the fact that in many of these countries mean energy intakes 
for both children and adults have dropped markedly in the past forty years /14/. It 
would seem unlikely that genes predisposing to obesity have become suddenly more 
prevalent in these societies, particularly as the pattern of developing obesity is 
common to geographically remote westernising societies. A westernised environment 
encourages the development of obesity in those who are genetically predisposed.
N u t r i t i o n a l  a s p e c t s
There have been many efforts to characterise diets of the obese and to distinguish 
'at risk' eating habits. No one finding explains obesity. It is our experience that many 
obese children have relatively undisciplined eating and often long lists of food 
dislikes, including particularly meat, wholemeal cereals, fruit and vegetables. Do 
these 'fads' reflect a reluctance to chew due to poor weaning practices? Whole foods 
require more chewing to consume and usually take longer to eat than their refined or 
prepared forms. They seem more filling because of greater bulkiness. Non starch 
polysaccharides may slow energy absorption in comparison with more refined 
versions of the same food. Insulin responses aie less because glucose is more slowly
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released during digestion. Reactive hypoglycaemia is thus less likely following 
ingestion and absorption resulting in less need to eat again quickly.
We can only speculate on factors in the western lifestyle which predispose to the 
development of obesity. In adult societies improved income leading to greater 
consumption of alcohol may be one cause. But this does not explain the increase in 
childhood obesity. High fat intakes leading to greater energy density of foods result in 
loss of some of the satiety introduced by the volume of food consumed. Fat may be 
more readily deposited as fat in certain 'at risk' individuals than the same amount of 
spare energy ingested as carbohydrate /15/.
Patterns of eating may be very relevant to the development of satiety signals in 
response to food. A meal enjoyed and prolonged with the family or. in pleasant 
company is likely to engender a greater feeling of satiety than a meal of similar 
energy content eaten alone in front of the television when little thought was given to 
what or how much was eaten.
Modern methods of marketing foods have significant effects on consumption. 
Foods are presented in different attractive packets and in different flavours so that 
satiety with one variety may be alleyed by the use of different flavours or 
presentations. Vigorous advertising at, for example, peak child viewing time on 
television, leads to peer group pressures on children to eat when they do not need 
food. Foods eaten under those circumstances are commonly high in energy and of low 
satiety value.
S o c i o e c o n o m i c  a s p e c t s
In developing societies it is the affluent who tends towards obesity. In most 
westernised societies it is children of the disadvantaged and of ethnic minorities who 
seem most at risk of obesity. Studies from Copenhagen /16/ suggest that the 
environment in which children are reared rather than the social class or education 
level of the parents is the main environmental factor predisposing to obesity in later 
childhood or adult life. Disadvantages such as lack of safe play areas and easily 
available, cheap, good quality fresh food may combine with parental depression from 
unsatisfactory housing, to encourage obesity.
Childhood obesity is common amongst children of single parent families (which 
may reflect socioeconomic deprivation), and single children within a family. Why the 
latter group should be at risk is not clear unless this reflects either overindulgence of 
single children or the energy consuming effects of living with brothers and sisters.
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P s y c h o l o g i c a l  c h a r a c t e r i s t i c s
There are no precise psychological habits which define obese children. 
Nevertheless there are some attitudes which seem common to many of the very obese 
who have presented at my clinics in the past. These characteristics may be helpful in 
indicating what might go wrong in the environment to predispose to obesity.
Children are often referred to obesity clinics because poor school progress is 
attributed to their size. Such children rarely make much effort to slim and give the 
impression of children who have a lot of self pity, poor peer group relationships and 
who have developed obesity as a consequence or association of their psychological 
problems, rather than as a precursor to their problems. Other obese children are well 
integrated with their friends and have few school problems despite their great size. 
They may or may not succeed with slimming depending on whether they perceive 
successful slimming as a high priority.
Some obese children are remarkable in their dependence on their parents. They 
expect to be dressed and undressed in the clinic at an age when most children would 
be doing these things for themselves. They do little to help with running the home and 
appear to expect parents to do everything for them. When confronted by dietary and 
lifestyle recommendations, comments such as 'I don't like it' and I don't want' are 
regarded as sufficient reason for failure to make efforts over changes in lifestyle. By 
contrast, other obese children meet the challenge of slimming by overcoming some 
dislikes to try and attain their objectives. Unfortunately slimming is neither easy nor 
quick even amongst those who make great efforts. Positive approaches to slimming 
need great support if they are not to lead to disillusion.
Some obese are clearly very inactive but many are not more obviously lazy than 
their non obese peers. Fat boys, because of their large size, may be very successful at 
sports. It is difficult to gauge whether fat children are using less or more energy than 
their peers in activities. Altered body composition makes overall energy consumption 
of the obese greater than that for their leaner peers, but difficulty estimating LBM 
accurately makes any estimate of energy consumption/kg LBM imprecise.
There seems good evidence to incriminate the popularity of television as 
entertainment for children in the modem epidemic of obesity /17/. Activity levels 
tend to be very low when watching; eating is common; sweets, crisps and other 
snacks may be consumed almost unnoticed; and frequent food advertisements can 
have subconscious influences.
Formal exercise in the form of sports and walking is important in prevention or 
reduction of fatness. However, most of the day is spent at relatively low levels of 
activity /18/. If a child uses little more than basal activity because of time spent 
watching television or sitting inactive at home, energy consumption overall may be
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considerably less in twentyfour hours than for a child who moves around the home, 
helping the rest of the family, taking an interest in others' activities and generally 
trying to adopt an active lifestyle without necessarily being very sporting. An outward 
looking attitude and the encouragement of responsible independence may be good 
preventives against the insidious development of obesity.
No one cause can usually explain obesity in an individual. Subtle genetic and 
environmental influences which induce high energy intakes and low energy 
expenditures have combined effects in obese individuals. These may be compounded 
by family or medical inaction over children's obesity because of despair or acceptance 
of other obesity within a family. Children only present when obesity is excessive and 
difficult to reverse. These varied factors together result in the disturbing increase in 
childhood obesity that is common in so much of Europe today.
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THE ROLE OF ENERGY EXPENDITURE IN THE DEVELOPMENT 
AND MAINTENANCE OF OBESITY IN CHILDREN
C. MAFFEIS
Department of Pediatrics, Polyclinic B.Roma, University of Verona, Verona, Italy
Genetic, environmental, and behavioural factors produce a positive energy balance 
which leads to the progressive increase of fat mass up to obesity. The 
etiopathogenesis of the defect in the regulation of energy balance which causes 
obesity has not been defined, in particular for the difficulty to obtain a reliable and 
valid assessment of the energy intake in free-living conditions /1, 2, 3/. On the 
contrary, the use of new techniques (doubly labelled water: ^■W'i ' °0 ), or the 
improvement of methods already available (indirect calorimetry and heart rate 
monitoring method), to assess the 24 h energy expenditure (TEE) and its main 
components (Basal metabolic rate [BMR], thermogenesis [T], energy expenditure for 
activity [ЕЕд], and the energy expenditure for growth [EEq ]) allowed a significant 
improvement of the knowledge on the other element of the energy balance, i.e., the 
energy expenditure.
Total energy expenditure. The TEE was found to be significantly higher in obese 
than in nonobese children and adolescents, both in males and in females /1, 3/. An 
index of activity, i.e., the ratio ТЕЕ/MR, was comparable in obese and nonobese 
children /3, 4/.
BMR. In a large number of studies, a significantly higher BMR in obese than in 
nonobese children and adolescents was found. While no difference between the two 
groups was found when BMR was adjusted for fat free mass [FFM] by ANCOVA, 
using FFM as the covariate /5, 6/. BMR adjusted for FFM was comparable in obese 
after weight loss and nonobese children /6, 7/. Weight loss induced a reduction of 
BMR which was directly proportional to the loss of FFM /6, 7/. In adult Pima 
Indians, a reduced BMR adjusted for FFM significantly correlated with subsequent 
weight gain /8/. However, no longitudinal data are available in children.
Thermic effect of food (TEM1. Obese children (at least part of them) and 
adolescents showed a slightly but significantly lower ТЕМ than nonobese children /9, 
10, 11/. After weight loss, ТЕМ increased to values comparable to those of nonobese 
children, suggesting that the reduction of ТЕМ was subsequent and not preceding 
obesity. However, the real impact of the energy saving due to the reduction of the 
ТЕМ have to be evaluated in the context of the total 24 h energy expenditure.
134 Pecs, Hungary, 3-5 November, 1994
Energy expenditure for activity. The results of a study of Roberts SB et al. /12/, 
suggested that "reduced energy expenditure, particularly on physical activity, was an 
important factor in the rapid weight gain during the first year of life in infants born to 
overweight mothers", underlining the importance of the ЕЕд in the pathogenesis of 
obesity. Data on children and adolescents showed that the daily ЕЕд (+ 
thermogenesis or: TEE-BMR) was comparable or higher in obese than in nonobese 
subjects /3, 4/. The assessment of the patterns of activity showed that obese children 
spent significantly more time in sedentary activities than nonobese children /13/. The 
higher energy cost of activity, due to the necessity to move a heavier body, may 
explain the discrepancy between a shorter time spent in activity and a comparable 
energy expenditure due to activity in the two groups /14/.
Nutrients balance. The quantity and composition of nutrient intake and oxidation 
may affect the regulation of energy intake and impaired regulation of energy intake 
may predispose to obesity. In particular, a key role seems to be played by fat 
oxidation /15/. Studies performed in adults showed that a lower 24 h fat oxidation rate 
was a predictive factor for subsequent body weight gain /16/ and that a lower 24 h fat 
oxidation rate is a risk factor for body weight regain after weight loss /17/. Recent 
studies in children and adolescents showed higher postabsorptive fat oxidation rate in 
obese than in nonobese children /18, 19/. In obese children the rate of fat oxidation 
correlated with fat mass which was able to explain an additional part of the variance 
of fat oxidation not already explained by FFM /19/. Therefore, in already obese 
children, a metabolic attempt to achieve fat balance, i.e., increasing fat oxidation, is 
reported, at least in postabsorptive conditions. At the present time, longitudinal data 
on the nutrients oxidation rate of children in the dynamic phase of obesity are not 
available.
CONCLUSIONS
On the basis of the results of the above mentioned studies, we may conclude that 
some progress on the role of energy expenditure in the genesis and maintenance of 
obesity in children have been achieved. Further investigations are needed to define 
the role played by the ЕЕд, which is the only discretional component of TEE, in the 
prevention and treatment of obesity, especially in children.
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METHODS TO EVALUATE BODY COMPOSITION
ROLLAND-CACHERA, Marie Françoise 
INSERM (U290), ISTNA, CNAM 
2 rue Conté, 75003 Paris - France
Body composition is often used as an indicator of nutritional status. It is 
influenced by age, sex, food intake, physical activity and diseases. The method used 
to measure body composition depends on the variable to be quantified. It may also 
depend on the practical conditions of the study. Elaborated methods give more 
accurate information, but they have a high cost and they are often based on 
hypotheses established in adults. Anthropometry remains the most widely used 
method. Measurements can be used directly. Various indices give complementary 
information on body composition /9/, such as the weight/height^ or body mass index 
(BMI), trunk/extremity skinfold ratio, waist/hip ratio, upper arm muscle area (UMA) 
and upper arm fat area (UFA), based on skinfolds and arm circumference. Body 
density and percentage body fat can be predicted from anthropometric measurements 
(weight, height or skinfolds), using regression equations.
Weight-for-age and height-for-age are the first indicators to be considered for 
growth surveillance. To assess under or overweight, weight-heigth indices are 
necessary. At adolescence, the Body Mass Index is preferred to weight-for-height as 
age can be taken into account. In addition, the BMI pattern reflects real changes in 
body shape and fatness (Figure 1), and early in life it is an indicator of later 
development. Changes which appear at adolescence actually have their origins much 
earlier, during the first years of life. This is clearly observed monitoring the BMI 
curves in individuals (Figure 2) or in populations.
Measures of weight and height should be augmented by skinfolds. The triceps 
skinfold is usually recommended and widely used, but trunk skinfolds, such as the 
subscapular, are better on many counts: association with internal fat, with risk factors 
and response to nutritional interventions (Tables I and II).
In conclusion, elaborated methods for measuring body composition are useful to 
obtain accurate information. However, valuable information on body composition is 
given by the combination of various anthropometric measurements. In addition 
patterns of anthropometric measurements during growth provide useful information to 
predict adult measurements.
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Figure 1: Development of adiposity assessed by the Wh/Ht^ Body Mass Index and 
by subscapular skinfold in girls (after Rolland-Cachera, 1993)
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DEVELOPMENT OF THE W / H 2 B O D Y  M A S S  INDEX DURING G R O W T H
S/GIRLS
i Médecin/Pysöcn............................................................
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ire 2: Examples of weight/height^ monitoring on BMI reference charts in girls. 
Case 1: fat at one year, remained fat after early rebound (2 years); case 2: 
fat at one year, did not stay fat after a late rebound (8 years); case 3: lean 
at one year, did not stay lean after an early rebound (4.5 years); case 4: 
lean at one year, remained lean after late rebound (8 years) (after Rolland- 
Cachera, 1993)
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TABLE I
Selection of Anthropometric Measurements According to Various Characteristics
(Out of SF and BMI)
Characteristics Age Males Females
Relationship with Body 6-13 yrs TRI TRI
Composition 13-18 yrs TRI TRI
% BODY FAT (density) [71 Adults W/H2 TRI
TOTAL BODY FAT 6-13 yrs W/H2 W/H2
density [7J 13-18 yrs ss W/T2
Adults W/H2 W/H2
CT Scan [121 Adults W/H2 W/H2
INTERNAL FAT
MRI [6] 11-12 yrs ss ss
CT Scans [ 12] Adults W/H2 W/H2
Specificity [31 8-19 yrs TRI W/H2
Association with Card Vase 12-17 yrs W/H2 W/H2
Risk Factors [11]
Tracking [101 Child- Adult W/H2 W/H2
Technical aspects
Availability, reference data all ages W/H2 W/H2
Acceptance all ages W/H2 W/H2
Reliability all ages W/H2 W/H2
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TABLE II
Selection of Anthropometric Measurements According to Various Characteristics 
(Out of Trunk & Extremity SF)
Characteristics Age Male Female
Relationship with Body 
Composition
% BODY FAT (density) [71 6-13 yrs TRI TRI
13-18 yrs TRI TRI
Adults SS TRI
TOTAL BODY FAT
density [7] 6-13 yrs SI SI
13-18 yrs SS SS
Adults SS all
INTERNAL FAT 
MRI [6] 11-12 yrs SS SS
Response to nutritional 
intervention
[4] all ages Trunk SF Trunk SF
Specificity
[3] 8-19 yrs TRI SS
Association with Card Vase Risk
Factors [11] 12-17 yrs Trunk SF Trunk SF
12] 11 -16 yrs Trunk SF Trunk SF
[1.5] Adults Trunk SF Trunk SF
Tracking
[10] Child-Adult Trunk SF Extr SF
Technical aspects [8]
Availability, reference data all ages TRI&SS TRI&SS
Acceptance all ages TRI TRI
Reliability (out of 13 SF) all ages TRI&SS TRI&SS
Abbreviations:
SF = skinfold, TRI = triceps SF, SS = subscapular SF, SI = suprailiac SF, W/H^ = 
BMI = body mass index
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OBESITY AND TYPE 1 DIABETES MELLITUS (IDDM)
FJ. GREGORY
University of Wales, College of Medicine, UK 
Received 5 December 1994
INTRODUCTION
The onset of obesity in adolescence may have significant adverse effects on 
health. Indirect evidence that obesity amongst adolescent girls with IDDM may 
predispose to obesity in adult women is suggested by data collected in the adult 
diabetes clinic in Ninewells Hospital, Dundee, Scotland (RT Jung, personal 
communication) which demonstrates that 17% of women (10% of men) with IDDM 
compared with 12% of non-diabetic women (8% of men) /11/ have a body mass index 
of 31 -40 kg/m2.
Excess body weight may increase morbidity in childhood. Body weight is a 
major factor determining blood pressure in young insulin-dependent diabetics /28/. In 
adolescent girls with IDDM, increased body mass index and poor glycaemic control 
are associated with menstrual irregularities and features of polycystic ovarian disease 
/2/. IDDM in the young, particularly females /29/ is associated with atherogenic lipid 
and lipoprotein profiles. In older patients with IDDM, adverse lipid profiles are 
associated with known body composition risk factors such as increased waist-hip 
ratios /27/. However, there are surprisingly few published data on body composition 
in young people with IDDM.
BODY COMPOSITION IN CHILDREN WITH IDDM
It is a common clinical impression that obesity is a problem in adolescents 
with IDDM although published data of body weight are inconsistent. Several studies 
have demonstrated that adolescents with IDDM and girls in particular are heavier than 
normal. Girls with poorly controlled IDDM are heavier than average, though those 
with good blood glucose control are of normal weight /7/. Others have shown that 
diabetic girls over the age of eight and boys over the age of eleven are heavier than 
local population standards /15/. The author made the inference that girls are more
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obese whereas the boys had increased muscle mass though no body composition data 
was presented to support such a conclusion /15/. Another study has shown that in 
diabetic patients ranging in age from 3 to 45 years old, females tended to be above 
average weight but both sexes had thicker than normal subscapular skinfolds /8/.
More recent work from Denmark shows that adolescent girls, particularly 
those on multiple injection regimens, have a higher body mass index than adolescent 
boys /20/. However, other uncontrolled studies of body weight suggest that whereas 
children and adolescents with IDDM are heavier than ideal, they may not be heavier 
than their non-diabetic peers /1, 10/. These latter studies are contradicted by a 
prospective study of newly diagnosed children with IDDM which has demonstrated 
that within two years of diagnosis, diabetic children become significantly heavier than 
controls /30/.
Obesity is more reliably assessed from measurements of body composition 
than by inference drawn from measurements of weight and height alone /25/. In 
adolescents with IDDM, skinfold thickness and bioelectrical impedance techniques 
have shown that pubertal girls have substantially more body fat than prepubertal girls 
and pubertal boys. 57% of Scottish pubertal girls with IDDM (compared with 29% of 
healthy young British adult women /11/, have a body fat in excess of the ideal 
maximum of 30% of body weight /12/. Further unpublished studies in Newcastle 
upon Tyne, England and Pécs, Hungary have confirmed these findings with 59% of 
adolescent girls in Newcastle and 71 % in Hungary having body fat in excess of 30% 
body weight. These findings demonstrate that adolescent girls with IDDM have a 
tendency to develop excessive body fat during puberty and detailed analysis shows 
that this is principally a phenomenon of the later stages of puberty coinciding with a 
time of increasing insulin dosage and poor glycaemic control.
RISK FACTORS FOR THE DEVELOPMENT OF OBESITY IN CHILDREN
WITH IDDM
In children with Type I IDDM, it is suggested that because of decreased 
insulin sensitivity at adolescence, insulin doses need to be significantly increased to
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Figure 1: Effect of puberty on body fat, insulin dose and HbAi
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maintain blood sugar control /14/ but despite the larger doses of insulin per kilogram 
body weight, blood glucose control often remains poor. Insulin has anti-lipolytic 
properties and in theory, larger doses of insulin may predispose to excess 
accumulation of fat.
However, although previous research /12/ has shown that girls in later puberty 
receive more insulin and have greater body fat than those in early puberty, there was 
no correlation between measures of insulin resistance /26/ or insulin dose (U/kg/d) 
/12/ and obesity. This finding suggests that failure to decrease insulin doses after the 
growth spurt is not the major factor predisposing to obesity though numbers in the 
groups studied were small.
Obesity occurs when energy intake exceeds energy expenditure. Energy 
expenditure is contributed to by basal metabolic rate (BMR), thermogenic response 
(e.g. to food and stress) and energy expended in activity. A decrease in any of these 
may predispose to weight gain and obesity.
IDDM and insulin therapy have significant effects on some components of 
energy expenditure. It is known that in children with IDDM, increased thermogenic 
responses to food /19/ and adrenaline occur /21/ compared to controls. In neither 
study however, were differences in BMR observed between children with IDDM and 
control subjects. In adults with poorly controlled IDDM, BMR is increased /23/ and a 
net loss of protein occurs /22/, though improved blood sugar control has been shown 
to decrease BMR and produce weight gain when no compensatory decrease in energy 
intake occurs /17/. It would therefore seem that as BMR is unaltered in patients with 
good glycaemic control and increased with poor control and as thermogenic responses 
in IDDM appear to be increased rather than decreased, reduced levels of physical 
activity may be the major mechanism resulting in decreased total energy expenditure 
and may thus have an important role in the development of increased body fat 
observed in adolescent girls with IDDM.
Little is known of the levels of physical activity in adolescents with IDDM. It 
may be hypothesized that levels of physical activity are decreased in these individuals 
because of concern about the concurrent risk of hypoglycaemic episodes during 
exercise. Questionnaire based studies have demonstrated that at all ages in healthy 
children, boys expend more energy than girls and that after the age of 14 years, there 
is an appreciable decline in physical activity levels in girls /24/. However, physical
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activity leading to improved physical fitness is known to alter glucose metabolism in 
IDDM. In combination with glycaemic control, physical fitness accounts for 73% of 
the variation of insulin mediated glucose utilization /6/, reducing the level of insulin 
resistance which occurs in puberty /4, 5/. However, exercise training alone in 
adolescents, whilst increasing insulin sensitivity and physical fitness, does not 
necessarily improve blood sugar control though it has been suggested that in 
association with alterations to diet and insulin, it may be of value in the management 
of IDDM /16/. Energy intake in adolescents with IDDM appears to be the same as 
that of healthy children /13/ though assessment of this by dietary recall may be 
unreliable in those diabetics with a tendency to overweight /3/. Although eating 
disorders are common in young women, there is no evidence that the incidence is 
greater in those with IDDM /9/.
FUTURE STRATEGIES FOR THE PREVENTION OF OBESITY IN 
CHILDREN WITH IDDM
In common with non-diabetics, it is likely that adolescents with IDDM take 
little physical exercise. They should be encouraged to take part in sporting activities 
which may be encouraged through participation in residential diabetic camps with an 
emphasis on outdoor pursuits. Advice on insulin reduction and increased glucose 
intake is necessary to ensure that such individuals are at minimal risk of 
hypoglycaemia which might dissuade them from future involvement in these 
activities.
In addition, it is important that a determined attempt is made to reduce 
background daily insulin dosages when adolescents approach the end of puberty and a 
resolution of the transient increased insulin resistance occurs /5/. This may also allow 
dietary education to focus on decreasing dietary calory intake with consequent 
benefits on lipid profiles /18/.
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OBESITY AND THE RISK TO PHYSICAL HEALTH
KFM. ZWIAUER
Department of Pediatrics, General Hospital St, Pölten, Austria
There are very few useful recent studies on the feelings and attitudes of obese 
children and their families towards their obesity and the consequences of being obese. 
The list of consequences for obese children and adolescents is long: girls are worried 
about figure, clothes, friends and partners, boys about restriction on sport and 
physical activity. All are teased at school and have higher levels of emotional 
troubles. Many obese children are characterized by low self-esteem, depression, lack 
of confidence and poor self-discipline. Misperception of body function and 
disturbance of body image is a consistent psychopathological feature. Parents feel that 
they had produced imperfect children by infantile overfeeding. Often there is 
considerable family conflict in the homes of obese yougsters who were harassed by 
lean siblings. The families are more often introverted, socially isolated and passive. 
Generally obese girls are more obsessed by their obesity than boys. Obesity of early 
onset appears to be associated with most striking body image problems. Those who 
become fat in childhood and adolescence are at risk of becoming emotionally 
disturbed as a consequence. Psychosocial problems in childhood persist in adults, 
however, obese adult persons rationalize the problems and many of them can cope 
and live with these problems. Obese children and adolescents, however, at least partly 
may become adult "bing" eaters or restrained eaters with disturbed eating behavior 
and likelihood of persistence and aggravation of obesity.
Numerous studies have shown that overweight people are at increased medical 
risk and there is no doubt that obesity in adulthood is strongly associated with a 
variety of serious diseases and an increased overall mortality rate /1, 2, 3/. 
Cardiovascular disorders, hypertension, dyslipidemia, cancer, gallbladder disease, 
gout, arthritis, psychosocial disability, orthopaedic, dermatological disorders, 
cholelithiasis and others are related to obesity. However, in childhood and 
adolescence problems for obese children and adolescents primarily result from
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psychological and social consequences. Children probably suffer more than adults 
from the fact "obesity".
For adults obesity generally is accepted to be a more or less serious health risk, the 
question is, however, whether this is true also for childhood and adolescence. In the 
short-term, there is little relationship between obesity and morbidity/mortality, 
whereas in the longer term there is a strong relationship. The Framingham Heart 
Study (data based on age adjusted rates for 2219 men who at the beginning of the 
follow-up were from 29 to 61 years of age, free of coronary heart disease and cancer 
and from whom weight, height, and smoking information was available) clearly 
demonstrated the increasing risk with the duration of obesity /4/. The relationship is J- 
shaped, with the lowest mortality occurring around the "desirable" value of 100. The 
longer the follow up, the stronger the association between obesity and mortality.
The long-term relationship between obesity and risk of cardiovascular disease is 
strong for both men and women /5/. However, is there any risk for children and 
adolescents? In terms of acute risk for cardiovascular diseases there is of course no 
immediate risk, however, even in children and adolescents there are demonstrable 
subtile metabolic effects of obesity and childhood obesity and in particular obesity of 
the adolescent tends to persist into adulthood and the likelihood of medical 
complications increase with duration of obesity. The medical risk of childhood 
obesity, therefore is a problem of persistence and duration. Nevertheless we should be 
aware that even in children obesity is associated with a number of risk factors, which 
are known to promote morbidity and mortality in adulthood.
It is well known that obese adults have high total cholesterol, LDL-cholesterol and 
triglycerid levels and low HDL-cholesterol levels /6/. Several studies found these 
adverse effects already present in childhood obesity. Hyperlipidemia occurs in 
approximately one-third of all adolescents, and there is some suggestion that the 
prevalence of hyperlipidemia is increased in obese adolescents.
In adults, obesity is the most powerful risk factor for noninsulin-dependent diabetes 
mellitus, with both its magnitude and duration being important considerations. The 
American Cancer Society Prospective Study showed that compared with persons of 
"ideal" weight, those with relative weight equal to or greater than 140% have 
mortality ratios of 5.2 (men) and 7.9 (women) because of diabetes mellitus. These 
mortality ratios are greater than for any other disease. In children diabetes mellitus is 
clearly a risk in patients with Prader Willi’s syndrome. Impaired glucose tolerance 
test and hyperinsulinemia, however, is frequently found already in obese children and 
adolescents: in a recent study we could find an abnormal glucose tolerance test in
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12% of the obese children and increased basal insulin levels in 48% /7/. Although 
the clinical relevance of these results is not clear, hyperinsulinemia and impaired 
glucose tolerance are potential risk factors not only for diabetes mellitus but also for 
hypertension and cardiovascular diseases.
During the last years, body fat distribution has gained considerable interest and 
besides obesity, different body fat patterns have been related to disease /8/. Several 
studies showed that upper body fat patterns are associated with diseases typically for 
obesity (hypertension, diabetes mellitus, hyperinsulinemia, hyperlipidemia etc.). This 
seems to be true also for adolescents: it is well known that obese children tend to have 
higher blood pressures than lean and these elevated levels do not appear to be due to 
increased salt intake or preference. Although hypertension occurs with a prevalence 
of approximately 1 to 2% in adolescents, obese adolescents account for approximately 
50% of all cases of adolescent hypertension. Moreover, in recent studies it could be 
demonstrated that besides the degree of obesity even in adolescents the body fat 
distribution plays an importance in regard to systolic and diastolic pressure /6/. Upper 
body fat distribution is closely and positively associated with higher levels of these 
risk parameters. Similar results have been found for hyperinsulinemia and 
dyslipidemia. Therefore, there is increasing evidence that body composition and 
adiposity localisation play an important role in the development of morbid aftereffects 
of obesity.
Whereas in adulthood medical consequences are directly threatening the health of 
obese patients, in childhood and adolescence major problems for obese children and 
adolescents are arising from psychological and social consequences /9, 10/. At no 
time persons are confronted so directly and frankly with psychosocial problems 
arising from being obese than in childhood and adolescence. In examining the world 
of obese children we must look at peers, family and school. The major problem of 
these children is not the excess weight alone, but the view of others in the 
environment. Few problems in childhood have as significant an impact on growth and 
development and psychosocial functioning as obesity in a child. Early studies 
demonstrated that children as young as five years of age had learned to associate 
obesity with a variety of negative characteristics. The images of ideal weight are 
probably reinforced by images of thinness on television.
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IS "IDEAL WEIGHT" IDEAL FROM EVERY ASPECTS?
E. MORAVA
National Public Health and Medical Officer Service, Baranya County Institute
Pécs, Hungary
In adult persons body mass index (BMI) is considered as a good indicator of the 
nutritional status and a reasonable estimate of body fatness. Life expectancy and 
incidence of major diseases among subjects belonging to different BMI ranges give 
good opportunity to determine the BMI ranges associated with the lowest health 
risks, i. e. the ideal weight range for a given height from the point of view of good 
health.
For adolescents the BMI is not an accepted tool to characterize body fatness. In 
this age group the assessment of risks for major diseases in later life in relation to 
fatness is difficult /2/. There are no well elaborated recommendation for the ideal 
level of fatness in adolescents. To evaluate the health impacts of body fat content in 
adolescent girls we studied the relationship of body fatness with iron status, skeletal 
size and serum lipids. Iron deficiency is the most frequent nutritional deficiency 
among young females in Hungary. It influences physical and mental working capacity 
and presents major problems during pregnancy. Skeletal size is an important indicator 
of skeletal development. In adolescents the skeletal size reflects the bone mineral 
content /3/. A well-developed skeleton is supposed to postpone the osteoporotic 
fractures characteristic to the postmenopausal years /4, 6/. Although the significance 
of elevated serum cholesterol in adolescent girls has not yet been fully clarified, 
higher levels of blood cholesterol may indicate higher risk for cardiovascular diseases 
in later life /5/.
354 girls aged 16.5-18.5 years, attending secondary schools at Pécs were studied. 
Standard procedures as described by Cameron were used to measure body mass, 
height, skinfolds and the wrist diameter /1/. The diameter of the clavicle was 
measured at the middle of the left clavicle on standing subjects, with shoulders 
slightly elevated and let forwards. The measurement was taken in the frontal vertical 
plane. At the same site, above the clavicle the skinfold was measured as well, using 
Lange caliper. The breadth of the clavicle was calculated by subtracting the skinfold 
value from the clavicle diameter. Fasting blood was taken from the cubital vein. 
Serum ferritin was determined with immunoradiometric assay (Izinta Hungary). 
Blood total cholesterol was determined by CHOD-PAP method (Boehringer). Sums
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of 3 trunk skinfolds (subscapular, suprailiac and chest lateral) and BMI were used as 
indices of obesity.
The sums of trunk skinfolds were positively related with the skeletal size 
parameters: girls with thin skinfolds had thin bones, girls with thick skinfolds had 
thick bones (Table I). Similar relationship was observed between BMI and skeletal 
size.
TABLE I
Relationship between skeletal size and the sum of trunk skinfolds in girls aged
17-18 years
Sum of trunk skinfolds 
quintiles
Clavicle width 
mm
Wrist width 
mm
1 15.5 (SD 2.0) 47.7 (SD 2.9)
2 16.2 (SD 2.1) 47.9 (SD 2.9)
3 16.4 (SD 2.2) 47.9 (SD 2.5)
4 17.0 (SD 2.7) 48.7 (SD 2.8)
5 17.5 (SD 2.4) 49.0 (SD 3.2)
Prevalence of blood total cholesterol levels exceeding 5,2 mmol/L was positively 
related with the level of fatness: it was highest in the fifth (highest) quintile of trunk 
skinfolds. Prevalence of low serum ferritin values was negatively related to trunk 
skinfolds: in the fourth and fifth quintiles of skinfolds the prevalence of low 
ferritin (< 13 pg/L) values was lower than in the first three quintiles. Both the 
prevalence of increased total cholesterol and of low ferritin concentrations in the 
lowest quintile of skinfolds did not fit into the general trend of prevalences (Table 
II). Similar observations could be made if the prevalences of low ferritin and high 
cholesterol values were investigated in the different quintiles of BMI.
Our findings indicate that in girls aged 17-18 year it is unwise to recommend strict 
and narrow ranges of indices for fatness (BMI or skinfold ranges), because the 
relatively low indices which are the best for healthy blood lipid levels are less 
favourable from the point of view of skeletal development and iron status. One must 
consider family history of the girls and nutrition related health risks in the community 
before making evaluation or giving advice concerning "ideal weight".
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TABLE II
Prevalence of low serum ferritin values (< 13 pg/L) and high blood total cholesterol 
levels (>5,2 mmol/L) in girls groupped according to the sum of trunk skinfolds
Sum of trunk skinfolds 
quintiles
Prevalence 
of low ferritin
%
Prevalence 
of high cholesterol
%
1 17.5 11.4
2 26.3 9.7
3 19.0 12.1
4 11.6 18.0
5 12.8 19.1
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SECONDARY OBESITY
G. CH1UMELLO, P. BRAMBILLA, P. MANZONI, A. PIETROBELLI
Pediatric Department, Endocrine Unit. Scientific Institute H San Raffaele, Milano,
Italy
Obesity can be a feature of a large variety of diseases even if 
secondary obesity represents only a small percentage (<5%) in the 
etiology of obesity. Although rare secondary obesity must be 
considered separately for its implications in differential diagnosis, 
clinical features, management and therapy.
DIFFERENTIAL DIAGNOSIS
Most cases of secondary obesity can be classified in two main groups: genetic or 
polimalformative syndromes (Prader Willi, Bardet-Biedl, Alstrom, Cohen, Down, 
Carpenter, etc.) and endocrine disorders (hypopituitarism, hypothyreodism, Cushing 
syndrome, hypothalamic lesions, etc.); others are often part of metabolic 
abnormalities (i.e. in IDDM).
Some clinical characterist are common and peculiar in the overall group. The 
presence of short stature, particularly if associated with mental retardation and 
delayed bone age, strongly suggests a secondary obesity. Furthermore the severe 
degree of long standing obesity may represent another useful marker in differential 
diagnosis from primary obesity. The further step is to look for other specific signs of 
each syndrome or of endocrine abnormalities (Table I).
Late diagnosis is still very common as a consequence of the difficulties in 
discriminating such cases from simple obesity. In addition in some of these 
syndromes the onset of excessive weight gain is not early in infancy as in Prader Willi 
Syndrome (PWS).
Patient history represents another interesting source of suggestions and must be as 
accurate as possible. Neonatal period, for example, shows additional clarifying details 
in many of the genetic syndromes. Food behaviour and school performance must be 
evaluated.
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TABLE I
Main clinical features associated with obesity in genetic syndromes
PWS Bardet-Biedl Alstrom
neonatal hypotonia retinitis pigmentosa deafness
hypogonadism plydactilia diabetes
acromicria hypogonadism nephropathy
dysmorphic features 
chr. 15 deletion
retinitis pigmentosa
CLINICAL FEATURES
Accurate clinical evaluation is fundamental in order to distinguish genetic 
syndromes from endocrine diseases.
Auxologic measurement reveals short stature as well as excessive body weight for 
height. Moreover dwarfism can be disharmonie in hypothyroidism.
Particular attention has to be dedicated to fat distribution; centrally distrbuted 
adiposity is characteristic of all the endocrine obesity and some of the genetic 
syndromes (Cohen, Bardet-Biedl). Dismorphism of the face or extremities are to be 
looked for. Eye abnormalities are common in genetic obesity, especially retinitis 
pigmentosa in Bardet-Biedl syndrome.
Hypogenitalism, pubertal delay and menstrual abnormalities are frequent in the 
majority of the genetic syndromes and in the most of the endocrine diseases; accurate 
clinical and hormonal evaluation is strongly suggested especially during adolescence. 
When an endocrine disorder is suspected, clinical examination must evaluate specific 
signs; for example striae rubre, hirsutism, hypertension suggest cushing's disease. 
Specific homonal tests suport the diagnosis in this group.
A common feature of all endocrine and some of the genetic syndromes is a 
reduced muscle compartment, leading to limb hypotrophy and muscle weakness. 
Bone mineral content is often reduced. This two latter aspects are peculiar to 
secondary obesity; while in simple obesity the excessive adiposity is generally 
associated with increased lean mass (muscles, internal organs and bone).
MANAGEMENT
For low prevalence and complexity of secondary obesity, patients are often referred 
to specialized departments.
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Nevertheless, knowledge and information about this rare type of obesity must be 
increased in order to improve early diagnosis and treatment.
In any case a multidisciplinary approach is needed. Ophthalmologic, radiologic, 
psychologic, endocrinologie and audiometric cheks are necessary for the correct 
diagnosis as well as for follow-up management. Psychological support is often 
indicated for frequent behavioural disorders. Difficulties in coping with abnormal 
food behaviour request frequent clinical controls with auxological examination and 
parental counselling. Periodic biochemical investigations on glucose tolerance and 
lipid profile are crucial, especially in genetic syndromes with higher incidence of 
cardiovascular diseases, dislipidemia and diabetes.
THERAPY
The causal treatment of the endocrine disorders usually resolves the excessive 
adiposity in few months. When a hypothalamic syndrome develops after surgery for 
hypothalamic-hypophyseal tumor (craniopharingioma, germinoma, etc.) obesity is 
very frequent (50% after 6 months and 90% after 1 year in our Department) and an 
efficient treatment is still unsatisfactory. Moreover the hypothalamic syndrome shows 
abnormal food behaviour with bulimia, aggressivity, hyperthermia and electrolyte 
inbalance which complicate the therapeutical approach. Few cases benefit from 
fluoxetine therapy even if long term results ate still controversial. In any case, 
compliance in dietary restriction is poor. Even in genetic syndromes a strict diet 
regimen is difficult.
Recently dexfenfluramine has been proposed in order to control appetite but in 
these cases benefits are only transient or absent. Physical activity is another 
potentially useful therapeutic tool: mental retardation as well as muscular hypotonia 
limit the efficacy of an exercise program is these patients.
New and interesting perspectives seem to derive from growth hormone treament. 
Despite an irrelevant effect on height, GH has shown dramatic influence on fat 
reduction and lean mass increase in PWS. Furthermore behavioural disorders 
improve, showing less aggressivity and autolesionism during GH therapy.
Specific treatment is indicated when ocular, renal or cardiac anomalies are present 
as well as in overt diabetic patients.
When obesity is severe, or leads to respiratory abnormalities (i.e. obstructive sleep 
apnea) a surgical approach has been proposed.

Proc, of Congress of Childhood Obesity 163
CONVENTIONAL TREATMENT OF CHILDHOOD OBESITY
W. BURNIAT, C. van AELST
University Children's Hospital "Reine Fabiola" Free University of Brussels,
Brussels, Belgium
The last decades, the prevalence of childhood obesity was growing in the 
industrialized countries /1/. Three questions might be asked: are these children to be 
treated, at which age and how? Obesity in children is often associated to health 
hazards: high blood pressure, hyperlipidemia, hyperinsulinism, orthopedic disorders, 
sleep disturbances and mainly psychological aftereffects /2/. But it is also in many 
cases the onset of adult obesity /3/. In this regard, treating young obese could be 
considered a prevention of obesity in adulthood. A precoce development of adiposity 
in childhood - before the age 5.5 - prognoses the maintaining of an excessive fat mass 
at the end of growth /4/. Therefore it appears suitable not to delay the management of 
obesity when developed in young children. In this regard, diet remains a cornerstone 
even if psychological and behavioral aspects are important and to be managed as well. 
Several treatment programmes have been described mostly pluridisciplinary involving 
paediatricians, nutritionists, psychologists and physiotherapists. They reported 
generally on small samples. Besides, the costs of these programmes, not only in 
money but also in time and medical staff, seem to be incompatible with the large 
number of children to be treated. Therefore we tried to develop a baseline therapeutic 
approach which could be promoted by pediatricians, general practitioners and 
dietetians.
From 1986 to 1994, about 1000 children attended our outpatient clinic for 
childhood obesity. Most patients experienced a "precoce adiposity rebound" 
according to the definition of Rolland-Cachera et al. /4/ and most also exhibited a 
Body Mass Index (BMI) superior to 150% of the P50 BMI for the age. The schedule 
of the management programme is summarized in Table I. A general examination was 
performed and blood biological data were recorded namely in order to exclude a 
secondary obesity or metabolic abnormalities associated to essential obesity. The 
daily food intake was recorded by the child and his parents in a three-days diary. This 
allowed the dietetian not only to evaluate the alimentation in terms of intakes but also 
to track eventual disorders of the timetable. We found the total caloric intake was 
close to the Recommanded Dietary Allowances (RDAs) but significantly higher in
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children whose BMI was superior to 150% of the P50 BMI for age and in children 
watching television for more than 15 hours a week - as a result of snacking /5/.
TABLE I
OUTLINE OF THE TREATMENT PROGRAMME
First visit
. interview
. physical examination 
. anthropometry
Biological tests Dietary evaluation
Second visit
. discussion of the dietary evaluation 
. presciption of a diet 
. physical activity programme 
. behavioral aspects 
. anthropometry
Next visits (on the 4th week)
. anthropometry 
. diet (adaptation)
. discussion
After a 6-month follow-up
. second dietary evaluation 
. diet modification
The fat content was high (38.7 and 39.5%, respectively in girls and boys) with a very 
low polyinsaturated fatty acids to saturated fatty acids ratio (P/S: mean=0.25). The 
fiber and the water intakes were poor. But this baseline diet was comparable to that 
we recently studied in young non obese scholars aged 6 to 11 years. We also found 
that nearly 20% of the obese children had usually no breakfast /5/. Most patients had
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lunch at school. School dinners in Belgium are generally delivered by private 
companies: they are rather fat, filling with sauce, lacking in vegetables and presenting 
with meat of a poor quality. This was an argument to recommend a "home made 
lunch”. The three days food diary was discussed with the child and his family. We 
proposed an alternative diet restricted to about 65% of the RDAs but providing 
enough of all the nutrients allowing a normal growth according to the Committee on 
Nutrition /6/. The lipids were lowered to 30 of the total caloric intake. In the 50% 
carbohydrates we reduced the amounts of sucrose and other additive sugars. The fiber 
intake was significantly increased by the consumption of more vegetables, fruits and 
cereals. The water intake was prescribed to a minimum of 1.5 ml/kCal/day. The 
schedule of this new diet is summarized in Table II. We insisted all the nutrients were 
common available supplies and not so-called "dietary" or "light" products. Only 
aspartam was authorized as a sugar taste additive. The purpose of such a hypocaloric 
balance alimentary programme was to offer a realistic and reasonable renewed 
gastronomy not only to the obese patient but also to all the members of his family. 
"No more chips, fried potatoes, candy bars, sweets and cola" was a rule but we 
insisted also on positive arguments: "we are going to help you to eat in a better way". 
And let us discover new cooking, new choices in nutrients that could promote better 
familial menus. We found an improvement of the alimentation in 75 children who 
succeeded in loosing excess BMI for more than 6 months /5/. However there was a 
difficulty to increase for instance the fiber consumption, mainly in young children 
who were often "reluctant" to most vegetables. Also the total water intake remained 
too low.
Besides the dietary prescription, a physical activity programme was proposed: sport 
(in clubs), summercamps, participation in youth associations, ... Behavioral and 
psychological aspects were discussed from the first session. Eventually, a specific 
management was organized with the help of a psychologist working in the team.
In 1993 /7/, we reviewed the course of 395 obese children aged > 6 to < 12 years 
(group 1) and 240 adolescents aged > = 12 to < 17 years (group 2). After 12 months, 
24% of the group 1 were still treated and 15% exhibited a further decrease of their 
excess BMI. In group 2 only 9% were still followed and 7% were still slimming. It 
must be emphasized that the adolescents were proportionally more obese than the 
younger children and had also a longer duration of their obesity: this was of worse 
prognosis. Also we might consider that young children were more "under the control" 
of their parents than were the adolescents. In this last group, the personal motivation 
was probably more determinant requiring a more specific support.
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TABLE II
OUTLINE OF THE DAILY REGIMEN
BREAKFAST - cereals, semi-skimmed milk, no sugar or
- slice(s) of bread, bread roll(s), 
thin scrape of low energy margarine, 
ham of other low calorie delicatessen 
or skim-milk cheese
- coffee, tea, semi-skimmed milk (if not added 
in cereals)
BREAK
LUNCH
HOME
SUPPER
- a fresh fruit or a juice fruit
- soup (skimmed) or salad vegetables
- slide(s) of bread, sandwich(es), 
low calorie delicatessen or cheese
- a fresh fruit
- low calorie yoghurt of skim-milk white cheese
- soup or salad vegetables
- lean meat (grilled or boiled), fish, chicken 
(without the skin)
- vegetables (large amounts), no sauce
- small portion of boiled potatoes, rice or
noodles
- a fresh fruit or a low energy pudding
Home made French dressing with low calorie nutrients (as low energy 
yoghurt).
No additive sugar-eventually aspartam.
Drink: water, sometimes a "light" lemonade.
We can compare this conventional treatment programme to more sophisticated 
strategies - very low calorie diet or family behavioral programmes, for instance. A 
recent study of Figueora-Colon et al. /8/ demonstrated a comparable success of 
hypocaloric balance diet and very low caloried diet in a small sample of adolescents.
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Epstein et al /9/ showed better results in a family trained group on the long term (10 
years) than in control groups. But again this was involving a very few patients and a 
very specialized medical team.
Considering the important and growing number of obese children and adolescents 
and their large number becoming obese adults, a baseline consensus for management 
is needed. This conventional therapeutic approach could be promoted as a primary 
therapy by general practitioners, pediatricians and dieticians. For the very obese 
children and for most adolescents more specific programmes, prepared by well 
trained pluridisciplinary teams are certainly needed. We have also to include in this 
prospect a preventive action towards nutrition in young children and the tracking of 
early weight excess development.
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DRUG TREATMENT OF OBESITY
Arne ASTRUP, S. TOUBRO
Research Department of Human Nutrition & Centre for Food Research, 
Copenhagen, Denmark
INTRODUCTION
Most of our experience in drug treatment of obesity comes from clinical trials 
carried out in adult obese patients. The majority of the published studies are carried 
out in women without reported obesity related complications. Therefore our 
knowledge on the effect and safety of the use of pharmacotherapy in children and 
adolescents is modest, and the health benefits of prolonged treatment are unknown. 
Based on surrogate end-points such as blood pressure, serum lipids and glucose 
tolerance tests it is obvious that weight reduction assisted by pharmacological agents 
is expected to reduce risk of atherosclerosis and type 2 diabetes. In addition, quality 
of life in an emotionally vulnerable period of life is another important parameter to 
take into consideration.
WHO SHOULD BE TREATED?
Eventually the decision about who to treat should be based on an individual 
assessment of all available factors. Serious efforts to achieve weight loss may be 
contraindicated in children where a family history of obesity is lacking, as it is known 
that about a third of those with childhood overweight and obesity will become normal 
weight adults, probably spontaneously. Nevertheless, pharmacological treatment 
should be considered in patients where diet therapy and behaviour modification have 
failed if:
1/ They have complications of obesity
2/ Abdominal fat distribution and other risk factors are present 
3/ Weight loss is critical e.g. pre-surgery.
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DURATION OF PHARMACOLOGICAL TREATMENT?
Currently available drugs potentiate an efficient diet by 0.5-1 kg per month for 
about 6 months. They subsequently prevent relapse. Treatment should continue until a 
desirable weight loss is achieved, and dietary habits and exercise behaviour are 
permanently changed. Anorectic agents do not seem to loose their effect during long­
term use, so permanent treatment is an option in high-risk patients with complications 
to obesity. One should be aware that pharmacological agents have no effect after 
discontinuation.
PHARMACOLOGICAL MANIPULATION OF FAT BALANCE
In the prevention and treatment of obesity it is often stressed that it is important to 
achieve an increased energy expenditure. This rests on the assumption that energy 
intake is not adjusted to match expenditure, which would maintain energy equilibrium 
and keep body energy stores unaltered. This assumption is certainly never entirely 
fulfilled, and it is more the exception than the rule that an increased energy 
combustion is entirely covered by oxidation of fat from the stores without any 
compensation in energy intake. The pharmacological corollary is that any use of 
thermogenic agents should include a suppression of energy intake, either 
pharmacologically, or voluntarily by diet. The principle pharmacological agents act 
mainly as appetite suppressants, but several compounds possess thermogenic 
properties. The adrenergic acting ß-agonists are probably the most promising of these. 
Dexfenfluramine (dF) has been demonstrated to exhibit both anorectic and 
thermogenic properties. Non-selective sympathomimetics possess well documented 
anti-obesity properties and they represent an alternative to serotonergic agents.
THERMOGENIC DRUGS
While energy expenditure may increase 10-fold during exercise, the thermogenic 
effect of pharmacological agents is much more modest. Sympathomimetic 
compounds and ß-adrenergic agonists can increase resting energy expenditure by 10- 
15%, and slightly potentiate the thermic effect of foods. Energy expenditure may be 
increased by 5-10% on a 24-h basis. When compared quantitatively with exercise, one 
realises that it is crucial that drug-induced thermogenesis is not fully compensated by
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an increased energy intake. According to the concept of macronutrient balances, 
compensation could be avoided if the increased energy expenditure increases the 
proportion of relative fat oxidation (i.e. decreased RQ).
USE OF SYMPATHOMIMETICS IN OBESITY
Ephedrine (E) decreases body fat in obese subjects by a dual action: suppression 
of appetite and stimulation of energy expenditure covered by fat oxidation. The 
thermogenic and clinical effects are potentiated by adenosine antagonists such as 
caffeine (C). The metabolic effects of ephedrine are mediated by beta-adrenergic 
receptors (BAR), and recent experimental studies show that not only BARj, and 
BAR2 , but also BARß are involved in its thermogenic effect.
Combinations of E+C seem to maintain their anti-obesity effect during continued 
treatment to 6 mo, and may subsequently prevent relapse (6-12 mo) /1/. E+C offsets 
the immediate antihypertensive impact of diet-induced weight loss, but this effect is 
transient, and after 8 weeks of treatment reduction in blood pressure is 
indistinguishable from that of a placebo-treated group. Independent of weight loss 
E+C prevents the decline in HDL-cholesterol associated with weight loss, and 
increases the ratio of HDL-C to total-C, whereas it has no effect on fasting glucose 
metabolism /2/. In a double-blind comparison of E+C and dexfenfluramine (dF) in 
overweight and obese subjects the weight loss after 15 weeks was similar (8.3 vs. 6.9 
kg), but in a subgroup (BMI > 30 kg/m^) weight loss was larger in E+C than in dF 
(9.0 vs. 7.0 kg) /3/. dF caused an immediate reduction in blood pressure, which was 
not found with E+C, but after 15 weeks blood pressures were similarly reduced. 
Whereas E+C may be more effective in more severe obesity, dF has been found to be 
more effecient in middle-aged and elderly patients, and is preferred for the 
management of obese hypertensives. With the current pharmacotherapy of obesity 
there is a need for increased knowledge to allow a more differentiated treatment, 
tailored individually to age, gender, BMI and metabolic characteristics. This 
shortcoming may be partly solved by newer, more selective BARß agonists which are 
promising agents and are presently being examined in obese patients.
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WHAT DOES AN INTERNIST EXPECT FROM PAEDIATRICIANS TO DO 
IN ORDER TO PREVENT OBESITY?
L. HALMI
Central Hospital of Ministry, V. Interior Department of Medicine Budapest, Hungary
According to the Hungarian Annual of Statistics /3/, our population has further 
decreased in 1993. While mortality is continuously increasing, the number of live 
births is decreasing in Hungary. These are well-known tendencies. The increasing 
mortality and morbidity are partly due to cardiovascular diseases which are frequently 
accompanied, or the consequences of obesity. According to our epidemiological 
survey /2/ the prevalence of obesity in a cohort of chronically ill patients was 39%. In 
1988 others /1/ found the prevalence of overweight in the Hungarian adult population 
25%. Obesity is an independent risk factor of coronary heart diseases, hypertension, 
stroke, diabetes mellitus, dyslipoproteinaemias and gall bladder diseases. In spite of 
all that, obesity is seldom recognised as a potentially harmful health problem and is 
not treated according to its importance. Unfortunately most of our treatment-schemes 
for obesity purely concentrate on weight reduction, which one of the reasons of the 
poor long-term results. The change of our life-style, our manners is indispensable. 
The regular and abundant meals (mainly supper), the increasing length of time we 
spent in the comfortable TV-arm-chairs, in front of the TV, the lack of regular sports 
activities all lead to energy-storage. Beside genetic components social and cultural 
factors also worsen the situation. The busy life-style (spare-time jobs, the struggle to 
earn enough money to meet the social requirements), friends with similar attitude, the 
general disinterestedness in healthy way of life, are all factors promoting weight-gain. 
The traditional Hungarian cuisine is very tasty but rich in energy and fat, and poor in 
fibre. Our energy-rich nutritional habits are the greenhouses of obesity.
If we invited a guest for a cup of tea and some cakes, or children for hot chocolate, 
we could not stand in front of the world. We generally offer much more to eat. Why 
can't we emphasise again conversation, chatting, listening to music or playing with 
the children instead of showing off with the menu?
Most of the people coming home in the evening open the fridge-door and start to 
eat immediately. We have forgotten the beautifully laid tables with flowers. Instead of 
calm family meals, we talk about unpleasant memories of the day, spoiling the mood 
and forcing the whole family to compensate for it by overeating. We need to pay 
attention to not only what and how much, but also when and how we eat.
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The other important feature of our life-style is the lack of sports activities, while in 
most of the Western European countries gymnastics, jogging, walking or cycling are 
quite common (at least in the upper social classes). It is true that sports wear is 
expensive for most of the Hungarian families. However, this cannot explain why so 
few tourists are seen during the weekends. Great variety of excuses are found for not 
cancelling the Sunday hike. We do not even visit museums, how could we think of 
climbing mountains.
It is no doubt, computers and TV teach the children a lot as they push all day long 
the remote control, but will they be fit enough to utilise their knowledge? The optimal 
ratio of physical and mental activities has to be found.
Since obese patients after weight reduction are post obese and not healthy persons 
with normal body weight, obesity can only be treated but never cured. So it is 
straightforward that the only possible way of influencing adult obesity is prevention. 
Intrauterine nutrition, nutrition during infancy and childhood and regular physical 
training are all of major importance in the prevention of childhood and adult obesity
The most important tasks are the following:
1/ Prevent obesity by educating, teaching children how to live a healthy
"preventive" life-style
2/ Treat obese children and follow them up thoroughly.
The obese and non-obese have to learn the magic four: what, how much, when and 
how to eat. To have a meal instead of just eating. To enjoy the meal even if it is a 
diet. Let or even encourage them to pursue some sport, since those who are not 
involved in any kind of sport during in the childhood years would scarcely start it in 
adulthood. They need to improve their self-esteem and self-discipline so as not to 
pursue dreams and not to look for resolution in eating. It is also important to teach 
them how to dress, not to put on old tight clothes in the hope of losing weight but to 
become too thin for their large dresses.
A close and continuous contact between the child and the doctor, psychologist, 
dietician, physiotherapist is essential because the key of the successful treatment is the 
good compliance.
Ensure continuous control for the children up to adulthood. The period of 
adolescence is extremely dangerous since at this age children's behaviour changes and 
their compliance decreases on one hand and this is the time when paediatricians 
release the hand of the obese child and the internist is unwilling to admit him among 
his elderly patients on the other.
Well, I know we internists expect too much from paediatricians, but the prevention 
of adult obesity is almost exclusively in their hands. On the other hand adults who
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have already acquired a healthier life-style will show a good example for their 
offsprings.
If a healthy life-style became natural in childhood it, would be easier to maintain it 
in adulthood. This work is not an easy task. Decades are needed to cure what decades 
have spoiled.
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CAN CHILDHOOD OBESITY BE PREVENTED?
M. CAROLI1, S. CHIARAPPA2, A. DI TORO1, F. PULLANO1
'Clinica Pediatrica III - 2Universita di Napoli. 2Divisione Pediatrica - Ospedale S. 
Maria degli Angeli, Putignano, Bari, Italy
All of us, and the majority of our children, live in an environment that overexposes 
us to obesity promoting factors (diet, media, advertisements, social eating habits, etc.) 
and underexposes us to protective physical activities (cars, elevators, few and 
dangerous and expensive places to perform physical activities). As a consequence, no 
one is immune to developing obesity in the developed countries. It may even be 
reasonable at this time to stress a structured preventive porgram to high risk subjects 
who basically consist of children of obese families. The efficacy of the program 
directed to high risk subjects should be increased through an informative general 
program directed to all the population using the mass media. This requires a change in 
social and economic policies because obesity prevention does not have any economic 
backing, while food advertising, and food sponsors, and even slimming products for 
both government and commercial television represent a lot of money.
We must try however to warn people of the risks of obesity in order to set limits 
for both the quality and the number of food commercials during the day. This is 
especially important during children's programs. We can accomplish this through the 
influence of the medical community on our governments, consumer unions and even 
health food companies. We have seen the success of the method already in other 
health campaigns for smoking, immunization, and AIDS. Only through a mass media 
prevention program, directed (openly and/or subliminally) to all the population is it 
possible to create an opinion movement in order to get a healthier behavior. In the last 
few years, psychologists and sociologists have gained a good knowledge of some of 
the factors involved in health-related behaviors. This knowledge is the theoretical 
base for planning strategies to induce favourable behavioral changes.
Hovewer, developing a preventive program for childhood obesity is not easy 
becuase of the multiple factors in its genesis. Among these factors the familial ones, 
both genetic and environmental, have a very strong power on the onset and on the 
outcome of obesity in childhood. One of the tasks of the family, all over the world, is 
to be a culture-transmitter through development and/or maintenance of knowledge, 
attitudes, values and habits. So, before trying to change "bad behaviors and habits", 
we need to understand why people have certain beliefs and then act in certain ways.
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We then need to consider what they get in return, by way of reinforcing factors that 
cause them to maintain this specific behavior.
The Bandura's conceptual model, called social-cognitive theory, is the theory most 
used for the development of health behavioral change programs.
This theory states that each subject develops, changes, and maintains positive or 
negative behaviors on the basis of several personal, behavioral and environmental 
factors. These factors are seen through direct and/or indirect relationships with 
parents, peers and media.
In the obesity field, in order to be successfully engaged in a preventive behavior, 
an individual must have: 1/ knowledge about the associations between certain 
behaviors (reduced activity and excess of nutrient intake) related to obesity; 2/  belief 
that he is susceptible of becoming obese and that the consequences of it will be 
negative; 3/ belief that a preventive behavior will prevent or reduce the onset or 
severity of obesity (outcome efficacy); 4/ trust in himself that he is capable of 
performing new preventive behaviors (self-efficacy) and in having or learning the 
skills required to perform these behaviors successfully; 5/ belief that the benefits of 
acquiring a different behavior outweigh the cost (benefits vs. difficulties); 6/ Last, he 
must get behavioral reinforcement from family, society and peers for performing the 
new behaviors.
Since the parents act as role models of behaviors and are the most important source 
of reinforcement for children, a family approach is necessary for successful 
prevention of childhood obesity. However, the role models of parents, which is very 
strong in early childhood, becomes less evident as the child enters the adolescent 
years. Then peers and media figures become the main role models, so the approach 
must be different at different ages.
A related question emerges: "When or at what age is it more convenient to start a 
preventive program?” We have arguments for and against each age.
Starting a preventive program in early childhood has the following positive 
arguments: 1/ persistent childhood obesity develops by age 4, 2/ access to food 
depends on the child's caretakers, so the program could focus only on parents, 
avoiding the problems posed on the required independence of adolescents. In later 
years the child's or adolescent's involvement outside the home (school, friends), may 
reduce parents motivation and power to address the problem.
On the other hand, children's health beliefs begin to be a coherent belief system 
about 9 years of age and become stable at about 10-11 years. Starting a preventive 
program at this age could present the positive effect to get an active involvement of 
the subject, who could also be tracked into the adolescence period of higher risk.
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The arguments against the two groups of age are: 1/ for early childhood there is a 
risk that the preventive effect will be very short and will finish before adolescence; 
2/ while it is a fact that the later age group may have health-beliefs and habits which 
are already too established to be permanently changed. In any case, there is no 
guarantee that preventive programs will be able to induce and maintain behavior 
changes until adulthood.
The second question that immediately raises: "When could we stop?"
For the time being there is still no answer. However, since the growing child comes 
from a simple environment, family, and goes into a more complex psycho-social 
environment of family, peers, school, media, the program should be established in the 
early childhood or childhood. Probably the best thing would be to perform new 
periods of training as "booster doses" appropriate to the developmental stage of the 
child.
The third question that may rise is: "Which behaviors should be targeted as top 
intervention priorities in order to accomplish a successful preventive program?"
Since childhood obesity is a multifaceted problem, the behaviors that need to be 
changed are not the same in different countries in different areas of the same country 
and in different families as well as at different ages of the subject. Instead of using the 
very same structured program for everybody, it could be more convenient evaluating 
the negative behaviors in the target population or family. After noting these negative 
behaviors, one could then evaluate their importance and their changeability, and try to 
act on the incentives that promote those behaviors. But "How can these behaviors be 
changed?" Incentives play a fundamental role in human behavior, so we must try to 
change the established negative incentives in favour of new healthier incentives. The 
social cognitive theory underlines that new, weak, or inappropriate-for-age incentives, 
can make the efforts to change the negative old behaviors useless. These must be kept 
in mind while working with children whose thinking is quite concrete and present 
oriented. Adolescents, even if they are more abstract and flexible in thinking, perceive 
themselves as independent and invulnerable and so are not oriented in changing their 
own behavior. In other words, speaking of good health and risk of morbidity in 
adulthood may have some effect on the parents of obese children, but it is almost 
totally ineffective when working with children and adolescents. So we should 
emphasize more proximal outcomes that are important for the young subjects, i.e. 
personal appearance for teenage-girls, good sport performance for teenage-boys, 
tangible rewards like toys for younger children. Once that the incentives have been 
decided, the child or adolescent must be helped in managing his behavior through 
learning and practicing self-regulatory skills.
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The first skill is self-monitoring to allow the child or adolescent to gain self­
diagnostic and self-motivational functions; in addition self-monitoring is useful for 
evaluating changes in behavior. The second skill is setting a goal which provides 
direction and reasons for behavior change. However, in childhood and adolescence, 
goals must be quite proximal, explicit, quite challenging, but not too difficult to 
achieve.
Since a positive judgment of self-efficacy is modified, by performance 
accomplishments, vicarious experience, emotional states, and verbal persuasion, the 
creation of a series of subgoals of increasing difficulty and their successive 
attainments may influence positively the child's or adolescent's self-efficacy and as a 
consequence, the feeling of power to change behavior.
The last question is: "Who should stimulate the obese family to change behaviors?" 
Behaviors are modeled by incentives and by leaders. The pediatrician can have a 
leading role in providing good incentives to the parents in order to achieve a positive 
health-related behavior. Since the family trusts the pediatrician from the very early 
age of the child, he can interact with the family, in order to change the behaviors of 
the child. At school age, the environment becomes more complex; there the help of 
teachers, psychologists and mass media is also an asset. The answer to the original 
question "Can childhood obesity be prevented?", is "Yes". We have the basic 
knowledge to start preventing childhood obesity by performing structured individual 
preventive programs for high risk subjects and at the same time starting a general 
preventive approach through mass media in order to improve the health-related 
behavior of the whole population. In conclusion, we pediatricians must always 
remember our outstanding role in prevention and in order to get positive results, all 
of us must strongly believe in the necessity and the possibility of preventing obesity.
ABSTRACTS
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OBESE CHILD?

Proc, of Congress of Childhood Obesity 183
INSULIN RESISTANCE, PLASMA SOMATOMEDIN-C (IGF-I) AND 
SERUM SEX HORMONE BINDING GLOBULIN (SHBG) IN CHILDHOOD
OBESITY
I. ILYÉS
Department of Pediatrics, University Medical School, Debrecen, Hungary
Childhood obesity may be characterised by basal and reactive hyperinsulinemia, 
insulin resistance, reduced growth hormone response to various provocative stimuli 
and normal or elevated plasma somatomedin-C (IGF-I) concentration. Obesity is 
commonly associated with low serum sex hormone binding globulin (SHBG) 
concentration in childhood, too.
For this reason the relationship between the degree of obesity (body mass index - 
BMI) serum immunoreactive insulin (IRI), plasma IGF-I and serum SHBG were 
investigated in children with obesity.
1. Insulin binding to erythrocytes (IB) and serum IRI were measured and 
relationship between these parameters and BMI wasinvestigated in obese children and 
age matched controls with normal body weight. IRI was increased and IB was 
decreased significantly in obese children compared to the data of the controls. The 
decreased IB was due to a decrease in the number of insulin receptors since it was not 
accompanied by alteration of half maximal inhibition dose (ID50). Strong negative 
correlations were found between BMI and IB and between BMI and IRI.
2. Serum IRI and plasma IGF-I were measured in children with obesity. Significant 
positive correlations were found between BMI and IRI, between BMI and IGF-I, and 
between IRI and IGF-I.
3. Serum IRI and serum SHBG were measured in children with obesity. Significant 
positive correlation was found between BMI and IRI, and significant negative 
correlations were found between BMI and SHBG and between IRI and SHBG.
These results suggest that /1/ there is an interrelationship between weight excess, 
hyperinsulinemia and insulin resistance in childhood obesity; /2/ IGF-I production in 
obesity is regulated by IRI depending on BMI and this regulating effect of insulin 
may be important in obesity since HGH production to provocative stimuli is reduced; 
/3/ insulin hypersecretion has an important role in determining the reduction of SHBG 
production in obesity.
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IS SCREENING FOR HYPERLIPIDEMIA IN OBESE CHILDREN 
WORTHWHILE?
Hilde AUDIENS, Karin DELANGHE, J. de SCHEPPER 
Department of Pediatrics, Academic Hospital Free University Brussels, Belgium
Given the tracking of lipid levels in childhood, obese children with an increased 
risk for cardiovascular disease might be identified very early by a screening for 
abnormalities in lipid metabolism.
In 80 obese children (27 boys, 53 girls) with an age between 5.0 and 15.9 years and 
a procentual overweight between 120 and 211%, a determination in fasting condition 
of cholesterol, trigliceride and HDL-cholesterol concentration was performed before 
treatment instauration.
The influence of age, sex, onset (before or after the age of 6 years) and degree of 
overweight (% overweight 120-140; 140-160; > 160%), body fat distribution 
(subscapular/triceps skinfold > or < 0 .8) and activity level (involvement in sport 
activities or not) on lipid levels was studied.
For the total group mean (±SD) concentration of cholesterol was 178 ± 34 mg/dl, 
or trigliceride 92 ± 43 mg/dl, of LDL cholesterol 118 + 30 mg/dl. Eleven patients 
presented a cholesterol concentration above 200 mg/dl, 7 patients a trigliceride level 
above 150 mg/dl and fifteen patients an LDL concentration above 135 mg/dl. Girls 
had significantly higher cholesterol (183 ± 38 versus 167 ±21 mg/dl (p < 0.05)) and 
trigliceride levels (99 ± 46 versus 77 ± 33 mg/dl (p < 0.005)). Age, onset and degree 
of overweight, type of fat distribution and activity level were without influence on the 
circulating lipid levels.
In conclusion, circulating lipid levels above normal adult values were found in 8 to 
18% of obese children. Given this relatively high frequency and the negative finding 
of a specific hyperlipidemia associated clinical status, screening for hyperlipidemia in 
all obese children seems justified.
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CONNECTION BETWEEN CHILDHOOD OBESITY AND LIPOPROTEIN
PARAMETERS
A. CZINNER
Heim Pál Children Hospital, Budapest, Hungary
Cardiovascular diseases stand on the first place of Hungarian morbidity and 
mortality statistics. Obesity is one of the main risk factors of cardiovascular illnesses. 
In order to determine body fat we did not use invasive method. To determine body 
surface fat we use ultrasound (soft tissue) method and the determination of visceral 
fat is possible with CT.
We examined the relationship of the visceral, body fat and the lipid and 
lipoprotein parameters (cholesterol, triglyceride, HDL cholesterol). We found a 
strong connection between the body surface fat and triglyceride level and the 
cholesterol and HDL-cholesterol level correllated with the visceral fat.
We found a relationship between the visceral (intraabdominal) fat quantity and 
the impaired glucose metabolism at the same time.
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CARBOHYDRATE METABOLISM IN CHILDHOOD OBESITY
L. BLATNICZKY
Buda Children's Hospital, Budapest, Hungary
Oral glucose tolerance test (OGTT) was performed in 91 obese (O) children from 8 
to 14 years of age being either in the stationary (S) or in the dynamic (D) phase of 
obesity. Capillary glucose (G), serum C-peptide (C-P) and immunoreactive insulin 
(IRI) were determined every 30 minutes for 180 minutes. The integrated values (Z) of 
curves and ZC-P/ZIRI ratio were calculated. The results were compared with data of 
15 nonobese children (relative weight < 120%) (C) of the same age. Specific insulin 
binding % of erythrocytes (SIB%) was determined in 9 S and 7 C children.
Weight
(kg)
ZG
(mmol/1)
ZC-P
(nmol/1)
ZIRI
(nmol/1)
ZC-P/ZIRI SIB
(%)
C (n=15) 28.3 31.8 5.66 1.00 6.11 6.5
DO(n=21) 12.6* 34.4* 16.47* 3.36° 4.77° -
SO(n=91) 77.8° 41.0* 17.01° 6.75* 2.77* 3.9*
°ns; *p<0.02
Relationship between ZC-P/ZIRI and SIB% is 0.702*.
Conclusions: 1. ZC-P/ZIRI ratio provides an indirect information about the insulin 
receptor function. 2. In obesity the C-P (beta-cell) response during OGTT is 
definitely increased and independent of the phase of obesity. 3. In DO, beside insulin 
hypersecretion, the normal ZC-P/ZIRI ratio indicates insulin resistance resulting 
decreased glucose utilization. 4. Metabolic changes of obesity during childhood are in 
S phase a predictive factor of multimetabolic syndrome (Syndrome X).
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OBESITY IN CHILDREN WITH ACCUMULATED ATHEROSCLEROTIC
FAMILY RISK
T. SZAMOSI, A. SZAMOSI, G. KOVÁCS
II. Department of Pediatrics, Semmelweis University Medical School Budapest,
Hungary
Children whose parents had premature coronary heart disease were investigated. 
BMI, blood pressure (included 24 h monitoring) and serum lipid profile of 1087 (3 - 
18 yr.) children were measured. Thirty-seven of the 61 obese children with a BMI 
above 25 had serum lipid abnormalities (together with high normal blood pressure in 
22 cases). High normal blood pressure as measured by ambulatory blood pressure 
monitor was detected without any lipid abnormalities in 20 cases. These results 
suggest the importance of the measurement of both parameters: the serum lipid 
profile and the 24 h blood pressure in obese children especially in cases with high risk 
atherosclerotic family history.
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MULTIMETABOLIC SYNDROME IN OBESE CHILDREN
G. CSÁBI, D. MOLNÁR
Department of Paediatrics, University Medical School of Pécs, Hungary
The occurrence of multimetabolic syndrome was studied in 114 (63 boys, 51 girls) 
obese children. From the blood sample taken after an overnight fast, blood sugar, 
serum insulin, and lipid levels were determined. During oral glucose tolerance test 
blood sugar concentrations were followed. Body mass index, body fat (on the basis of 
skinfold measurements), lean body mass and waist/hip ratio were calculated and 
blood pressure was measured 6 times in all subjects. Multimetabolic syndrome was 
found in 16% of boys and 19.6% of girls. No significant sex difference in the 
frequency of multimetabolic syndrome was found. Patients with multimetabolic 
syndrome could not be characterized by high waist/hip ratio or any other 
antropometric parameter. The duration of obesity was significantly higher in subjects 
with multimetabolic syndrome than in those not suffering from the syndrome. This 
finding supports the hypothesis that the development of multimetabolic syndrome is 
a process. Authors emphasize the significance of this problem and the importance of 
early recognition and prevention.

WORKSHOP 2: PREVENTION OF CHILDHOOD
OBESITY
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OBESITY IN LONG-TERM SURVIVORS OF CHILDHOOD 
MALIGNANCY
J.T. WARNER1, J.W. GREGORY1, D.K.H. WEBB2
1 Department of Child Health, University of Wales College of Medicine, 2Llandough 
Hospital Cardiff, United Kingdom
Improved survival from childhood malignancy has led to the prediction that by the 
year 2000 approximately of 1 in 1000 adults in their third decade will be a long-term 
survivor of childhood cancer. Numerous adverse sequelae associated with treatment 
are now recognised. We have retrospectively investigated a clinical impression that 
obesity is one of these adverse late effects in two groups of patients. Group 1 (12 
boys and 26 girls) were long-term survivors of acute lymphoblastic leukaemia (ALL) 
treated with prophylactic low dose cranial irradiation (18 Gy and (n=32) or 24 Gy 
(n=6)) and adjuvant cytototoxic chemotherapy. Group 2 (17 boys and 21 girls) were 
long-term survivors of other childhood malignancies who received cytotoxic 
chemotherapy but no radiotherapy. Body mass index (BMI) was calculated at 
diagnosis and 2, 4, 6 and 8 years thereafter and expressed as standard deviation scores 
(SDS).
There was no statistically significant difference in age at diagnosis between the two 
groups (median 3.4, range 0.9-9.9 years for group 1 and median 3.0, range 0.4-13.4 
years for group 2). Mean BMI SDS for all patients (SE of mean) at diagnosis and at 
2, 4, 6 and 8 years thereafter are shown in the table.
Diagnosis 2 years 4 years 6 years 8 years
Group 1 -0.27(0.18) 0.55(0.15)* 0.67(0.18)* 0.76(0.26)f 1.12(0.28)1
Group 2 -0.13(0.21) 0.41(0.18)* 0.28(0.21)# 0.12(0.28) -0.71(0.29)
(*jx0.001; t  p=0.004; ф p=0.003; #p=0.008 compared to BMI SDS at diagnosis).
Both males and females had significant changes in BMI SDS within group 1 at all 
time periods compared to BMI SDS at diagnosis, but within group 2 only the females 
had significant positive changes at 2 and 4 years after diagnosis and not thereafter. 
BMI SDS between groups showed significant differences at 8 years (pcO.001) for all 
patients. Although there was no significant difference between males, females were 
significantly more obese in group 1 than group 2 (p=0.03 and p=0.01) 4 and 8 years 
after diagnosis.
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We conclude that obesity is a late long-term effect of treatment for childhood ALL 
but only temporarily so for other childhood malignancies. This may be as a 
consequence of cranial radiotherapy, though the mechanism in unknown.
Supported by LATCH, Llandough Hospital, Cardiff.
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IS OBESITY PREVENTABLE IN PRADER-WILLI SYNDROM (PWS)? 
THE POSSIBLE ROLE OF GH DEFICIENCY
L. BOSIO, F. BENZI, P. MANZONI, L. BECCARIA
Department of Pediatrics - Endocrine Unit - Scientific institute H San Raffaele - 
University of Milan, Italy
In the last few years relevant amount of evidence about GH deficiency in PWS 
syndrome has been acquired. So far, the efficacy of GH therapy has been reported to 
be successful in improving height velocity, life quality and weight control in few 
PWS children and adolescents. Although an impairment of GH response to different 
diagnostic tests may be due to obese state, the abnormality in GH secretion in PWS 
appears to be more complex and a neurohypothalamic defect is suspected in these 
patients.
We have therefore studied GH secretion in 19 PWS subjects (M/F 10/9; 
age 17.1 ± 5.3; BMI 29.7 ± 7.3 kg/square meter). The diagnosis of PWS was 
determined by chromosome 15 deletion in 48% of subjects, uniparenteral disomy 
(UPD) in 5% had an unbalanced translocation involving chromosome 15.42% of 
patients, without deletion, were included according to the score of Holm et al. (mean 
score: 9.4 ± 0.4). GH secretion has been studied by GH RIA assay after clonidine test 
and GRF+pyridostigmine test. IGF-1 has been measured by RIA. Mean GH peak after 
clonidine was 4±5.4 ng/ml; obese subjects showed mean GH peak values after 
clonidine significantly different from non obese (3 ± 4 vs 13 ± 9 ng/ml, p < 0.006). 
After GRF-P, mean GH peak value was 12.3 ± 10.5 ng/ml; obese subjects showed 
mean GH peak values significantly different from non obese (10 ± 7 vs 
34 ± 12, p < 0.0005). 100% of obese patients showed GH levels less than cut off 
value after clonidine and all but one patient did not normalize GH response after 
GRF-P. Mean IGF-1 values were 128 ± 47, with no differences between obese and 
non-obese subjects. An inverse relationship between BMII and GH response 
(clonidine: r -0.55, p < 0.01; GRF-P: r -0.74; p < 0.0005) was found. A similar 
relationship was seen between age and GH secretion (clonidine: r -0.45, ns; GRF-P: 
r -0.67, p < 0.002). Intractable obesity in PWS children seems to develop together 
with the onset of GH deficiency. Moreover, mean GH peak values in PWS appear 
markedly reduced with respect to normal population even after pyridostigmine, 
suggesting an underlying cause for GH deficiency other then obese state. GH
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deficiency could be a characteristic feature of PWS and a necessary premise for 
obesity development; in this case an adequate follow up programme of GH secretion 
should be able to detect early derangements in order to start substitutive therapy to 
prevent severe obesity.
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SECULAR TRENDS IN BODY MASS INDEX (W/H2) DISTRIBUTIONS AT 
AGES 7-14 YEARS IN A POPULATION OF 142,000 DANISH BOYS BORN
1930 THROUGH 1965
T.I.A. SORENSEN, B.L. THOMSEN, B. RONN
Institute of Preventive Medicine, Copenhagen Health Services and University of 
Copenhagen, DK-1399 Copenhagen K, and Department of Biostatistics, Faculty of 
Health Sciences, University of Copenhagen, Copenhagen, Denmark
Previous studies of Danish young men examined at the draft boards have shown 
that the prevalence of extreme overweight (BMI >31.0  kg/m2) was almost stable at 
about 1 per 1000 from 1943 until 1960. Thereafter a steep increase began, which 
continued until mid-1970s when it levelled off at a several fold higher level. The 
central part of the body mass index distribution, reflected for example in the median 
body mass index, remained unchanged throughout this period, although moderate 
overweight showed a slight increase in the early 1960s. The increase began with the 
birth cohort 1942 and continued until the birth cohorts of the mid-1950s. The 
observation indicates a striking increase during this period in exposure to an 
environmental cause of obesity during childhood or adolescence. To identify the 
cause, it would be helpful to know at what age and in which years the change began.
All schools (public and private, general or specialized) in the Copenhagen 
municipality have carried out annual measurements of height and weight of the pupils 
born 1930 and later. The school health records are available until birth year 1965. We 
have computerized the measurements for all the boys from this period, in total app. 
142,000 subjects. For each measurement the body mass index was computed, and 
interpolations were performed to estimate BMI at exact ages if measurements were 
available before and after the particular age with less than 2 years interval between 
them. The 1, 2.5, 5, 10, 25, 50, 75, 80, 85, 90, 95, 97.5, 99, 99.5 percentiles were 
estimated for each of the ages 7 through 14 years within each birth cohort. In order to 
assess the changes in prevalence of extreme overweight during childhood, the age- 
specific 99.9 percentiles were defined for the birth cohorts 1930-34, and these 
percentiles were then used as definition of extreme overweight throughout.
The lower percentiles including the median of the body mass index distribution (50 
percentile) was remakably stable at all ages throughout this 35-year period. The 75, 
80, and 85 percentiles showed a steady increase from birth year 1930 until a peak at 
birth year 1944, wherafter it levelled off, most pronounced for the higher percentiles
202 Pécs, Hungary, 3-5 November, 1994
and for the older ages and barely detectable at age 7. For the 90, 95, 97.5, 99 and 99.5 
percentiles the same pattern was observed, but peaking later and later.
The prevalence of extreme overweight showed in all age groups a low stable level 
at about 1 per 1000 until the birth cohorts in the early 1940s, whereafter a steep 
increase began, which was most pronounced and most similar to that seen among the 
draftees at age 10.
Thus, there was a complex secular trend in the central part of the BMI 
distributions, which was not directly compatible with the trends in extreme 
overweight among the draftees.
However, the prevalence of extreme overweight in childhood showed virtually the 
same secular trend pattern as it did for the draftees suggesting that the environmental 
exposure leading to extreme overweight began afflicting the birth cohorts 1942 and 
onwards before age 7. The nature of this environmental exposure remains unknown.
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FAMILY FACTORS IN CHILDHOOD AND RISK OF OBESITY IN YOUNG
ADULTHOOD
Inge LISSAU
Department of Paediatrics GGK, Prospective Paediatric Research Unit 7112, National 
University Hospital of Denmark, Denmark
The purpose of the study was to analyze the effect of various family factors in 
childhood on risk of obesity in young adulthood.
In 1974, a simple random selection of children aged 9-10 years from the third 
grade in Copenhagen schools was performed. Ten years later the population was 
followed up and 86 percent of the persons eligible for follow-up participated / 1/. 
Degree of fatness was assessed using the body mass index. The effect of the family 
factors was analyzed by logistic regression analysis with overweight (90th percentile) 
and obesity (95th percentile) as dependent variables.
The results showed that among four social factors quality of dwellings in 
residential area was the most important factor. Being reared in areas with poor quality 
of dwellings increased the risk of becoming overweight more than three times while 
controlling for the effect of body mass index in childhood and sex. Neither parental 
school education nor householder's occupational status had similar effect Д/.
A child whose mother was not aware of her offspring's sweet eating habits had a 
more than fourfold increased risk of overweight compared to children who's mother 
was aware of these habits. Furthermore, having a mother who expressed acceptance 
of eating of sweets or having received much money for sweets during childhood 
doubled the risk of overweight /3/.
Family structure (biological or other parents and siblings) did not significantly 
affect the risk of adult obesity. Parental neglect increased the risk in comparison with 
harmonious support seven folds. Dirty and neglected children had a ten fold increased 
risk of adult obesity compared to averagely groomed children. However, being only 
child receiving overprotective parental support, or being well-groomed had no e. .ect 
/4/.
In conclusion, it seems as if family factors in childhood, especially being 
neglected, greatly influence the risk of being obese in young adulthood. For 
preventive purposes it might be important to identify children suffering from parental 
neglect.
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NUTRIENT INTAKE AND FATNESS DEVELOPMENT
M.F. ROLLAND-CACHERA1, M. DEHEEGER1, M. AKROUT1-
C. ROSSIGNOL2
•iNSERM-ISTA-CNAM 2 rue Conte-75003 Paris, 2CBSE-CPAM 96 rue Amelot-
75011 Paris, France
Nutrition has a strong influence on growth. Obese children show some acceleration 
in height and maturation. This is generally attributed to energy excess, but less is 
known about the role of the composition of the diet on fatness development. On the 
basis of a French longitudinal study of nutrition and growth started in 1985, we 
compared the BMI pattern from birth up to the age of 8 years in 126 children 
according to high, medium and low energy and nutrient intakes at the age of 2 years 
/11/. Fatness development assessed by the BMI or skinfolds display several phases: an 
increase during the first year, followed by a decrease. The subsequent increase 
(named adiposity rebound) occurring at the age of 6 years in average, is associated 
with adult fatness, and bone age. Correlation coefficients between intake (energy and 
nutrients) at the age of two years and age at adiposity rebound show a negative and 
significant association only for the protein content (%) of the diet, i.e., the higher the 
protein content of the diet at the age of two years, the earlier the rebound.
The early rebound reflecting accelerated growth is a precocious characteristic of 
obesity development. It is concluded that protein excess should be avoided early in 
life.
REFERENCE
1. Rolland-Cachera MF (1994). Prediction of adult body composition from infant and
childhood measurements. In body composition techniques in health and diseases. 
Ed Davies PSW and Cole TJ. Cambridge 1994; Cambridge University Press.
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EFFECT OF CHANGES IN BODY COMPOSITION DURING WEIGHT 
LOSS ON REGAIN OF WEIGHT IN OBESE CHILDREN
J. SCHWINGSHANDL, M. BORKENSTEIN
Department of Paediatrics, University of Graz, Austria
Changes in lean body mass associated with changes in metabolic rate during rapid 
weight loss in obese adults have been shown to predispose for later regain of weight 
/1/. Lean body mass and metabolic rate are also closely correlated in children /2/. The 
present study aimed to investigate, whether changes in body composition of obese 
children during rapid weight-loss might predict the medium term outcome.
Body composition was measured before and after a three weeks weight reduction 
program using a non-invasive method (Bioelectrical impedance analysis [BIA]). 
Percentage weight for height was more than 120% in all 41 subjects (19 M, 22 F, age 
8.5 - 14.8 [median 11.8] years).
Mean percentage weight for height at baseline was 151% (SD20) and decreased 
significantly during the three weeks (139% SD18), P = 0.005). Also the mean 
percentage body fat significantly decreased during the three weeks (from 34.0 SD 5.0 
to 31.3 SD 5.1, P = 0.02). Percentage body fat was lower in boys compared with girls 
at baseline (32.3 SD 5.8 vs. 35.1 SD 3.9 %, P = 0.08), this difference reaching 
statistical significance at the end of the three weeks (29.6 SD 5.7 vs 33.3 SD 3.9%, P 
= 0.02). The individual change in body-fat was inversely correlated with the change 
in lean body mass (R= -0.64, P = 0.0001). After 4 months, 18 out of the 41 children 
could be reevaluated for height and weight. The regain in body weight during these 4 
months was positively correlated with the decrease in lean body mass and body cell 
mass during the weight reduction program (R = 0.66, P = 0.003, and R = 0.67, P =
0.003, respectively).
It is concluded that a reduction in lean body mass and body cell mass during rapid 
weight loss predisposes to later regain of weight due to a reduction in resting 
metabolic rate in obese children. This confirms studies in obese adults. Weight 
reduction programs for children should therefore not only focus on caloric restriction 
but also on maintenance of metabolic active tissue. Measuring body composition by 
an easy to perform, non-invasive method (BIA) during a weight reduction program 
might help to improve the longterm outcome by optimising the strategies.
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BIOELECTRICAL IMPEDANCE AS AN EASY METHOD TO STUDY 
CHANGES OF BODY COMPOSITION DURING WEIGHT LOSS IN 
CHILDREN: VALIDATION BY DEUTERIUM DILUTION
M. WABITSCH, U. HENTSCHEL, E. HEINZE, H. MAYER, W. TELLER,
C. FUSCH
Department of Pediatrics I, University of Ulm, Children's Hospital Hochried, Mumau 
and Department of Neonatology, University of Bem, Switzerland
Aims: Many different programmes for weight reduction in children are known. The 
success of such programmes depends also on the changes in body composition during 
weight loss. The best success would be a loss of body fat with no changes in lean 
body mass. Aim of the present study was 1) to establish a relation between total body 
water (TBW) and bioelectrical impedance (BIA) in obese children and 2) to 
investigate the degree of loss of lean body mass during our presently used weight 
reduction programme.
Methods: 67 obese children (23 boys, 44 girls), mean age 13.9 ± 17.2 kg 
participated in a 6 week weight reduction programme with a mean daily energy intake 
of 1000 kcal and a 2 hour sport programme every day. At the beginning (day 2) and 
at the end (day 38) of the weight reduction programme the following measurements 
were performed: skinfold thickness at 4 sites (ST), BIA using an AKERN 101, and 
TBW (oral load of 0.4 mL 99.8% D20/kg BW, pre-dose and post-dose urine and post­
dose serum sample, analysis of 2H enrichment as described by Fusch 1993).
BW(kg) ST (mm) H2/l(cm2/omega) TBW(L) TBW(BW(%))
Day 2 84.3+17.2 101.7+24.6 54.6+12.6 35.3+6.9 41.6+4.2
Day 38 75.7+14.9 81.9+20.7 53.7+12.8 35.6+6.8 46.2+5.4
Results: see table; linear regression revealed a significant correlation between TBW 
and BIA before (r = 0.906) and after (r =0. 013) weight loss.
Discussion: 1) TBW was constant during weight loss suggesting no changes in lean 
body mass. Weight loss seems to be merely due to loss of fat mass. 2) A close 
relationship between BIA and TBW was found which was stable during weight loss. 
Equation formulas for the calculation of TBW from BIA are going to be presented.
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BODY COMPOSITION OF CHILDREN BY SKINFOLD AND BIA
METHODS
É. ERHARDT, D. MOLNÁR
Department of Paediatrics, University Medical School of Pécs, Hungary
The exact assessment of body composition in children is a difficult task. A great 
variety of techniques for assessing human body composition have been developed and 
used.
The aim of the present study was to evaluate the reliability and reproducibility of 
body composition assessed by bioelectrical impedance analyzer (BIA) and to compare 
it with conventional skinfold methods. The subjects in this study were Hungarian 
children (40 males, 60 females ; age: 6-19.3 years; 32 obese children, 68 non-obese 
children). Skinfold thicknesses were measured by Holtain caliper, and impedance was 
determined using the BIA 101, RJL systems, Detroit MI, USA equipment. The 
measurements were done by two observers, twice in a week to determine the intra- 
and inter-observer variability. Data were elaborated by SOLO Statistical Programme 
(BMDP Statistical Software, Los Angeles, California).
The amount of lean body mass (LBM) was determined by different equations (for 
skinfold: Parizkova, Brook-Durnn-Rahaman, Deurenberg; for impedance:
Deurenberg, Newman, Schaefer, Weight Manager Programme). LBM values of 
normal children estimated by different impedance and skinfold equations were 
similar, except that calculated by the Schaefer equation, which grossly 
underestimated the LBM. Whereas in obese children the calculated LBM values were 
much more equation dependent. The inter-observer error was markedly lower in 
impedance measurements compared to skinfold measurements.
Advantage of BIA technique is, that it can be used throughout childhood, it is 
painless, rapid, and independent of inter-observer variability. Disadvantage of the 
method is, that recently no age, sex and population specific equations are yet 
available.
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INCREASED POSTABSORPTIVE FAT OXIDATION IN OBESE 
CHILDREN: A METABOLIC DEFENCE TO FURTHER WEIGHT GAIN?
C. MAFFEIS1, L. PINELLI1, Y. SCHUTZ2
1 Department of Pediatrics, University of Verona, Italy; institu te of Physiology, 
University of Lausanne, Switzerland
This study was performed to measure the postabsorptive fat oxidation at rest and to 
assess the association between fat mass and fat oxidation in a group of 72 prepubertal 
children. Children were divided into two groups: 35 obese (weight: 44.5 ± 9.7 kg, 
FM: 31.7 ± 5.4%) and 37 non obese (weight: 30.8 ± 6.8 kg, FM: 17.5 ± 6.7%). 
Postabsorptive metabolic rate was measured by means of indirect calorimetry 
(Deltatrac, Datex Inc., Finland) and fat mass by anthropometry.
Postabsorptive fat oxidation expressed in absolute value was significantly higher in 
obese than in nonobese children (31.4 ± 9.7 vs 21.9 ± 10.2 mg/min, P < 0.001) but 
not when adjusted for fat-free mass by ANCOVA, using FFM as the covariate (28.2 ± 
10.6 vs 24.9 ± 10.5 mg/min). In the obese children, as well as in the total group, fat 
mass and fat oxidation were significantly correlated (r = 0.651, P < 0.001). The slope 
of the relationship indicated that for each 10 kg additional fat mass in these children, 
fat oxidation increased by 18 g/day.
In conclusion, obese prepubertal children have a higher postabsorptive rate of fat 
oxidation than nonobese children. This metabolic process may favour the 
achievement of a new equilibrium in fat balance, opposing adipose tissue gain.
Supported by the National Research Council, project "Prevention and control 
disease factors", subproject No. 7, contract No. 94.00. 164PF41.
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LIPOPROTEIN LIPASE AND HEPATIC LIPOPROTEIN LIPASE 
ACTIVITY IN OBESE CHILDREN DURING WEIGHT REDUCTION
E. MALTECKA-TENDERA, D. PISKORSKA, B. KOEHLER, A. RAMOS, 
B. DOBROWOLSKA-WICIAK
Department of Pediatric Endocrinology, Silesian Medical Academy, Katowice,
Poland
The objective of this study was to investigate the changes on plasma lipoprotein 
lipase activity (LPL) and hepatic lipoprotein lipase activity (HLPL) and then- 
relationship to the amount of weight loss and changes in plasma lipids in obese 
children during weight reduction.
Thirty obese children (20 girls and 10 boys) in the mean age of 14 ± 2 years, with 
the mean weight excess of 75 ± 16% and body mass index (BMI) 29 ± 4 were treated 
with 900 Kcal diet for three weeks. Dietary treatment resulted in a significant weight 
reduction of 14 ± 6%, and a significant decrease in LPL and HLPL activity 
(from 37.5 ± 12.0 to 25.9 ±13.3 pmol FFA/min/ ml; p <  0.001, and from 35.9 ± 
10.1 to 28.2 ± 9.8 pmol FFA/min/ml; p < 0.001, respectively).
The amount of weight loss correlated weakly but significantly with the decrease in 
LPL activity (R = 0.42, p = 0.02), but showed no correlation with the HLPL activity.
Weight reduction resulted in a significant decrease in total cholesterol level 
(from 4.3 ± 1.1 to 3.6 ± 1.1 mmol/1; p < 0.001) and HDL3 cholesterol level (from 
1.04 ± 0.3 to 0.71 ± 0.2 mmol/l; p < 0.001). HDL2 cholesterol and triglycerides 
remained almost constant. LPL and HLPL activities showed no significant correlation 
with the lipid levels.
These findings suggest that the amount of weight loss may be related to the 
suppression of LPL activity during the period of weight reduction. Our data do not 
confirm the suggestion that HLPL activity is closely related to the HDL2 cholesterol 
levels.
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INHIBITED PLASMA DELTA 6 DESATURASE ACTIVITY AND 
ABNORMAL MEMBRANE ESSENTIAL FATTY ACID (efa) PATTERN IN 
OBESE CHILDREN. IMPACT OF WEIGHT LOSS
M L. FRELUT2, P. THEROND1, M.C. CAMUSO1, K. BENALI1,
L. CATHELINEAU2, J. NAVARRO1
Gastroenterology, Biochemestry, Biostatistics Depts Hospital Robert Debré, Unité 
Inserm 321, Paris, 2Centre Thérapeutique Pédiatrique, Margency, France
Weight gain leads to the accumulation and further release of the fat cell content 
which is poorly known. Adequate amounts of EFA are required in order to promote 
growth and development. The aim of this study is 1) to determine if obesity induces 
changes in desaturase activity and membrane and plasma EFA pattern in obese 
children, 2) to evaluate the impact of weight loss. Plasma delta 6 desaturase activity 
was measured by mean of the 18:3 n-6/18:2 n-6 ratio. The molecular species, 
principally those containing linoleic, arachidonic and docosahexaneoic acids of 
phosphadidylethanolamine (PE) and phosphatidylicholine (PC) of erythrocyte 
membranes were measured by high performance liquid chromatography (HPLC), 
plasma EFA pattern by gas liquid chromatography, non-esterified fatty acids (NEFA) 
by enzymatic assay. HPLC results are expressed as a percentage of PE or PC 
molecular species.
20 obese children were studied before and after weight loss (weight/size2 
= 32.1 ± 3.8 vs 26.6 ± 2.5kg/m2, p = .001) and compared to 5 controls. Weight loss 
leads to a decrease in NEFA (0.84 ± 0.25 vs 0.46 ±0 .19  mmol/1, p = .001), and 
increased delta 6 desaturase activity (.024 ± .011 vs .038 ±. 014, p = .0001), and 
plasma long chain FA content (20 : 3 n-6 , 20 : 4 n-6, 20 : 5 n-3, p = .001). Membrane 
PE 16 : 0/20 : 4 n-6 is low in cases vs control before weight loss (14.83 ± 1.67% vs 
37.09 ± 6.54%, p = 0.0001) and does not turn to normal with weight loss. PC 16 : 
0/20 : 4 n-6 raises above control values after weight loss (19.27 ± 2.09 vs 15.42 ± 
3.62%, p = .006). Delta 6 desaturase activity is negatively correlated with 1 8 : 2  n-6 
PC (n= -.48, p < .05) and positively with 22 : 6 n-6 PC (r = +.8, p < .01) content 
before weight loss. Obesity significantly afters EFA metabolism in children. Weight 
loss leads to a significant but limited improvement.
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PLASMA RETINOL AND TOCOPHEROL VALUES IN OBESE CHILDREN
T. DECSI1, D. MOLNÁR1, B. KOLETZKO2
department of Paediatrics, University Medical School of Pécs, Hungary, 
2Kinderpoliklinik der Ludwig-Maximilians-Universität, Munich, Germany
The metabolic and endocrinological disturbances of obesity may influence vitamin 
status. Subnormal vitamin A (retinol, RET) and E (tocopherol, TOCO) values were 
reported for obese adults (Eur J Clin Nutr 46: 803, 1993; J Int Med 234: 53, 1993). 
We are unaware of data on vitamin A and E values in obese children (OB).
Subjects and methods: Plasma RET and TOCO concentrations were measured with 
high performance liquid chromatography in 17 OB (10 boys and 7 girls, age: 13.9 ± 
1.4 years, mean ± SD) and related to anthropometric parameters and plasma 
cholesterol (CHOL), triglyceride (TG) and basal immunoreactive insulin (IRI) 
concentrations.
Results: Mean body weights (BW) were 88.9 ±21.7 kg, body heights (BH) 165 ± 
10 cm, relative body weights (RBW) 165 ± 24%, body fat contents (BF) 39 ± 5% and 
lean body masses (LBM) 54.3 ± 13.5 kg. Plasma concentrations of CHOL, TG and 
IRI were 4.31 ± 0.62 mmol/1, 1.43 ± 0.45 mmol/1, and 17.2 ± 6.5 pU/ml, respectively. 
Plasma RET concentrations were 0.58 ± 0.19 pg/ml. Plasma alpha-TOCO, 
beta+gamma-TOCO and delta-TOCO concentrations were 7.98 ± 2,84, 0.68 ± 0.28 
and 0.02 ± 0.01 pg/ml, respectively. Mean RET, alpha-TOCO and alpha- 
TOCO/CHOL (1.83 ± 0.61 pg/pmol) values were close to those reported for healthy 
children aged 12-13 years (RET: 0.42 (0.24 - 0.66| and alpha-TOCO: 8.80 [4.8 - 
13.1] pg/ml, alpha-TOCO/CHOL:2.06 (1.42 - 2.60] pg/pmol, median [range], n = 77, 
(Int J Epidemiol 22: 237, 1993). Neither plasma RET, nor TOCO concentrations were 
related to the age of OB. Plasma RET concentrations were positively related to BW, 
BH and LBM, whereas significant inverse correlations were seen between plasma 
alpha-TOCO concentrations and BF and IRI (Table). Alpha-TOCO referred to CHOL 
or CHOL CHOL + TG (1.39 ±0.49 pg/pmol) were also inversely related to IRI 
(r = -0.59, P < 0.05 and r=-0.57, P<0.05).
222 Pccs, Hungary, 3-5 November, 1994
TABLE
Linear correlation coefficients (г) (*P<0.05, **P<0.01).
BW BH BF LBM IRI
Retinol 0.60* 0.65** -0.22 0.68** -0.08
alpha-TOCO -0.18 0.08 -0.49* -0.03 -0.53*
Conclusions: 1. Mean retinol and alpha-tocopherol concentrations in obese 
children were comparable with those in healthy children. 2. Plasma retinol 
concentrations were positively related to body size, particularly LBM, but not to body 
fat. In contrast, plasma alpha-tocopherol concentrations were not related to body size, 
but were inversely related to body fat. 3. Plasma alpha-tocopherol concentrations 
were inversely related to IRI (a parameter indicative of glucose intolerance), even 
after correction for lipidaemia. 4. Since oxidation of low-density-lipoproteins is 
causally involved in atherogenesis (Lancet 339: 1183, 1992) and preceeded by the 
loss of endogenous antioxidants (Am J Clin Nutr 53: 314, 1991), obese children with 
pronounced obesity (high BF) andor/or advanced glucose intolerance (high IRI) may 
be at risk of subnormal antioxidant protection by tocopherols.
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ROLE OF THE CRITERION USED TO DEFINE FETAL HYPERTROPHY 
IN RELATION WITH THE RISK OF OBESITY AT AGE 6
Y. LEHINGUE1, M. MIGINIAC1, E. LOCARD2, N. MAMELLE1 
'inserm U 265, 69424 Lyon Cédex 03; 2ADES du Rhone, 69002 Lyon, France
Fetal hypertrophy is a recognized factor of childhood obesity. We have examined 
how the definition of fetal hypertrophy influences this relation. The weight and size 
of French children are routinely recorded from birth in a so-called health book. The 
data of 9261 children in the Lyon area have been collected and studied in 1989 as 
they entered primary school. 6.2% of these children had a weight two standard 
deviations above the size-related average of the reference French population. This 
limit has been chosen as the criterion for obesity at age 6. Fetal hypertrophy was 
associated with a higher risk of later obesity, which varied according to the definition 
chosen. In act, the relative risk ranged from 1.70 to 2.14, according to whether the 
criterion of fetal hypertrophy was a single weight limit (gestational age and sex taken 
into account)(common attitude) or additional constitutional features were also 
considered. The definition that also takes the mother's size and weight and the birth 
order into account had a stronger predictive power for obesity, than the "common 
attitude".
Conclusion: 1. among the definitions tested, the new definition is associated with 
the highest risk of obesity; 2. children who were regarded as hypertrophic on the basis 
of the common attitude and who were not selected according to this new definition do 
not present with a significantly increased risk of obesity.
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CHANGE IN THE INCIDENCE OF CHILDHOOD OBESITY DURING THE
LAST DECADE
I. DÓBER
Department of Child Health, Pécs, Hungary
The aim of the present study was 1. to determine the prevalence of obesity in the 
town of Pécs, in 1993; 2. to relate these results to the incidence of obesity measured 
10 years earlier, in 1983. Methods: anthropometric survey was carried out to 
determine the prevalence of obesity in a representative sample of 3529, 6-18 years old 
schoolchildren. Triceps skinfold above the 90th percentiles on a local standard was 
the criterion of obesity. To evaluate the change in the incidence of obesity between 
1983 and 1993 the two results were compared.
Conclusion: the incidence of obesity among schoolchildren in the town of Pécs has 
increased during the last ten years.
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REPORT ABOUT A TRAINING-EDUCATING-NURSING CENTRE OF 
OBESE CHILDREN IN THE FACULTY OF HEALTH SCIENCES IN
BUDAPEST
Magdolna RÔDÉ
Haynal Imre University of Health Sciences, Faculty of Medical Sciences, Budapest,
Hungary
The Department of Medical Sciences was instituted on I July, 1994 in our Faculty. 
The Faculty of Health Sciences in multilateral, preparing programmes for a wide 
range of the paramedical professions (health visitors, physiotherapists, dieteticians, 
etc.). One of the planned programmes is a consultation for obese children. This 
consultation - as a complex health preserving, illness-preventing training-educating- 
nursing activity - is based on the speciality of the Faculty and serves this pedagogical 
purpose.
The consultation has a very good and fruitful relationship with the Hungarian 
Foundation for the Study of Obesity. Our poster demonstrates the program of the 
project and the expected favourable consequences. The incorporation of obesitology 
into the graduate and postgraduate education, as well as the edition of a textbook 
about obesitology are important future plans.
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EXPERIENCES ON DIETARY TREATMENT OF CHILDREN WITH 
OVERWEIGHT (FATTY CAMPS)
Z. HORVÁTH
St. Rókus Hospital, Budapest, Hungary
Nowadays obesity give us much trouble. The frequency of obesity is increasing, 
due to inadequate feeding and physical inactivity. In childhood nutritional habits can 
be influenced easier than in adults. Children do not suffer from the diseases that are 
considered to be the consequences of obesity such as coronary diseases, hypertension, 
type II diabetes, some types of cancer etc. Therefore, early weight reduction programs 
can prevent the late consequences.
Three camps were held in summer-time between 1987 and 1989. The conception 
was that the low calorie diet alone cannot result in lasting weight loss, but physical 
training, manual occupations, psychological treatment and education all together 
conduce to acquire a healthy lifestyle. The different specialists (dietetician, 
psychologist, gymnast, educationalist) worked in a team, and their group occupations 
were held like revolving stage. The diets contained 1200 calories, 12-18% 
proteins, 20-25% fat and 58-60% carbohydrates with no sugar added. The main meals 
consisted of vegetables, fruits and other high dietary fibre containing foodstuffs 
completed with meat, cold plates, milk products, fish, poultry and some soya 
products. Great emphasis was given to teach the children how to continue the diet at 
home, and show them as wide assortment of low calorie meals as it was possible 
during the two weeks of the camps. Children were given 5 meals a day in the same 
time every day. Courses were held on nutritional physiology, on different slimming 
diets, on cookery, on the main components of light meals for the children as well as 
for the parents during the family weekend.
One hundred and seven children from 9 to 16 years of age took part in our 3 
camps. They had 2 to 31 kilograms overweight as calculated with the modified Broca 
index. During the two weeks 96% of them lost 0.5 to 8.5 kg. None of them gained 
weight. Analysing the nutritional habits of these children we found that the main 
causes of childhood obesity were the abundant feeding, the incorrect rhythm of meals, 
the physical inactivity, and some familial and psychological effects.
The success of the slimming program can be measured not only by the kilograms 
lost during the two-week camp, but by the effectiveness of the education which may 
result in decreasing obesity in the families of the children attending the Fatty Camps.
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SELECTED PHYSICAL PARAMETERS OF CZECH OIJESE CHILDREN 
AND CHANGES WHICH OCCURRED DURING THE REDUCTION
PROGRAM
P. BLÁHA, L. LISÁ, V. VANCATA, J. SRAJER
Institute of Sport Medicine Prague, Nad Královskou oborou 53, 170 00 Praha 7, 
Czech Republic; 1st Department of Paediatrics, 2nd Medical School, Charles 
University Prague 5-Motol, Czech Republic
The development of body built and its changes in ontogenetic development of 
obese children differs from the normal population. To cover its development and the 
objective evaluation of obese children therapy primarily directed to body mass 
decrease the processing of data on body height and body mass of 3865 Czech obese 
boys and girls in age from 6 up to 16 years was conducted by the standard 
anthropometric technique of Martin and Sailer. Body composition was determined by 
Matiegka's equations. The pair T-test was used as a criterion for the evaluation of the 
significance of a given measurement with respect to successfulness where a decrease 
of body mass was the main aim. On the basis of the pair T-test results we settled the 
order of importance of selected circumferential diameters and thickness’ of skinfolds. 
Matiegka's equations for the Czech population are recommended to determine the 
components of body composition. For a more objective use the BMI index should be 
differentiated into body fat component and the lean body mass component.
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